Table A.1 U.S. Incidence Counts of Reported ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 AGE AT ESRD 0- 4 120 130 123 136 121 144 128 185 193 181 5- 9 90 112 138 119 107 114 152 157 141 135 10-14 200 188 207 217 209 217 233 281 260 267 15-19 443 502 466 416 457 451 503 550 566 486 20-24 814 807 828 856 931 886 945 1030 1017 887 25-29 1306 1467 1468 1486 1492 1496 1671 1660 1661 1571 30-34 1747 1968 1988 2041 2133 2156 2386 2511 2444 2262 35-39 2077 2206 2340 2488 2749 2667 3084 3331 3347 3113 40-44 2131 2443 2744 3064 3229 3173 3542 4139 4284 3967 45-49 2304 2727 2804 3171 3526 3721 4360 4959 5247 5041 50-54 2878 3123 3319 3504 3999 4125 5047 5544 5696 5895 55-59 3562 3922 4155 4464 4905 4912 5969 6504 6700 6848 60-64 4672 5178 5528 6055 6379 6471 7352 8151 8346 8469 65-69 5345 6443 7086 7632 8271 8556 9403 9659 10025 10759 70-74 4559 5535 6117 6996 7900 8408 9387 9694 10475 11297 75-79 3409 4187 4577 5295 5945 6214 7045 7455 8218 9439 80-84 1657 2099 2401 2698 3199 3435 3979 4325 4831 5800 85 plus 592 804 962 1098 1274 1478 1613 1854 2197 2685 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37906 43841 47251 51736 56826 58624 66799 71989 75648 79102 RACE White 25208 29138 31626 34439 37543 38420 42948 45276 47654 51171 Black 10824 12924 13629 15094 16729 17331 20108 21756 22574 22926 Asian 1120 957 1159 1307 1448 1701 2174 2470 2584 2383 Native Amer. 494 583 640 684 847 780 967 1188 1315 928 Other 163 121 92 99 114 193 370 1139 1387 1558 Unknown 97 118 105 113 145 199 232 160 134 136 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37906 43841 47251 51736 56826 58624 66799 71989 75648 79102 SEX Male 20494 23660 25606 27797 30268 31336 35351 37962 40535 42129 Female 17412 20181 21645 23939 26558 27288 31448 34027 35113 36973 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37906 43841 47251 51736 56826 58624 66799 71989 75648 79102 PRIMARY DIAGNOSIS Diabetes 11818 14404 16261 18671 20800 21319 25656 29149 31643 33096 Hypertension 10788 12786 14033 15626 17549 17333 20286 18670 19296 20066 Glomeruloneph. 5393 5863 6067 6152 6396 6439 7314 7817 7967 7390 Cystic Kidney 1282 1307 1458 1526 1620 1624 1777 1925 1815 1772 Other Urologic 693 772 804 891 887 888 1035 1344 1507 1388 Other Cause 3922 4453 4540 5016 5436 5400 6358 8043 8368 8284 Unknown Cause 2427 2209 2289 2551 2885 2621 2794 2646 2946 2920 Missing Cause 1583 2047 1799 1303 1253 3000 1579 2395 2106 4186 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37906 43841 47251 51736 56826 58624 66799 71989 75648 79102 U.S. 37739 43660 47077 51499 56520 58135 65666 71658 75518 79030 Presumed U.S. 167 181 174 237 306 489 1133 331 130 72 Puerto Rico 477 550 554 604 707 666 846 848 937 979 Other non-U.S. 49 58 68 75 77 88 104 123 131 167 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 38432 44449 47873 52415 57610 59378 67749 72960 76716 80248 Age is as of start of ESRD therapy. Table A.2 1997 Incidence Counts of Reported ESRD Therapy by Age, Sex, and Primary Disease Causing ESRD for Patients Residing Outside 50 States and D.C. --------------------------------------------------- | |Puerto Rico |Other non-US| | |------------+------------| | | Count | Count | |-----------------------+------------+------------| |ALL PATIENTS | 979| 167| |AGE AT ESRD | | | |0-19 | 13| 1| |20-44 | 127| 34| |45-64 | 440| 69| |65-74 | 226| 54| |75 plus | 173| 9| |SEX | | | |Male | 573| 86| |Female | 406| 81| |PRIMARY DIAGNOSIS | | | |Diabetes | 540| 91| |Hypertension | 154| 35| |Glomeruloneph. | 111| 7| |Cystic Kidney | 19| 4| |Other Urologic | 29| 2| |Other Cause | 63| 11| |Unknown Cause | 25| 4| |Missing Cause | 38| 13| --------------------------------------------------- Age is as of start of ESRD therapy. Table A.3 Incidence Rates per Million Population of Reported ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD Unadjusted 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 AGE AT ESRD 0- 4 7 7 7 7 6 7 6 9 10 9 5- 9 5 6 8 7 6 6 8 8 7 7 10-14 12 11 12 12 12 12 12 15 14 14 15-19 24 28 26 24 27 26 28 30 30 25 20-24 41 42 43 45 49 47 51 57 58 51 25-29 60 68 69 72 74 76 87 88 87 83 30-34 82 91 91 92 96 97 108 115 115 109 35-39 109 113 117 121 130 123 140 149 148 138 40-44 132 144 154 163 172 165 180 204 206 186 45-49 178 203 203 225 230 234 261 284 285 273 50-54 262 279 292 301 332 324 382 406 409 389 55-59 332 372 397 428 468 460 546 586 590 582 60-64 433 484 521 572 611 632 729 811 835 842 65-69 544 647 703 761 829 855 944 973 1013 1102 70-74 584 700 762 849 933 976 1075 1098 1193 1293 75-79 577 695 745 844 930 960 1072 1115 1196 1336 80-84 447 549 610 669 774 809 915 968 1060 1249 85 plus 205 271 316 345 385 431 455 507 584 694 0-19 12 13 13 12 12 13 14 16 15 14 20-44 82 90 94 98 104 102 115 125 126 117 45-64 295 326 342 368 389 388 447 481 484 473 65-74 562 671 730 801 877 911 1005 1032 1098 1192 75 plus 453 553 605 674 753 786 874 920 1003 1151 RACE White 122 140 151 163 176 179 198 208 217 231 Black 364 429 446 485 528 539 616 657 674 675 Other 217 195 209 220 244 265 333 427 452 405 SEX Male 172 197 211 226 243 249 278 295 312 322 Female 139 159 169 185 204 207 236 253 259 271 PRIMARY DIAGNOSIS Diabetes 48 58 65 74 82 83 99 111 119 124 Hypertension 44 52 56 62 69 67 78 71 73 75 Glomeruloneph. 22 24 24 24 25 25 28 30 30 28 Cystic Kidney 5 5 6 6 6 6 7 7 7 7 Other Urologic 3 3 3 4 3 3 4 5 6 5 Other Cause 16 18 18 20 21 21 24 31 32 31 Unknown Cause 10 9 9 10 11 10 11 10 11 11 Missing Cause 6 8 7 5 5 12 6 9 8 16 CRUDE RATE 155 178 189 205 223 227 257 274 285 296 Includes residents of 50 states and District of Columbia only. The reporting and coding of race changed in 1982. Rates are not reported for some race categories for reasons discussed in notes at beginning of this Section. The population base is U.S. resident population on July 1 of each year. Age is as of start of ESRD therapy. See Tables A.6 and following for rates adjusted for age, race, and sex. Table A.4 Incidence Counts of Reported ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD after Dropping Patients With Race "Other" and "Unknown" 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 AGE AT ESRD 0- 4 116 124 121 132 115 138 121 169 177 167 5- 9 90 110 132 117 100 109 147 149 132 129 10-14 195 180 203 211 200 212 225 271 245 254 15-19 435 499 455 410 447 440 490 533 543 450 20-24 802 795 817 844 919 867 926 994 977 837 25-29 1281 1442 1454 1466 1476 1478 1638 1615 1609 1504 30-34 1728 1948 1975 2023 2114 2122 2354 2444 2357 2191 35-39 2056 2186 2324 2466 2730 2651 3028 3270 3262 3024 40-44 2116 2430 2724 3048 3210 3144 3492 4048 4160 3857 45-49 2276 2714 2783 3154 3507 3690 4313 4844 5120 4902 50-54 2858 3110 3302 3492 3979 4090 4996 5404 5558 5712 55-59 3542 3905 4144 4445 4892 4896 5906 6348 6519 6662 60-64 4653 5154 5515 6044 6359 6438 7277 7989 8138 8255 65-69 5326 6419 7072 7613 8248 8512 9343 9488 9878 10563 70-74 4538 5518 6102 6980 7877 8369 9351 9617 10351 11145 75-79 3392 4172 4570 5291 5928 6190 7019 7389 8132 9349 80-84 1651 2093 2399 2693 3195 3418 3965 4279 4791 5754 85 plus 591 803 962 1095 1271 1468 1606 1839 2178 2653 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37646 43602 47054 51524 56567 58232 66197 70690 74127 77408 RACE White 25208 29138 31626 34439 37543 38420 42948 45276 47654 51171 Black 10824 12924 13629 15094 16729 17331 20108 21756 22574 22926 Asian 1120 957 1159 1307 1448 1701 2174 2470 2584 2383 Native Amer. 494 583 640 684 847 780 967 1188 1315 928 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37646 43602 47054 51524 56567 58232 66197 70690 74127 77408 SEX Male 20361 23509 25497 27677 30131 31127 35044 37270 39763 41261 Female 17285 20093 21557 23847 26436 27105 31153 33420 34364 36147 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37646 43602 47054 51524 56567 58232 66197 70690 74127 77408 PRIMARY DIAGNOSIS Diabetes 11773 14384 16238 18640 20752 21229 25448 28581 30937 32351 Hypertension 10761 12755 14011 15609 17522 17293 20155 18465 19077 19808 Glomeruloneph. 5347 5833 6040 6131 6374 6406 7241 7643 7792 7209 Cystic Kidney 1276 1305 1456 1521 1620 1617 1762 1899 1789 1750 Other Urologic 690 772 802 889 886 883 1025 1328 1486 1369 Other Cause 3907 4440 4532 5003 5421 5380 6290 7920 8225 8156 Unknown Cause 2411 2195 2279 2540 2869 2608 2764 2598 2879 2854 Missing Cause 1481 1918 1696 1191 1123 2816 1512 2256 1942 3911 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 37646 43602 47054 51524 56567 58232 66197 70690 74127 77408 Includes residents of 50 states and District of Columbia only. This table reports cases which are excluded in most of the following tables because race is Other or Unknown. Note that the "missing" disease group is disproportionately represented. Table A.5 Percent Decrease In Incidence Counts of Reported ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD after Dropping Patients with Race "Other" and "Unknown" 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 AGE AT ESRD 0- 4 3.3 4.6 1.6 2.9 5.0 4.2 5.5 8.6 8.3 7.7 5- 9 0.0 1.8 4.3 1.7 6.5 4.4 3.3 5.1 6.4 4.4 10-14 2.5 4.3 1.9 2.8 4.3 2.3 3.4 3.6 5.8 4.9 15-19 1.8 0.6 2.4 1.4 2.2 2.4 2.6 3.1 4.1 7.4 20-24 1.5 1.5 1.3 1.4 1.3 2.1 2.0 3.5 3.9 5.6 25-29 1.9 1.7 1.0 1.3 1.1 1.2 2.0 2.7 3.1 4.3 30-34 1.1 1.0 0.7 0.9 0.9 1.6 1.3 2.7 3.6 3.1 35-39 1.0 0.9 0.7 0.9 0.7 0.6 1.8 1.8 2.5 2.9 40-44 0.7 0.5 0.7 0.5 0.6 0.9 1.4 2.2 2.9 2.8 45-49 1.2 0.5 0.7 0.5 0.5 0.8 1.1 2.3 2.4 2.8 50-54 0.7 0.4 0.5 0.3 0.5 0.8 1.0 2.5 2.4 3.1 55-59 0.6 0.4 0.3 0.4 0.3 0.3 1.1 2.4 2.7 2.7 60-64 0.4 0.5 0.2 0.2 0.3 0.5 1.0 2.0 2.5 2.5 65-69 0.4 0.4 0.2 0.2 0.3 0.5 0.6 1.8 1.5 1.8 70-74 0.5 0.3 0.2 0.2 0.3 0.5 0.4 0.8 1.2 1.3 75-79 0.5 0.4 0.2 0.1 0.3 0.4 0.4 0.9 1.0 1.0 80-84 0.4 0.3 0.1 0.2 0.1 0.5 0.4 1.1 0.8 0.8 85 plus 0.2 0.1 0.0 0.3 0.2 0.7 0.4 0.8 0.9 1.2 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 0.7 0.5 0.4 0.4 0.5 0.7 0.9 1.8 2.0 2.1 SEX Male 0.6 0.6 0.4 0.4 0.5 0.7 0.9 1.8 1.9 2.1 Female 0.7 0.4 0.4 0.4 0.5 0.7 0.9 1.8 2.1 2.2 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 0.7 0.5 0.4 0.4 0.5 0.7 0.9 1.8 2.0 2.1 PRIMARY DIAGNOSIS Diabetes 0.4 0.1 0.1 0.2 0.2 0.4 0.8 1.9 2.2 2.3 Hypertension 0.3 0.2 0.2 0.1 0.2 0.2 0.6 1.1 1.1 1.3 Glomeruloneph. 0.9 0.5 0.4 0.3 0.3 0.5 1.0 2.2 2.2 2.4 Cystic Kidney 0.5 0.2 0.1 0.3 0.0 0.4 0.8 1.4 1.4 1.2 Other Urologic 0.4 0.0 0.2 0.2 0.1 0.6 1.0 1.2 1.4 1.4 Other Cause 0.4 0.3 0.2 0.3 0.3 0.4 1.1 1.5 1.7 1.5 Unknown Cause 0.7 0.6 0.4 0.4 0.6 0.5 1.1 1.8 2.3 2.3 Missing Cause 6.4 6.3 5.7 8.6 10.4 6.1 4.2 5.8 7.8 6.6 ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ 0.7 0.5 0.4 0.4 0.5 0.7 0.9 1.8 2.0 2.1 Includes residents of 50 states and District of Columbia only. This table reports cases which are excluded in most of the following tables because race is Other or Unknown. Note that the "missing" disease group is disproportionately represented. Table A.6 Incidence Rates per Million Population of Reported ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD Adjusted for Age, Race, and Sex 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 AGE AT ESRD 0- 4 6 7 6 7 6 7 6 8 9 8 5- 9 5 6 7 6 5 6 8 8 7 6 10-14 12 11 12 12 11 11 12 14 13 13 15-19 23 26 25 23 25 24 26 28 28 23 20-24 40 40 42 43 47 44 48 52 53 45 25-29 59 66 68 70 72 74 83 83 82 77 30-34 82 90 90 92 95 95 106 111 109 104 35-39 111 115 119 122 131 124 139 147 145 133 40-44 140 153 162 170 177 169 183 205 205 184 45-49 188 217 216 240 247 250 278 297 295 278 50-54 280 298 311 322 354 347 411 430 433 410 55-59 365 403 431 463 506 496 583 617 621 608 60-64 482 538 577 627 671 688 784 864 879 884 65-69 613 721 788 849 920 943 1032 1045 1089 1167 70-74 668 800 863 952 1047 1102 1209 1238 1328 1425 75-79 677 801 871 978 1075 1097 1241 1282 1369 1505 80-84 553 681 751 830 947 985 1108 1162 1278 1476 85 plus 306 363 438 480 525 565 614 667 790 897 0-19 11 12 12 12 12 12 13 14 14 13 20-44 86 93 96 99 104 101 112 120 119 109 45-64 329 364 384 413 444 445 514 552 557 545 65-74 640 760 825 901 983 1023 1120 1142 1209 1296 75 plus 512 615 687 763 849 882 988 1037 1146 1292 RACE White 120 137 147 158 170 172 190 198 206 218 Black 477 564 588 641 696 708 802 846 865 873 Asian 252 197 232 244 256 289 348 383 387 344 Native Amer. 397 465 490 507 629 563 657 782 849 586 SEX Male 196 223 239 256 274 278 308 321 339 348 Female 133 152 161 175 191 192 218 231 234 242 PRIMARY DIAGNOSIS Diabetes 50 60 67 76 83 84 99 109 117 120 Hypertension 47 54 59 64 71 69 79 71 72 73 Glomeruloneph. 23 24 25 25 26 25 28 29 29 27 Cystic Kidney 6 6 6 6 7 6 7 7 7 6 Other Urologic 3 3 3 4 4 3 4 5 6 5 Other Cause 16 18 19 20 22 21 24 30 31 30 Unknown Cause 10 9 9 10 11 10 11 10 11 11 Missing Cause 6 8 7 5 4 11 6 9 7 15 CRUDE RATE 154 177 189 204 222 226 254 269 280 289 ADJUSTED RATE 161 183 195 210 227 230 257 271 280 287 Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. All rates are therefore slightly low but are consistently defined and are comparable. The bias introduced by excluding the cases with race Other or Unknown is unpredictable. Age is as of start of ESRD therapy. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. Rates by age are adjusted for race and sex. Rates by sex are adjusted for race and age. Rates by race adjusted for sex and age. Rates by primary disease and "adjusted rate" row adjusted for age, race, and sex. The "crude rate" row is not adjusted. Table A.7 Incidence Counts of Reported ESRD Therapy by Age, Sex, and Race 1992-1994 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 190 44 * * 237| 109 18 * * 137| 299 62 11 * 374| | 5- 9 | 163 45 10 * 223| 104 21 * * 133| 267 66 14 * 356| | 10-14 | 229 74 16 * 322| 230 67 13 * 315| 459 141 29 * 637| | 15-19 | 424 273 31 12 740| 383 208 34 12 637| 807 481 65 24 1377| | 20-24 | 846 584 70 14 1514| 661 464 53 20 1198| 1507 1048 123 34 2712| | 25-29 | 1463 1015 79 24 2581| 1198 724 65 24 2011| 2661 1739 144 48 4592| | 30-34 | 2218 1499 127 33 3877| 1602 971 112 28 2713| 3820 2470 239 61 6590| | 35-39 | 2782 2182 139 66 5169| 1796 1285 118 41 3240| 4578 3467 257 107 8409| | 40-44 | 3205 2467 161 96 5929| 2146 1534 168 69 3917| 5351 4001 329 165 9846| | 45-49 | 3867 2482 211 142 6702| 2688 1843 171 106 4808| 6555 4325 382 248 11510| | 50-54 | 4234 2561 218 129 7142| 3270 2341 172 140 5923| 7504 4902 390 269 13065| | 55-59 | 5121 2649 238 158 8166| 4222 2916 232 158 7528| 9343 5565 470 316 15694| | 60-64 | 6861 2815 260 166 10102| 5978 3508 260 226 9972| 12839 6323 520 392 20074| | 65-69 | 9641 2832 384 147 13004| 8333 4171 383 212 13099| 17974 7003 767 359 26103| | 70-74 | 10287 2247 354 112 13000| 8551 3540 343 163 12597| 18838 5787 697 275 25597| | 75-79 | 8274 1465 251 70 10060| 6395 2347 241 94 9077| 14669 3812 492 164 19137| | 80-84 | 4506 755 146 37 5444| 3678 1269 137 50 5134| 8184 2024 283 87 10578| | 85 plus | 1677 336 66 11 2090| 1579 616 45 15 2255| 3256 952 111 26 4345| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 65988 26325 2763 1226 96302| 52923 27843 2560 1368 84694|118911 54168 5323 2594 180996| ----------------------------------------------------------------------------------------------------------------------- 1995-1997 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 228 68 14 * 313| 138 48 10 * 200| 366 116 24 * 513| | 5- 9 | 170 56 * * 234| 133 33 * * 176| 303 89 13 * 410| | 10-14 | 274 117 10 * 406| 237 98 22 * 364| 511 215 32 12 770| | 15-19 | 540 307 32 * 888| 374 220 34 10 638| 914 527 66 19 1526| | 20-24 | 807 637 61 21 1526| 637 561 60 24 1282| 1444 1198 121 45 2808| | 25-29 | 1410 1084 84 27 2605| 1116 896 73 38 2123| 2526 1980 157 65 4728| | 30-34 | 2226 1692 110 53 4081| 1503 1257 101 50 2911| 3729 2949 211 103 6992| | 35-39 | 3011 2450 154 93 5708| 1917 1700 160 71 3848| 4928 4150 314 164 9556| | 40-44 | 3848 3099 176 134 7257| 2425 2104 185 94 4808| 6273 5203 361 228 12065| | 45-49 | 4647 3484 245 185 8561| 3396 2520 225 164 6305| 8043 6004 470 349 14866| | 50-54 | 5472 3199 329 191 9191| 4114 2898 260 211 7483| 9586 6097 589 402 16674| | 55-59 | 6277 3303 351 214 10145| 5172 3653 302 257 9384| 11449 6956 653 471 19529| | 60-64 | 8204 3453 422 184 12263| 7083 4378 401 257 12119| 15287 7831 823 441 24382| | 65-69 | 11081 3216 501 167 14965| 9422 4714 544 284 14964| 20503 7930 1045 451 29929| | 70-74 | 12706 2733 473 121 16033| 10009 4318 530 223 15080| 22715 7051 1003 344 31113| | 75-79 | 10770 1923 432 83 13208| 8197 2937 411 117 11662| 18967 4860 843 200 24870| | 80-84 | 6366 999 248 27 7640| 5173 1712 238 61 7184| 11539 2711 486 88 14824| | 85 plus | 2665 473 117 15 3270| 2353 916 109 22 3400| 5018 1389 226 37 6670| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 80702 32293 3765 1534 118294| 63399 34963 3672 1897 103931|144101 67256 7437 3431 222225| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.8 Incidence Rates per Million Population of Reported ESRD Therapy Specific Rates by Sex, Race, and Age, and Rates Adjusted for Age, Race, and Sex 1992-1994 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * * | * * * * | * * * * | * * | * | | 5- 9 | * 10 * * | * * * * | * * * * | * * | * | | 10-14 | 10 17 15 * | 11 16 13 * | 10 17 14 * | 11 12 | 11 | | 15-19 | 20 67 32 41 | 19 52 37 43 | 19 59 34 42 | 26 24 | 25 | | 20-24 | 36 147 59 47 | 30 113 47 74 | 33 130 53 61 | 51 41 | 46 | | 25-29 | 60 265 69 86 | 51 173 54 90 | 55 219 61 88 | 87 67 | 76 | | 30-34 | 80 379 106 118 | 59 216 88 99 | 69 296 96 108 | 119 80 | 99 | | 35-39 | 103 586 124 263 | 67 303 97 156 | 85 441 110 208 | 166 99 | 131 | | 40-44 | 132 799 166 448 | 88 428 151 305 | 110 608 158 374 | 220 135 | 176 | | 45-49 | 190 1107 282 845 | 130 690 203 598 | 159 891 241 714 | 314 207 | 259 | | 50-54 | 264 1461 391 1021 | 197 1091 284 1025 | 229 1269 335 1026 | 426 320 | 371 | | 55-59 | 381 1850 556 1604 | 295 1600 475 1466 | 337 1721 512 1532 | 583 476 | 528 | | 60-64 | 538 2213 769 2120 | 424 2086 590 2534 | 480 2148 673 2332 | 772 658 | 714 | | 65-69 | 803 2492 1403 2360 | 575 2706 1029 2845 | 687 2600 1205 2607 | 1052 880 | 965 | | 70-74 | 1021 2709 1672 2454 | 653 2873 1281 2769 | 832 2791 1462 2613 | 1269 974 | 1119 | | 75-79 | 1167 2638 1927 2405 | 609 2517 1437 2232 | 882 2575 1664 2319 | 1390 894 | 1137 | | 80-84 | 1099 2393 1904 2164 | 491 2077 1522 1803 | 787 2229 1698 2009 | 1299 739 | 1014 | | 85 plus | 650 1485 1347 860 | 233 1125 657 591 | 436 1300 987 711 | 781 364 | 568 | | All Age | 209 575 218 377 | 161 549 192 415 | 185 561 205 396 | 255 214 | 234 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 221 808 346 623 | 144 667 262 610 | 177 735 298 616 | 287 201 | 238 | ------------------------------------------------------------------------------------------------------------------------- 1995-1997 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * 15 11 * | * 11 * * | * 13 * * | 10 * | * | | 5- 9 | * 12 * * | * * * * | * * * * | * * | * | | 10-14 | 12 26 * * | 11 23 20 * | 11 25 14 17 | 14 13 | 13 | | 15-19 | 23 70 30 * | 17 51 33 32 | 20 60 32 31 | 30 22 | 26 | | 20-24 | 37 164 52 73 | 31 141 52 88 | 34 153 52 80 | 54 46 | 50 | | 25-29 | 61 290 67 92 | 49 220 54 141 | 55 254 60 117 | 90 72 | 81 | | 30-34 | 84 429 87 189 | 58 282 74 181 | 71 354 80 184 | 129 88 | 108 | | 35-39 | 107 615 125 345 | 69 378 120 259 | 88 494 123 301 | 174 112 | 142 | | 40-44 | 147 893 159 571 | 93 528 148 379 | 120 708 154 475 | 246 153 | 198 | | 45-49 | 203 1286 267 971 | 147 782 212 818 | 174 1030 241 896 | 349 235 | 290 | | 50-54 | 303 1661 489 1349 | 220 1223 348 1382 | 261 1439 419 1371 | 491 362 | 424 | | 55-59 | 440 2146 685 2013 | 342 1853 530 2182 | 390 1997 610 2105 | 678 556 | 615 | | 60-64 | 660 2694 1073 2217 | 520 2566 822 2714 | 588 2628 947 2475 | 946 808 | 876 | | 65-69 | 930 2699 1629 2578 | 673 2955 1268 3650 | 799 2829 1445 3130 | 1194 1009 | 1100 | | 70-74 | 1233 3191 1940 2371 | 756 3431 1616 3527 | 990 3312 1775 2962 | 1516 1150 | 1330 | | 75-79 | 1405 3175 2792 2521 | 749 3028 1945 2515 | 1068 3095 2367 2542 | 1685 1096 | 1385 | | 80-84 | 1398 3047 2724 1315 | 656 2691 2032 1954 | 1017 2863 2370 1643 | 1650 974 | 1305 | | 85 plus | 925 1894 1842 917 | 320 1512 1193 650 | 614 1694 1502 790 | 1077 504 | 785 | | All Age | 249 677 267 450 | 189 662 245 549 | 219 669 256 500 | 304 256 | 279 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 261 935 427 691 | 168 793 331 776 | 207 862 371 739 | 336 236 | 279 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.9 Standard Errors for Adjusted Incidence Rates per Million Population of Reported ESRD Therapy by Sex, Race, and Age, Adjusted for Age, Race, and Sex 1992-1994 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 0.6 1.4 * * | 0.5 0.9 * * | 0.4 0.8 1.5 * | 0.5 0.4 | 0.3 | | 5- 9 | 0.6 1.5 3.1 * | 0.5 1.1 * * | 0.4 0.9 1.8 * | 0.5 0.4 | 0.3 | | 10-14 | 0.7 2.0 3.8 * | 0.7 2.0 3.6 * | 0.5 1.4 2.6 * | 0.6 0.7 | 0.5 | | 15-19 | 1.0 4.0 5.7 11.9 | 1.0 3.6 6.3 12.3 | 0.7 2.7 4.3 8.6 | 1.0 1.0 | 0.7 | | 20-24 | 1.2 6.1 7.1 12.6 | 1.2 5.3 6.4 16.5 | 0.9 4.0 4.8 10.4 | 1.3 1.2 | 0.9 | | 25-29 | 1.6 8.3 7.8 17.5 | 1.5 6.4 6.7 18.4 | 1.1 5.2 5.1 12.7 | 1.7 1.5 | 1.1 | | 30-34 | 1.7 9.8 9.4 20.6 | 1.5 6.9 8.3 18.7 | 1.1 6.0 6.2 13.9 | 1.9 1.5 | 1.2 | | 35-39 | 1.9 12.5 10.5 32.3 | 1.6 8.5 8.9 24.4 | 1.2 7.5 6.9 20.1 | 2.3 1.7 | 1.4 | | 40-44 | 2.3 16.1 13.1 45.7 | 1.9 10.9 11.7 36.7 | 1.5 9.6 8.7 29.1 | 2.9 2.2 | 1.8 | | 45-49 | 3.0 22.2 19.4 70.9 | 2.5 16.1 15.5 58.1 | 2.0 13.6 12.4 45.3 | 3.9 3.0 | 2.4 | | 50-54 | 4.1 28.9 26.5 89.9 | 3.4 22.6 21.7 86.6 | 2.6 18.2 17.0 62.6 | 5.1 4.2 | 3.3 | | 55-59 | 5.3 36.0 36.1 127.6 | 4.5 29.6 31.2 116.6 | 3.5 23.2 23.7 86.2 | 6.6 5.5 | 4.3 | | 60-64 | 6.5 41.7 47.7 164.6 | 5.5 35.2 36.6 168.6 | 4.2 27.2 29.7 117.9 | 7.9 6.7 | 5.1 | | 65-69 | 8.2 46.8 71.6 194.7 | 6.3 41.9 52.6 195.4 | 5.1 31.3 43.9 137.9 | 9.5 7.9 | 6.1 | | 70-74 | 10.1 57.2 88.9 231.8 | 7.1 48.3 69.2 216.9 | 6.1 37.3 55.7 158.5 | 11.7 9.0 | 7.3 | | 75-79 | 12.8 68.9 121.6 287.4 | 7.6 52.0 92.6 230.2 | 7.4 42.9 75.5 183.5 | 14.6 9.9 | 8.8 | | 80-84 | 16.4 87.1 157.6 355.7 | 8.1 58.3 130.1 255.0 | 9.0 51.9 101.3 221.4 | 18.6 11.2 | 10.7 | | 85 plus | 15.9 81.0 165.8 259.3 | 5.9 45.3 97.9 152.6 | 8.3 45.9 94.8 146.9 | 17.8 8.4 | 9.7 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 0.9 5.2 7.1 19.0 | 0.6 4.0 5.5 16.9 | 0.5 3.2 4.4 12.6 | 0.9 0.7 | 0.6 | ------------------------------------------------------------------------------------------------------------------------- 1995-1997 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 0.6 1.8 2.9 * | 0.5 1.6 2.5 * | 0.4 1.2 1.9 * | 0.6 0.5 | 0.4 | | 5- 9 | 0.6 1.6 * * | 0.5 1.3 * * | 0.4 1.0 1.6 * | 0.5 0.5 | 0.3 | | 10-14 | 0.7 2.4 2.7 * | 0.7 2.3 4.2 * | 0.5 1.7 2.6 4.9 | 0.7 0.7 | 0.5 | | 15-19 | 1.0 4.0 5.3 * | 0.9 3.5 5.6 10.1 | 0.7 2.6 3.9 7.0 | 1.0 0.9 | 0.7 | | 20-24 | 1.3 6.5 6.7 15.9 | 1.2 6.0 6.8 17.9 | 0.9 4.4 4.8 12.0 | 1.4 1.3 | 0.9 | | 25-29 | 1.6 8.8 7.3 17.8 | 1.5 7.4 6.3 22.9 | 1.1 5.7 4.8 14.6 | 1.8 1.6 | 1.2 | | 30-34 | 1.8 10.4 8.3 25.9 | 1.5 8.0 7.4 25.6 | 1.2 6.5 5.5 18.2 | 2.0 1.6 | 1.3 | | 35-39 | 1.9 12.4 10.1 35.8 | 1.6 9.2 9.5 30.8 | 1.2 7.7 6.9 23.5 | 2.3 1.8 | 1.5 | | 40-44 | 2.4 16.0 11.9 49.4 | 1.9 11.5 10.9 39.1 | 1.5 9.8 8.1 31.5 | 2.9 2.2 | 1.8 | | 45-49 | 3.0 21.8 17.1 71.4 | 2.5 15.6 14.2 63.9 | 1.9 13.3 11.1 48.0 | 3.8 3.0 | 2.4 | | 50-54 | 4.1 29.4 27.0 97.6 | 3.4 22.7 21.6 95.1 | 2.7 18.5 17.3 68.5 | 5.2 4.2 | 3.3 | | 55-59 | 5.6 37.3 36.6 137.6 | 4.8 30.7 30.5 136.1 | 3.6 24.1 23.9 97.0 | 6.8 5.8 | 4.4 | | 60-64 | 7.3 45.8 52.2 163.5 | 6.2 38.8 41.1 169.3 | 4.8 29.9 33.2 118.0 | 8.7 7.4 | 5.7 | | 65-69 | 8.8 47.6 72.8 199.5 | 6.9 43.0 54.4 216.6 | 5.6 32.0 45.2 147.7 | 10.0 8.4 | 6.5 | | 70-74 | 10.9 61.0 89.2 215.6 | 7.6 52.2 70.2 236.2 | 6.6 40.0 56.5 160.3 | 12.5 9.7 | 7.8 | | 75-79 | 13.5 72.4 134.3 276.7 | 8.3 55.9 95.9 232.5 | 7.8 45.4 82.3 182.0 | 15.4 10.6 | 9.3 | | 80-84 | 17.5 96.4 173.0 253.1 | 9.1 65.0 131.7 250.2 | 9.7 57.7 108.2 178.3 | 20.1 12.3 | 11.6 | | 85 plus | 17.9 87.1 170.3 236.8 | 6.6 50.0 114.2 138.6 | 9.4 49.5 101.4 137.6 | 19.5 9.4 | 10.7 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 0.9 5.4 7.5 18.6 | 0.7 4.3 5.7 18.2 | 0.5 3.4 4.6 13.1 | 1.0 0.7 | 0.6 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.10 Incidence Counts of Reported ESRD Therapy by Age, Sex, Race and Primary Disease Causing ESRD 1994-1997 Diabetes ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | * * * * 12| * * * 0 10| 11 * * * 22| | 5- 9 | * 0 0 0 *| * * 0 0 *| * * 0 0 *| | 10-14 | * * 0 0 *| * * 0 0 *| * * 0 0 *| | 15-19 | 10 * 0 0 15| 11 * * 0 21| 21 14 * 0 36| | 20-24 | 96 58 * 0 156| 128 88 * * 225| 224 146 * * 381| | 25-29 | 547 196 * * 754| 577 242 * 12 837| 1124 438 12 17 1591| | 30-34 | 1303 334 19 21 1677| 905 300 23 23 1251| 2208 634 42 44 2928| | 35-39 | 1793 492 41 43 2369| 1089 503 30 40 1662| 2882 995 71 83 4031| | 40-44 | 2206 835 70 95 3206| 1405 785 50 75 2315| 3611 1620 120 170 5521| | 45-49 | 2877 1320 127 167 4491| 2135 1393 96 154 3778| 5012 2713 223 321 8269| | 50-54 | 3573 1728 201 170 5672| 2832 2087 146 205 5270| 6405 3815 347 375 10942| | 55-59 | 4233 2037 257 207 6734| 3914 2771 220 251 7156| 8147 4808 477 458 13890| | 60-64 | 5113 2069 289 176 7647| 5393 3414 310 266 9383| 10506 5483 599 442 17030| | 65-69 | 6075 1906 342 142 8465| 6636 3614 422 288 10960| 12711 5520 764 430 19425| | 70-74 | 5640 1425 279 104 7448| 6058 2924 381 197 9560| 11698 4349 660 301 17008| | 75-79 | 3511 799 221 48 4579| 3741 1712 246 93 5792| 7252 2511 467 141 10371| | 80-84 | 1501 333 99 * 1940| 1641 765 121 45 2572| 3142 1098 220 52 4512| | 85 plus | 400 103 41 * 549| 494 245 44 15 798| 894 348 85 20 1347| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 38887 13646 1995 1191 55719| 36967 20861 2101 1669 61598| 75854 34507 4096 2860 117317| ----------------------------------------------------------------------------------------------------------------------- Hypertension ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | * * 0 0 11| * * 0 * 14| * 15 0 * 25| | 5- 9 | * * 0 0 *| * * 0 0 *| * * 0 0 *| | 10-14 | * * 0 0 10| 10 * * 0 14| 14 * * 0 24| | 15-19 | 26 57 * * 87| 26 24 * * 54| 52 81 * * 141| | 20-24 | 90 260 10 * 367| 45 131 * * 188| 135 391 14 15 555| | 25-29 | 209 449 19 * 683| 97 262 * * 371| 306 711 27 10 1054| | 30-34 | 255 732 29 11 1027| 155 418 21 * 597| 410 1150 50 14 1624| | 35-39 | 355 1186 35 20 1596| 168 651 24 12 855| 523 1837 59 32 2451| | 40-44 | 574 1507 40 25 2146| 258 828 48 19 1153| 832 2335 88 44 3299| | 45-49 | 719 1686 65 34 2504| 399 900 52 14 1365| 1118 2586 117 48 3869| | 50-54 | 915 1491 79 25 2510| 529 967 70 19 1585| 1444 2458 149 44 4095| | 55-59 | 1312 1357 84 27 2780| 799 1180 64 25 2068| 2111 2537 148 52 4848| | 60-64 | 2269 1480 119 28 3896| 1405 1452 106 25 2988| 3674 2932 225 53 6884| | 65-69 | 3941 1506 144 29 5620| 2595 1818 144 35 4592| 6536 3324 288 64 10212| | 70-74 | 5611 1401 185 28 7225| 3586 1992 138 47 5763| 9197 3393 323 75 12988| | 75-79 | 5600 1159 189 27 6975| 3778 1570 169 32 5549| 9378 2729 358 59 12524| | 80-84 | 3754 612 130 17 4513| 2976 1071 100 20 4167| 6730 1683 230 37 8680| | 85 plus | 1627 335 56 * 2026| 1465 667 55 10 2197| 3092 1002 111 18 4223| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 27268 15231 1186 294 43979| 18297 13945 1008 276 33526| 45565 29176 2194 570 77505| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.10(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race and Primary Disease Causing ESRD 1994-1997 Glomeruloneph. ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 25 * * 0 37| 25 * * 0 35| 50 14 * 0 72| | 5- 9 | 48 17 * * 73| 45 12 * * 61| 93 29 * * 134| | 10-14 | 80 29 * * 118| 86 51 * * 151| 166 80 15 * 269| | 15-19 | 236 195 22 * 456| 186 101 12 * 304| 422 296 34 * 760| | 20-24 | 392 291 41 11 735| 267 202 36 * 513| 659 493 77 19 1248| | 25-29 | 537 327 53 15 932| 299 229 45 13 586| 836 556 98 28 1518| | 30-34 | 639 373 76 16 1104| 336 302 53 24 715| 975 675 129 40 1819| | 35-39 | 743 497 70 21 1331| 421 327 102 18 868| 1164 824 172 39 2199| | 40-44 | 793 581 79 29 1482| 440 337 88 14 879| 1233 918 167 43 2361| | 45-49 | 905 487 76 23 1491| 502 272 75 18 867| 1407 759 151 41 2358| | 50-54 | 888 345 77 16 1326| 516 216 42 * 780| 1404 561 119 22 2106| | 55-59 | 944 286 56 15 1301| 536 220 57 13 826| 1480 506 113 28 2127| | 60-64 | 1127 254 37 11 1429| 629 188 42 19 878| 1756 442 79 30 2307| | 65-69 | 1399 198 83 14 1694| 828 217 52 15 1112| 2227 415 135 29 2806| | 70-74 | 1582 172 76 13 1843| 956 200 57 * 1222| 2538 372 133 22 3065| | 75-79 | 1321 109 64 11 1505| 848 129 39 11 1027| 2169 238 103 22 2532| | 80-84 | 826 57 29 * 915| 508 67 36 * 615| 1334 124 65 * 1530| | 85 plus | 313 27 17 * 358| 256 51 * 0 316| 569 78 26 * 674| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 12798 4254 870 208 18130| 7684 3126 761 184 11755| 20482 7380 1631 392 29885| ----------------------------------------------------------------------------------------------------------------------- Cystic Kidney ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 23 * 0 0 25| 23 * * 0 28| 46 * * 0 53| | 5- 9 | 14 * * * 20| 18 * 0 0 21| 32 * * * 41| | 10-14 | 17 * * * 23| 19 * * 0 27| 36 10 * * 50| | 15-19 | 14 * 0 * 20| 14 * * 0 19| 28 * * * 39| | 20-24 | 16 * 0 0 18| 16 * * 0 20| 32 * * 0 38| | 25-29 | 23 * 0 * 30| 30 * * * 35| 53 * * * 65| | 30-34 | 73 19 * * 95| 52 18 * * 72| 125 37 * * 167| | 35-39 | 187 31 * * 228| 128 32 * * 166| 315 63 13 * 394| | 40-44 | 373 60 * * 443| 236 63 11 0 310| 609 123 17 * 753| | 45-49 | 499 74 12 * 586| 385 78 12 * 479| 884 152 24 * 1065| | 50-54 | 516 57 19 * 595| 406 75 * * 493| 922 132 28 * 1088| | 55-59 | 375 42 14 * 433| 347 55 * * 414| 722 97 21 * 847| | 60-64 | 276 44 10 * 334| 281 43 * * 334| 557 87 18 * 668| | 65-69 | 312 38 10 * 361| 299 39 * * 347| 611 77 16 * 708| | 70-74 | 247 29 * 0 284| 259 45 * 0 311| 506 74 15 0 595| | 75-79 | 157 24 * 0 184| 153 24 * 0 180| 310 48 * 0 364| | 80-84 | 79 20 * * 103| 73 11 * * 88| 152 31 * * 191| | 85 plus | 34 * * * 43| 24 * 0 0 31| 58 14 * * 74| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 3235 468 98 24 3825| 2763 512 78 22 3375| 5998 980 176 46 7200| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.10(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race and Primary Disease Causing ESRD 1994-1997 Other Urologic ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 16 * 0 0 23| * * 0 0 *| 22 * 0 0 30| | 5- 9 | 15 * 0 0 19| 13 * 0 0 17| 28 * 0 0 36| | 10-14 | 41 * 0 0 47| 30 * * * 34| 71 * * * 81| | 15-19 | 39 16 0 0 55| 34 * * * 42| 73 22 * * 97| | 20-24 | 53 * * 0 63| 56 * * * 69| 109 15 * * 132| | 25-29 | 75 14 * * 92| 65 14 0 0 79| 140 28 * * 171| | 30-34 | 72 13 * * 91| 79 * * * 94| 151 22 * * 185| | 35-39 | 99 18 * * 127| 100 12 * * 116| 199 30 * * 243| | 40-44 | 99 19 * * 120| 83 28 * 0 119| 182 47 * * 239| | 45-49 | 96 25 * * 127| 95 17 * 0 118| 191 42 11 * 245| | 50-54 | 109 23 * * 137| 110 18 * * 135| 219 41 * * 272| | 55-59 | 150 33 * * 190| 115 26 11 0 152| 265 59 15 * 342| | 60-64 | 218 52 13 * 286| 126 24 * * 157| 344 76 18 * 443| | 65-69 | 315 77 10 * 406| 171 32 12 * 216| 486 109 22 * 622| | 70-74 | 408 68 * * 487| 191 25 12 * 229| 599 93 20 * 716| | 75-79 | 417 43 * * 472| 164 15 * * 185| 581 58 11 * 657| | 80-84 | 297 45 * * 350| 81 21 * 0 105| 378 66 * * 455| | 85 plus | 156 19 * 0 180| 50 10 * 0 62| 206 29 * 0 242| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 2675 489 74 34 3272| 1569 272 82 13 1936| 4244 761 156 47 5208| ----------------------------------------------------------------------------------------------------------------------- Other Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 169 50 * * 230| 84 26 * * 117| 253 76 13 * 347| | 5- 9 | 117 36 * 0 157| 66 15 * * 87| 183 51 * * 244| | 10-14 | 172 67 * * 247| 113 38 * * 163| 285 105 15 * 410| | 15-19 | 266 86 14 * 372| 179 85 18 * 287| 445 171 32 11 659| | 20-24 | 254 142 11 * 411| 238 232 29 * 506| 492 374 40 11 917| | 25-29 | 331 303 12 * 652| 293 327 29 11 660| 624 630 41 17 1312| | 30-34 | 361 551 13 * 932| 333 471 30 * 838| 694 1022 43 11 1770| | 35-39 | 457 699 13 23 1192| 436 525 19 15 995| 893 1224 32 38 2187| | 40-44 | 499 697 16 13 1225| 499 454 33 12 998| 998 1151 49 25 2223| | 45-49 | 546 520 18 12 1096| 588 342 27 16 973| 1134 862 45 28 2069| | 50-54 | 668 300 19 14 1001| 621 270 26 11 928| 1289 570 45 25 1929| | 55-59 | 760 249 22 12 1043| 679 225 25 13 942| 1439 474 47 25 1985| | 60-64 | 1037 245 27 10 1319| 906 235 20 14 1175| 1943 480 47 24 2494| | 65-69 | 1491 226 31 13 1761| 1167 201 37 11 1416| 2658 427 68 24 3177| | 70-74 | 1662 202 24 * 1896| 1264 196 33 11 1504| 2926 398 57 19 3400| | 75-79 | 1493 174 34 * 1708| 1074 154 21 * 1254| 2567 328 55 12 2962| | 80-84 | 839 99 16 * 956| 662 105 12 * 782| 1501 204 28 * 1738| | 85 plus | 371 47 10 * 433| 273 55 * * 335| 644 102 16 * 768| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 11493 4693 298 147 16631| 9475 3956 382 147 13960| 20968 8649 680 294 30591| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.10(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race and Primary Disease Causing ESRD 1994-1997 Unknown Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 13 * 0 0 14| * * 0 0 *| 19 * 0 0 23| | 5- 9 | * * 0 0 13| 13 * * * 17| 22 * * * 30| | 10-14 | * 16 * * 27| 26 15 * 0 42| 34 31 * * 69| | 15-19 | 53 27 * * 82| 43 23 * * 72| 96 50 * * 154| | 20-24 | 108 49 * * 168| 59 33 * * 99| 167 82 13 * 267| | 25-29 | 101 73 11 * 187| 77 37 * * 121| 178 110 16 * 308| | 30-34 | 121 116 * * 243| 67 59 11 * 140| 188 175 15 * 383| | 35-39 | 142 145 19 * 313| 109 63 14 * 187| 251 208 33 * 500| | 40-44 | 163 138 13 * 320| 103 91 12 * 211| 266 229 25 11 531| | 45-49 | 177 132 14 * 330| 136 81 15 * 234| 313 213 29 * 564| | 50-54 | 201 88 10 * 301| 138 75 18 * 235| 339 163 28 * 536| | 55-59 | 251 123 12 * 392| 195 94 14 * 309| 446 217 26 12 701| | 60-64 | 368 112 21 * 506| 257 98 25 * 385| 625 210 46 10 891| | 65-69 | 511 118 27 11 667| 409 124 20 * 561| 920 242 47 19 1228| | 70-74 | 808 108 20 * 941| 484 143 31 * 666| 1292 251 51 13 1607| | 75-79 | 784 93 31 * 914| 492 101 18 * 615| 1276 194 49 10 1529| | 80-84 | 544 62 19 * 626| 409 81 16 * 508| 953 143 35 * 1134| | 85 plus | 272 32 10 0 314| 257 60 * * 326| 529 92 17 * 640| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 4634 1437 223 64 6358| 3280 1183 217 57 4737| 7914 2620 440 121 11095| ----------------------------------------------------------------------------------------------------------------------- Missing Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0- 4 | 26 * * 0 35| 21 * * 0 27| 47 10 * 0 62| | 5- 9 | 26 * * 0 34| 17 * * 0 23| 43 11 * 0 57| | 10-14 | 33 14 0 * 48| 23 11 * 0 37| 56 25 * * 85| | 15-19 | 51 23 * 0 77| 27 24 * * 53| 78 47 * * 130| | 20-24 | 64 43 * * 116| 42 34 * 0 80| 106 77 11 * 196| | 25-29 | 92 85 * * 189| 85 63 * * 158| 177 148 17 * 347| | 30-34 | 139 121 * * 270| 124 69 * * 200| 263 190 13 * 470| | 35-39 | 185 156 14 * 358| 109 104 * * 221| 294 260 20 * 579| | 40-44 | 199 179 11 * 390| 126 109 * 0 240| 325 288 16 * 630| | 45-49 | 232 222 11 * 466| 144 113 12 * 274| 376 335 23 * 740| | 50-54 | 246 153 12 * 417| 160 108 13 * 285| 406 261 25 10 702| | 55-59 | 229 153 * * 393| 144 154 * * 302| 373 307 11 * 695| | 60-64 | 282 187 16 * 487| 248 195 * * 455| 530 382 23 * 942| | 65-69 | 413 131 10 * 555| 339 179 13 * 539| 752 310 23 * 1094| | 70-74 | 471 117 * * 598| 328 148 * * 487| 799 265 15 * 1085| | 75-79 | 455 75 * * 539| 299 104 * * 411| 754 179 12 * 950| | 80-84 | 245 47 * * 297| 175 74 * 0 252| 420 121 * * 549| | 85 plus | 123 27 * * 155| 102 48 * 0 153| 225 75 * * 308| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 3511 1746 136 31 5424| 2513 1545 102 37 4197| 6024 3291 238 68 9621| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.11 Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age, and Rates Adjusted for Age, Race, and Sex 1994-1997 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * * | * * * 0 | * * * * | * * | * | | 5- 9 | * 0 0 0 | * * 0 0 | * * 0 0 | * * | * | | 10-14 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 15-19 | * * 0 0 | * * * 0 | * 12 * 0 | * * | * | | 20-24 | 33 112 * 0 | 46 165 * * | 40 139 * * | 42 61 | 52 | | 25-29 | 176 393 * * | 191 445 * 337 | 183 420 35 235 | 198 218 | 208 | | 30-34 | 366 634 113 560 | 259 504 128 621 | 310 567 121 592 | 391 288 | 338 | | 35-39 | 480 935 253 1210 | 296 845 172 1103 | 386 889 211 1158 | 536 368 | 450 | | 40-44 | 642 1839 483 3082 | 410 1502 306 2301 | 523 1668 395 2686 | 808 561 | 681 | | 45-49 | 960 3769 1070 6711 | 703 3342 703 5874 | 829 3546 892 6314 | 1368 1081 | 1221 | | 50-54 | 1512 6834 2312 9179 | 1158 6715 1514 10254 | 1328 6777 1905 9704 | 2277 1950 | 2110 | | 55-59 | 2247 10050 3867 14774 | 1958 10679 2970 16218 | 2098 10348 3431 15484 | 3396 3217 | 3306 | | 60-64 | 3082 12129 5650 16081 | 2958 15064 4841 21291 | 3020 13620 5224 18758 | 4431 4714 | 4581 | | 65-69 | 3819 12075 8512 16542 | 3532 17083 7531 27980 | 3675 14615 7992 22385 | 5142 5602 | 5386 | | 70-74 | 4109 12549 8733 15536 | 3433 17473 8978 23599 | 3765 15048 8830 19621 | 5441 5582 | 5523 | | 75-79 | 3483 10060 11050 11191 | 2586 13363 9066 15271 | 3009 11715 9957 13369 | 4629 4283 | 4460 | | 80-84 | 2516 7649 8383 * | 1572 9050 8067 10987 | 2020 8349 8171 6853 | 3360 2825 | 3090 | | 85 plus | 1060 3144 5040 * | 511 3083 3781 3475 | 774 3075 4282 2946 | 1463 971 | 1212 | | All Age | 904 2158 1081 2643 | 830 2981 1071 3649 | 866 2590 1076 3150 | 1079 1142 | 1111 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 920 3118 1752 4093 | 747 3644 1491 5260 | 825 3414 1609 4752 | 1169 1061 | 1112 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * 0 0 | * * 0 * | * 13 0 * | * * | * | | 5- 9 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 10-14 | * * 0 0 | * * * 0 | * * * 0 | * * | * | | 15-19 | * 98 * * | * 43 * * | * 70 * * | 21 14 | 17 | | 20-24 | 31 501 64 * | 16 246 * * | 23 371 45 201 | 92 47 | 69 | | 25-29 | 67 900 116 * | 32 482 * * | 49 687 80 135 | 175 90 | 131 | | 30-34 | 72 1389 173 293 | 44 702 117 * | 58 1037 145 184 | 243 130 | 184 | | 35-39 | 95 2254 216 563 | 46 1094 137 331 | 70 1664 177 444 | 377 184 | 276 | | 40-44 | 167 3318 276 811 | 75 1585 294 583 | 120 2440 286 702 | 577 279 | 422 | | 45-49 | 240 4814 548 1366 | 131 2159 381 534 | 185 3474 467 943 | 843 402 | 613 | | 50-54 | 387 5897 909 1350 | 216 3111 726 950 | 302 4489 825 1150 | 1116 610 | 853 | | 55-59 | 697 6695 1264 1927 | 400 4548 864 1615 | 546 5616 1064 1783 | 1490 954 | 1213 | | 60-64 | 1368 8676 2326 2558 | 771 6407 1655 2001 | 1062 7518 1997 2278 | 2337 1526 | 1920 | | 65-69 | 2477 9541 3584 3378 | 1381 8594 2570 3400 | 1917 9066 3073 3401 | 3420 2355 | 2876 | | 70-74 | 4088 12338 5790 4183 | 2032 11904 3252 5630 | 3039 12120 4493 4945 | 5195 3356 | 4259 | | 75-79 | 5555 14592 9450 6295 | 2611 12255 6228 5255 | 4051 13386 7845 5804 | 6844 3986 | 5385 | | 80-84 | 6292 14057 11008 6383 | 2852 12670 6667 4883 | 4528 13344 8731 5651 | 7433 4246 | 5809 | | 85 plus | 4310 10227 6883 * | 1514 8392 4726 2316 | 2870 9268 5747 3108 | 5129 2498 | 3787 | | All Age | 634 2409 642 652 | 411 1993 514 603 | 520 2190 576 628 | 852 622 | 734 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 694 3462 1154 1105 | 341 2451 763 911 | 487 2931 926 998 | 986 554 | 737 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.11(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age, and Rates Adjusted for Age, Race, and Sex 1994-1997 Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * 0 | * * * 0 | * 12 * 0 | * * | * | | 5- 9 | 15 27 * * | 15 20 * * | 15 24 * * | 18 16 | 17 | | 10-14 | 26 49 * * | 29 90 * * | 28 70 51 * | 30 39 | 35 | | 15-19 | 78 336 157 * | 66 179 89 * | 72 257 123 * | 114 82 | 97 | | 20-24 | 133 560 262 285 | 96 380 235 * | 114 467 247 252 | 193 138 | 165 | | 25-29 | 173 656 323 389 | 99 421 255 365 | 135 536 289 378 | 241 148 | 193 | | 30-34 | 179 708 454 427 | 96 507 294 648 | 137 605 373 540 | 258 160 | 208 | | 35-39 | 199 945 432 591 | 114 549 583 496 | 156 743 511 543 | 305 190 | 246 | | 40-44 | 231 1279 545 941 | 128 645 538 429 | 178 957 548 681 | 381 212 | 294 | | 45-49 | 302 1390 641 924 | 165 653 549 687 | 232 1014 599 795 | 458 245 | 348 | | 50-54 | 376 1364 886 864 | 211 695 436 * | 293 1023 659 584 | 525 282 | 400 | | 55-59 | 501 1411 843 1071 | 268 848 769 840 | 382 1124 808 954 | 634 365 | 496 | | 60-64 | 679 1489 723 1005 | 345 830 656 1521 | 509 1152 691 1268 | 787 428 | 603 | | 65-69 | 879 1254 2066 1631 | 441 1026 928 1457 | 655 1138 1490 1545 | 977 541 | 755 | | 70-74 | 1153 1515 2379 1942 | 542 1195 1343 * | 841 1351 1854 1509 | 1250 659 | 948 | | 75-79 | 1310 1372 3200 2565 | 586 1007 1437 1806 | 940 1182 2311 2186 | 1397 681 | 1032 | | 80-84 | 1385 1309 2456 * | 487 793 2400 * | 925 1047 2428 * | 1410 600 | 997 | | 85 plus | 829 824 2090 * | 265 642 * 0 | 539 731 1406 * | 869 327 | 593 | | All Age | 297 673 471 462 | 173 447 388 402 | 234 554 428 432 | 351 218 | 283 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 308 804 641 632 | 158 491 453 499 | 225 642 534 560 | 378 207 | 284 | ------------------------------------------------------------------------------------------------------------------------- Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * 0 0 | * * * 0 | * * * 0 | * * | * | | 5- 9 | * * * * | * * 0 0 | * * * * | * * | * | | 10-14 | * * * * | * * * 0 | * * * * | * * | * | | 15-19 | * * 0 * | * * * 0 | * * * * | * * | * | | 20-24 | * * 0 0 | * * * 0 | * * * 0 | * * | * | | 25-29 | * * 0 * | * * * * | * * * * | * * | * | | 30-34 | 21 36 * * | 15 30 * * | 18 33 * * | 22 17 | 19 | | 35-39 | 50 59 * * | 35 54 * * | 42 56 39 * | 51 37 | 44 | | 40-44 | 109 132 * * | 69 121 67 0 | 88 126 55 * | 109 75 | 92 | | 45-49 | 167 211 101 * | 127 187 88 * | 147 200 93 * | 169 134 | 151 | | 50-54 | 218 225 219 * | 166 241 * * | 192 233 153 * | 219 173 | 196 | | 55-59 | 199 207 211 * | 174 212 * * | 186 210 155 * | 200 177 | 188 | | 60-64 | 166 258 195 * | 154 190 * * | 160 223 160 * | 181 158 | 169 | | 65-69 | 196 241 249 * | 159 184 * * | 177 212 175 * | 203 161 | 182 | | 70-74 | 180 255 * 0 | 147 269 * 0 | 163 262 204 0 | 190 161 | 176 | | 75-79 | 156 302 * 0 | 106 187 * 0 | 130 241 * 0 | 173 116 | 143 | | 80-84 | 132 459 * * | 70 130 * * | 101 290 * * | 180 84 | 130 | | 85 plus | 90 * * * | 25 * 0 0 | 57 149 * * | 110 31 | 70 | | All Age | 75 74 53 53 | 62 73 40 48 | 69 74 46 51 | 74 63 | 68 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 76 102 72 72 | 58 85 46 63 | 66 92 58 66 | 78 61 | 69 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.11(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age, and Rates Adjusted for Age, Race, and Sex 1994-1997 Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 5- 9 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 10-14 | 13 * 0 0 | 10 * * * | 12 * * * | 12 * | 11 | | 15-19 | 13 28 0 0 | 12 * * * | 13 19 * * | 14 12 | 13 | | 20-24 | 18 * * 0 | 20 * * * | 19 14 * * | 17 20 | 19 | | 25-29 | 24 28 * * | 21 26 0 0 | 23 27 * * | 24 21 | 23 | | 30-34 | 20 25 * * | 23 * * * | 22 20 * * | 21 22 | 22 | | 35-39 | 27 34 * * | 27 20 * * | 27 27 * * | 29 26 | 27 | | 40-44 | 29 42 * * | 24 54 * 0 | 26 48 * * | 30 28 | 29 | | 45-49 | 32 71 * * | 31 41 * 0 | 31 56 45 * | 37 33 | 35 | | 50-54 | 46 91 * * | 45 58 * * | 46 75 * * | 52 47 | 50 | | 55-59 | 80 163 * * | 58 100 148 0 | 68 131 106 * | 90 66 | 78 | | 60-64 | 131 305 254 * | 69 106 * * | 100 203 165 * | 159 75 | 116 | | 65-69 | 198 488 249 * | 91 151 214 * | 144 315 232 * | 239 103 | 169 | | 70-74 | 297 599 * * | 108 149 283 * | 201 368 265 * | 334 120 | 224 | | 75-79 | 414 541 * * | 113 117 * * | 259 323 247 * | 433 117 | 271 | | 80-84 | 498 1034 * * | 78 248 * 0 | 282 633 * * | 566 102 | 328 | | 85 plus | 413 580 * 0 | 52 126 * 0 | 226 350 * 0 | 435 65 | 245 | | All Age | 62 77 40 75 | 35 39 42 28 | 48 57 41 52 | 63 36 | 49 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 67 121 67 132 | 33 45 53 34 | 46 77 57 76 | 72 34 | 49 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 54 82 * * | 28 44 * * | 41 63 38 * | 57 30 | 43 | | 5- 9 | 37 58 * 0 | 22 25 * * | 30 41 * * | 39 23 | 31 | | 10-14 | 56 114 * * | 39 67 * * | 47 90 51 * | 63 43 | 53 | | 15-19 | 88 148 100 * | 63 151 133 * | 75 150 117 133 | 96 77 | 87 | | 20-24 | 86 273 70 * | 86 436 189 * | 86 357 131 148 | 110 135 | 123 | | 25-29 | 106 608 73 * | 97 602 164 309 | 101 605 120 234 | 169 165 | 167 | | 30-34 | 101 1046 78 * | 95 791 167 * | 98 915 124 146 | 221 186 | 202 | | 35-39 | 122 1328 80 647 | 118 882 109 414 | 120 1100 95 527 | 278 217 | 246 | | 40-44 | 145 1535 110 422 | 146 869 202 368 | 145 1194 158 396 | 322 241 | 279 | | 45-49 | 182 1485 152 482 | 194 821 198 610 | 188 1140 173 548 | 347 276 | 309 | | 50-54 | 283 1186 219 756 | 254 869 270 550 | 268 1022 249 657 | 399 335 | 365 | | 55-59 | 404 1228 331 856 | 340 867 337 840 | 370 1043 339 848 | 509 410 | 458 | | 60-64 | 625 1436 528 914 | 497 1037 312 1121 | 560 1231 419 1030 | 726 564 | 643 | | 65-69 | 937 1432 772 1514 | 621 950 660 1069 | 776 1184 715 1287 | 999 668 | 830 | | 70-74 | 1211 1779 751 * | 716 1171 778 1318 | 959 1465 759 1261 | 1265 781 | 1018 | | 75-79 | 1481 2191 1700 * | 742 1202 774 * | 1099 1682 1218 1209 | 1574 799 | 1178 | | 80-84 | 1406 2274 1355 * | 634 1242 800 * | 1007 1745 1056 * | 1500 717 | 1099 | | 85 plus | 983 1435 1229 * | 282 692 * * | 621 1050 867 * | 1057 340 | 691 | | All Age | 267 742 161 326 | 213 565 195 321 | 239 649 179 324 | 322 259 | 290 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 280 908 240 472 | 194 614 226 399 | 229 750 228 426 | 352 245 | 290 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.11(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age, and Rates Adjusted for Age, Race, and Sex 1994-1997 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * 0 0 | * * 0 0 | * * 0 0 | * * | * | | 5- 9 | * * 0 0 | * * * * | * * * * | * * | * | | 10-14 | * 27 * * | * 26 * 0 | * 27 * * | * 11 | * | | 15-19 | 17 47 * * | 15 41 * * | 16 44 * * | 21 19 | 20 | | 20-24 | 37 94 * * | 21 62 * * | 29 78 42 * | 45 27 | 36 | | 25-29 | 32 146 67 * | 25 68 * * | 29 106 48 * | 48 31 | 39 | | 30-34 | 34 220 * * | 19 99 61 * | 26 158 43 * | 57 31 | 44 | | 35-39 | 38 276 117 * | 30 106 80 * | 34 189 99 * | 72 41 | 56 | | 40-44 | 47 304 90 * | 30 174 73 * | 39 238 82 175 | 83 51 | 66 | | 45-49 | 59 377 118 * | 45 194 110 * | 52 284 117 * | 104 66 | 84 | | 50-54 | 85 348 115 * | 56 241 187 * | 71 294 151 * | 120 86 | 102 | | 55-59 | 133 607 181 * | 98 362 189 * | 115 484 189 411 | 198 137 | 167 | | 60-64 | 222 657 411 * | 141 432 390 * | 181 542 401 426 | 286 189 | 236 | | 65-69 | 321 748 672 1281 | 218 586 357 * | 268 665 519 1015 | 396 274 | 334 | | 70-74 | 589 951 626 * | 274 855 731 * | 428 902 683 849 | 638 371 | 502 | | 75-79 | 778 1171 1550 * | 340 788 663 * | 553 977 1121 1020 | 860 411 | 631 | | 80-84 | 912 1424 1609 * | 392 958 1067 * | 644 1183 1350 * | 994 490 | 737 | | 85 plus | 721 977 1229 0 | 266 755 * * | 484 858 880 * | 757 339 | 544 | | All Age | 108 227 121 142 | 74 169 111 125 | 90 197 116 133 | 123 88 | 105 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 116 311 198 223 | 64 201 149 173 | 86 252 168 197 | 140 80 | 105 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * 0 | * * * 0 | * * * 0 | * * | * | | 5- 9 | * * * 0 | * * * 0 | * * * 0 | * * | * | | 10-14 | 11 24 0 * | * 19 * 0 | * 22 * * | 12 * | 11 | | 15-19 | 17 40 * 0 | * 43 * * | 13 41 * * | 20 14 | 17 | | 20-24 | 22 83 * * | 15 64 * 0 | 19 74 36 * | 31 22 | 26 | | 25-29 | 30 170 * * | 28 116 * * | 29 142 49 * | 49 40 | 44 | | 30-34 | 39 230 * * | 35 116 * * | 38 172 37 * | 64 46 | 55 | | 35-39 | 50 296 86 * | 30 175 * * | 39 233 59 * | 82 48 | 65 | | 40-44 | 58 394 76 * | 37 209 * 0 | 46 294 51 * | 99 57 | 77 | | 45-49 | 77 634 93 * | 47 271 88 * | 61 435 90 * | 145 77 | 110 | | 50-54 | 104 605 138 * | 65 348 135 * | 82 467 131 247 | 167 103 | 134 | | 55-59 | 122 755 * * | 72 593 * * | 95 667 78 * | 200 136 | 167 | | 60-64 | 170 1096 313 * | 136 860 * * | 153 975 205 * | 292 229 | 259 | | 65-69 | 260 830 249 * | 180 846 232 * | 220 838 242 * | 331 272 | 301 | | 70-74 | 343 1030 * * | 186 884 * * | 263 955 206 * | 426 276 | 350 | | 75-79 | 451 944 * * | 207 812 * * | 323 875 261 * | 504 284 | 392 | | 80-84 | 411 1080 * * | 168 875 * 0 | 284 973 * * | 488 256 | 370 | | 85 plus | 326 824 * * | 105 604 * 0 | 209 710 * * | 390 171 | 278 | | All Age | 82 276 74 69 | 56 221 52 81 | 69 247 62 75 | 105 78 | 91 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 85 365 96 96 | 51 258 60 116 | 66 309 76 106 | 115 72 | 91 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.12 Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age, Adjusted for Age, Race, and Sex 1994-1997 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * * * | * * * 0.0 | 0.5 * * * | 0.8 0.8 | 0.6 | | 5- 9 | * 0.0 0.0 0.0 | * * 0.0 0.0 | * * 0.0 0.0 | * * | * | | 10-14 | * * 0.0 0.0 | * * 0.0 0.0 | * * 0.0 0.0 | * * | * | | 15-19 | 1.0 * 0.0 0.0 | 1.2 * * 0.0 | 0.8 3.3 * 0.0 | 1.0 1.2 | 0.8 | | 20-24 | 3.3 14.7 * 0.0 | 4.1 17.6 * * | 2.6 11.5 * * | 3.3 4.1 | 2.7 | | 25-29 | 7.5 28.1 * * | 7.9 28.6 * 97.3 | 5.5 20.1 10.2 57.0 | 7.2 7.6 | 5.2 | | 30-34 | 10.1 34.7 26.0 122.3 | 8.6 29.1 26.6 129.5 | 6.6 22.5 18.7 89.2 | 9.6 8.1 | 6.3 | | 35-39 | 11.3 42.2 39.6 184.5 | 9.0 37.7 31.3 174.4 | 7.2 28.2 25.1 127.1 | 11.0 9.0 | 7.1 | | 40-44 | 13.7 63.6 57.7 316.2 | 10.9 53.6 43.3 265.7 | 8.7 41.5 36.1 206.1 | 14.3 11.7 | 9.2 | | 45-49 | 17.9 103.7 95.0 519.3 | 15.2 89.6 71.7 473.4 | 11.7 68.4 59.9 352.7 | 20.6 17.6 | 13.5 | | 50-54 | 25.3 164.4 163.1 704.0 | 21.8 147.0 125.3 716.2 | 16.6 110.2 102.6 501.7 | 30.7 27.0 | 20.4 | | 55-59 | 34.5 222.7 241.2 1026.9 | 31.3 202.9 200.2 1023.7 | 23.2 150.1 157.4 724.2 | 42.0 38.2 | 28.3 | | 60-64 | 43.1 266.7 332.3 1212.1 | 40.3 257.8 275.0 1305.4 | 29.5 185.3 214.6 893.4 | 51.6 49.0 | 35.6 | | 65-69 | 49.0 276.6 460.3 1388.2 | 43.4 284.2 366.6 1648.7 | 32.7 198.2 292.5 1082.0 | 57.4 54.4 | 39.5 | | 70-74 | 54.7 332.4 522.8 1523.4 | 44.1 323.1 460.0 1681.3 | 35.0 231.5 346.8 1135.7 | 66.0 59.1 | 44.2 | | 75-79 | 58.8 355.9 743.3 1615.3 | 42.3 323.0 578.0 1583.5 | 35.8 239.3 465.8 1140.5 | 72.6 59.3 | 46.7 | | 80-84 | 64.9 419.2 842.5 * | 38.8 327.2 733.4 1637.9 | 37.2 264.0 555.7 961.8 | 81.7 60.3 | 50.3 | | 85 plus | 53.0 309.8 787.1 * | 23.0 196.9 569.9 897.2 | 28.3 179.8 471.9 699.1 | 65.4 38.0 | 37.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.7 27.4 41.4 123.4 | 3.9 25.4 33.7 131.2 | 3.0 18.6 26.3 91.4 | 5.0 4.3 | 3.2 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | * * 0.0 0.0 | * * 0.0 * | * 3.3 0.0 * | 0.8 0.9 | 0.6 | | 5- 9 | * * 0.0 0.0 | * * 0.0 0.0 | * * 0.0 0.0 | * * | * | | 10-14 | * * 0.0 0.0 | 1.1 * * 0.0 | 0.6 * * 0.0 | 0.8 1.0 | 0.6 | | 15-19 | 1.7 13.0 * * | 1.8 8.7 * * | 1.2 7.7 * * | 2.2 1.9 | 1.5 | | 20-24 | 3.2 31.1 20.2 * | 2.4 21.5 * * | 2.0 18.8 12.0 51.9 | 4.8 3.5 | 2.9 | | 25-29 | 4.6 42.5 26.6 * | 3.3 29.8 * * | 2.8 25.8 15.5 42.8 | 6.7 4.7 | 4.0 | | 30-34 | 4.5 51.3 32.1 88.5 | 3.6 34.3 25.4 * | 2.8 30.6 20.5 49.2 | 7.6 5.3 | 4.6 | | 35-39 | 5.0 65.4 36.5 125.8 | 3.5 42.9 28.0 95.5 | 3.1 38.8 23.0 78.5 | 9.4 6.3 | 5.6 | | 40-44 | 7.0 85.5 43.7 162.2 | 4.7 55.1 42.4 133.7 | 4.2 50.6 30.6 105.8 | 12.5 8.2 | 7.4 | | 45-49 | 8.9 117.2 68.0 234.3 | 6.6 72.0 52.8 142.7 | 5.5 68.6 43.4 136.3 | 17.0 10.9 | 9.9 | | 50-54 | 12.8 152.7 102.3 270.0 | 9.4 100.1 86.8 218.0 | 8.0 90.9 67.8 173.5 | 22.6 15.4 | 13.5 | | 55-59 | 19.2 181.7 137.9 370.9 | 14.1 132.4 108.0 323.1 | 11.9 112.1 87.6 247.5 | 28.7 21.1 | 17.6 | | 60-64 | 28.7 225.5 213.3 483.5 | 20.6 168.1 160.8 400.2 | 17.5 139.8 133.9 313.3 | 38.2 28.1 | 23.5 | | 65-69 | 39.5 245.8 298.7 627.3 | 27.1 201.5 214.1 574.8 | 23.8 158.5 183.1 426.1 | 46.7 35.2 | 29.1 | | 70-74 | 54.6 329.6 425.7 790.5 | 33.9 266.7 276.8 821.2 | 31.8 211.2 251.9 573.7 | 63.8 45.6 | 38.9 | | 75-79 | 74.2 428.6 687.4 1211.5 | 42.5 309.3 479.1 928.9 | 42.3 262.4 419.4 765.7 | 86.4 56.1 | 50.9 | | 80-84 | 102.7 568.2 965.5 1548.0 | 52.3 387.2 666.7 1091.9 | 56.8 341.1 579.5 947.5 | 117.4 70.4 | 67.6 | | 85 plus | 106.9 558.8 919.8 * | 39.6 324.9 637.2 732.5 | 55.8 319.1 556.5 774.1 | 118.5 57.5 | 64.8 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.2 29.3 35.8 69.3 | 2.5 20.9 25.2 56.2 | 2.3 17.5 20.9 43.6 | 4.8 3.0 | 2.6 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.12(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age, Adjusted for Age, Race, and Sex 1994-1997 Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.6 * * 0.0 | 1.7 * * 0.0 | 1.2 3.1 * 0.0 | 1.5 1.5 | 1.1 | | 5- 9 | 2.2 6.7 * * | 2.3 5.8 * * | 1.6 4.4 * * | 2.1 2.1 | 1.5 | | 10-14 | 2.9 9.2 * * | 3.2 12.5 * * | 2.2 7.8 13.2 * | 2.8 3.2 | 2.1 | | 15-19 | 5.1 24.1 33.5 * | 4.8 17.9 25.6 * | 3.5 15.0 21.2 * | 5.4 4.7 | 3.6 | | 20-24 | 6.7 32.9 40.9 85.9 | 5.9 26.7 39.1 * | 4.5 21.1 28.2 57.8 | 7.1 6.1 | 4.7 | | 25-29 | 7.4 36.3 44.4 100.5 | 5.7 27.8 38.0 101.3 | 4.7 22.7 29.3 71.5 | 7.9 6.1 | 5.0 | | 30-34 | 7.1 36.6 52.0 106.7 | 5.2 29.2 40.4 132.3 | 4.4 23.3 32.9 85.5 | 7.8 6.0 | 4.9 | | 35-39 | 7.3 42.4 51.7 128.9 | 5.6 30.4 57.7 117.0 | 4.6 25.9 39.0 86.9 | 8.4 6.5 | 5.2 | | 40-44 | 8.2 53.1 61.3 174.7 | 6.1 35.1 57.4 114.8 | 5.1 31.6 42.5 103.9 | 9.9 7.1 | 6.1 | | 45-49 | 10.0 63.0 73.5 192.7 | 7.4 39.6 63.4 161.8 | 6.2 37.0 49.0 124.3 | 12.0 8.4 | 7.2 | | 50-54 | 12.6 73.5 100.9 216.0 | 9.3 47.3 67.2 * | 7.8 43.4 60.6 124.7 | 14.6 10.1 | 8.8 | | 55-59 | 16.3 83.4 112.6 276.4 | 11.6 57.2 101.9 233.0 | 9.9 50.3 76.2 180.5 | 17.8 12.8 | 10.9 | | 60-64 | 20.2 93.4 118.9 303.0 | 13.8 60.5 101.2 348.9 | 12.1 55.2 78.2 231.8 | 21.1 14.5 | 12.7 | | 65-69 | 23.5 89.1 226.7 435.9 | 15.3 69.6 128.7 376.3 | 13.9 56.3 129.6 287.7 | 24.3 16.5 | 14.6 | | 70-74 | 29.0 115.5 272.9 538.6 | 17.5 84.5 177.9 * | 16.8 71.1 162.0 323.2 | 30.2 19.4 | 17.8 | | 75-79 | 36.1 131.4 400.0 773.3 | 20.1 88.7 230.2 544.6 | 20.4 78.5 230.1 471.3 | 37.8 22.3 | 21.7 | | 80-84 | 48.2 173.4 456.0 * | 21.6 96.8 400.0 * | 26.0 98.3 303.1 * | 48.8 26.6 | 27.4 | | 85 plus | 46.9 158.6 506.8 * | 16.5 89.9 * 0.0 | 24.4 90.3 279.6 * | 47.6 20.0 | 25.4 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.7 12.8 23.7 47.3 | 1.8 8.9 17.3 38.2 | 1.6 7.6 14.2 29.8 | 2.8 1.9 | 1.6 | ------------------------------------------------------------------------------------------------------------------------- Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.5 * 0.0 0.0 | 1.6 * * 0.0 | 1.1 * * 0.0 | 1.3 1.4 | 1.0 | | 5- 9 | 1.2 * * * | 1.4 * 0.0 0.0 | 0.9 * * * | 1.1 1.2 | 0.8 | | 10-14 | 1.3 * * * | 1.5 * * 0.0 | 1.0 2.8 * * | 1.2 1.4 | 0.9 | | 15-19 | 1.2 * 0.0 * | 1.3 * * 0.0 | 0.9 * * * | 1.1 1.2 | 0.8 | | 20-24 | 1.4 * 0.0 0.0 | 1.4 * * 0.0 | 1.0 * * 0.0 | 1.2 1.3 | 0.9 | | 25-29 | 1.5 * 0.0 * | 1.8 * * * | 1.2 * * * | 1.4 1.6 | 1.1 | | 30-34 | 2.4 8.3 * * | 2.1 7.1 * * | 1.6 5.4 * * | 2.3 2.0 | 1.5 | | 35-39 | 3.7 10.6 * * | 3.1 9.5 * * | 2.4 7.1 10.7 * | 3.4 2.9 | 2.2 | | 40-44 | 5.6 17.1 * * | 4.5 15.2 20.3 0.0 | 3.6 11.4 13.3 * | 5.2 4.3 | 3.3 | | 45-49 | 7.5 24.6 29.2 * | 6.5 21.2 25.4 * | 4.9 16.3 19.1 * | 7.0 6.1 | 4.6 | | 50-54 | 9.6 29.9 50.1 * | 8.2 27.9 * * | 6.3 20.4 29.1 * | 9.1 7.8 | 6.0 | | 55-59 | 10.3 32.0 56.3 * | 9.3 28.6 * * | 6.9 21.4 33.9 * | 9.7 8.7 | 6.5 | | 60-64 | 10.0 38.9 61.8 * | 9.2 28.9 * * | 6.8 24.1 37.9 * | 10.0 8.7 | 6.6 | | 65-69 | 11.1 39.1 78.7 * | 9.2 29.5 * * | 7.2 24.3 44.2 * | 10.9 8.8 | 6.9 | | 70-74 | 11.5 47.4 * 0.0 | 9.1 40.1 * 0.0 | 7.3 30.9 53.2 0.0 | 11.7 9.4 | 7.4 | | 75-79 | 12.4 61.7 * 0.0 | 8.5 38.2 * 0.0 | 7.5 35.5 * 0.0 | 13.3 9.0 | 7.9 | | 80-84 | 14.9 102.7 * * | 8.2 39.2 * * | 8.4 53.9 * * | 19.0 9.6 | 10.4 | | 85 plus | 15.4 * * * | 5.1 * 0.0 0.0 | 8.0 43.1 * * | 17.5 5.8 | 9.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.3 4.9 7.8 15.9 | 1.1 3.8 5.4 13.6 | 0.9 3.0 4.6 10.0 | 1.3 1.0 | 0.8 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.12(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age, Adjusted for Age, Race, and Sex 1994-1997 Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.3 * 0.0 0.0 | * * 0.0 0.0 | 0.7 * 0.0 0.0 | 1.2 * | 0.7 | | 5- 9 | 1.2 * 0.0 0.0 | 1.2 * 0.0 0.0 | 0.9 * 0.0 0.0 | 1.1 1.1 | 0.8 | | 10-14 | 2.1 * 0.0 0.0 | 1.9 * * * | 1.4 * * * | 1.8 1.6 | 1.2 | | 15-19 | 2.1 6.9 0.0 0.0 | 2.1 * * * | 1.5 4.1 * * | 1.9 1.8 | 1.3 | | 20-24 | 2.5 * * 0.0 | 2.7 * * * | 1.8 3.7 * * | 2.2 2.4 | 1.6 | | 25-29 | 2.8 7.5 * * | 2.7 6.9 0.0 0.0 | 1.9 5.1 * * | 2.5 2.4 | 1.7 | | 30-34 | 2.4 6.8 * * | 2.5 * * * | 1.8 4.2 * * | 2.2 2.3 | 1.6 | | 35-39 | 2.7 8.1 * * | 2.7 5.8 * * | 1.9 4.9 * * | 2.5 2.4 | 1.7 | | 40-44 | 2.9 9.6 * * | 2.7 10.1 * 0.0 | 2.0 7.0 * * | 2.7 2.6 | 1.9 | | 45-49 | 3.3 14.3 * * | 3.2 9.9 * 0.0 | 2.3 8.7 13.5 * | 3.4 3.0 | 2.2 | | 50-54 | 4.4 19.0 * * | 4.3 13.7 * * | 3.1 11.7 * * | 4.5 4.1 | 3.0 | | 55-59 | 6.5 28.3 * * | 5.4 19.7 44.8 0.0 | 4.2 17.2 27.3 * | 6.6 5.3 | 4.2 | | 60-64 | 8.9 42.3 70.5 * | 6.2 21.6 * * | 5.4 23.5 39.0 * | 9.6 6.0 | 5.6 | | 65-69 | 11.2 55.6 78.7 * | 7.0 26.7 61.8 * | 6.5 30.4 50.0 * | 12.1 7.1 | 6.9 | | 70-74 | 14.7 72.6 * * | 7.8 29.9 81.6 * | 8.2 38.6 59.7 * | 15.7 8.1 | 8.7 | | 75-79 | 20.3 82.6 * * | 8.9 30.2 * * | 10.8 43.1 76.0 * | 20.9 8.9 | 11.1 | | 80-84 | 28.9 154.1 * * | 8.6 54.2 * 0.0 | 14.7 80.4 * * | 32.0 10.6 | 16.5 | | 85 plus | 33.1 133.1 * 0.0 | 7.3 39.8 * 0.0 | 16.5 68.6 * 0.0 | 33.5 9.0 | 17.0 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.3 5.8 8.5 24.3 | 0.8 2.8 6.1 10.0 | 0.7 2.9 4.9 11.8 | 1.3 0.8 | 0.7 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 4.1 11.6 * * | 3.1 8.6 * * | 2.6 7.2 10.5 * | 3.8 2.8 | 2.4 | | 5- 9 | 3.5 9.7 * 0.0 | 2.7 6.4 * * | 2.2 5.8 * * | 3.2 2.5 | 2.0 | | 10-14 | 4.3 13.9 * * | 3.6 10.8 * * | 2.8 8.8 13.1 * | 4.0 3.4 | 2.6 | | 15-19 | 5.4 16.0 26.8 * | 4.7 16.4 31.3 * | 3.6 11.4 20.7 40.2 | 5.0 4.6 | 3.4 | | 20-24 | 5.4 23.0 21.2 * | 5.6 28.6 35.1 * | 3.9 18.4 20.7 44.7 | 5.4 6.0 | 4.1 | | 25-29 | 5.8 34.9 21.1 * | 5.7 33.3 30.5 93.1 | 4.1 24.1 18.8 56.8 | 6.6 6.4 | 4.6 | | 30-34 | 5.3 44.5 21.5 * | 5.2 36.4 30.4 * | 3.7 28.6 18.9 44.0 | 7.2 6.4 | 4.8 | | 35-39 | 5.7 50.2 22.3 134.9 | 5.7 38.5 24.9 106.8 | 4.0 31.5 16.8 85.5 | 8.1 6.9 | 5.3 | | 40-44 | 6.5 58.1 27.6 117.0 | 6.5 40.8 35.1 106.3 | 4.6 35.2 22.6 79.2 | 9.2 7.6 | 5.9 | | 45-49 | 7.8 65.1 35.8 139.2 | 8.0 44.4 38.0 152.6 | 5.6 39.0 25.8 103.7 | 10.6 8.9 | 6.8 | | 50-54 | 10.9 68.5 50.1 202.0 | 10.2 52.9 52.9 165.9 | 7.5 43.0 37.2 131.5 | 12.8 11.0 | 8.4 | | 55-59 | 14.6 77.9 70.6 247.2 | 13.0 57.8 67.5 233.0 | 9.8 48.2 49.5 169.8 | 16.0 13.4 | 10.4 | | 60-64 | 19.4 91.8 101.6 288.9 | 16.5 67.6 69.8 299.5 | 12.7 56.6 61.4 210.5 | 20.3 16.5 | 13.0 | | 65-69 | 24.3 95.2 138.6 420.0 | 18.2 67.0 108.5 322.2 | 15.1 57.7 87.6 263.4 | 24.3 18.0 | 15.0 | | 70-74 | 29.7 125.2 153.3 * | 20.1 83.7 135.4 397.3 | 17.8 74.5 101.3 290.5 | 30.0 20.7 | 18.0 | | 75-79 | 38.3 166.1 291.6 * | 22.7 96.9 168.9 * | 22.0 95.0 165.9 353.7 | 39.8 23.4 | 22.8 | | 80-84 | 48.6 228.5 338.7 * | 24.7 121.2 231.0 * | 26.8 127.7 200.5 * | 51.0 27.1 | 28.4 | | 85 plus | 51.0 209.3 388.7 * | 17.1 93.3 * * | 26.3 112.5 220.2 * | 52.6 20.0 | 27.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.6 13.9 15.2 42.2 | 2.0 9.9 12.2 34.1 | 1.6 8.3 9.3 26.0 | 2.8 2.1 | 1.7 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.12(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age, Adjusted for Age, Race, and Sex 1994-1997 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.1 * 0.0 0.0 | * * 0.0 0.0 | 0.7 * 0.0 0.0 | 1.0 * | 0.6 | | 5- 9 | * * 0.0 0.0 | 1.2 * * * | 0.8 * * * | 0.9 1.1 | 0.7 | | 10-14 | * 6.8 * * | 1.7 6.8 * 0.0 | 1.0 4.8 * * | 1.2 1.7 | 1.0 | | 15-19 | 2.4 9.0 * * | 2.3 8.5 * * | 1.7 6.2 * * | 2.3 2.3 | 1.6 | | 20-24 | 3.5 13.5 * * | 2.8 10.8 * * | 2.2 8.6 11.6 * | 3.5 2.7 | 2.2 | | 25-29 | 3.2 17.1 20.2 * | 2.9 11.2 * * | 2.2 10.2 11.9 * | 3.5 2.8 | 2.3 | | 30-34 | 3.1 20.4 * * | 2.3 12.9 18.4 * | 1.9 12.0 11.2 * | 3.7 2.7 | 2.2 | | 35-39 | 3.2 22.9 26.9 * | 2.8 13.3 21.4 * | 2.1 13.1 17.2 * | 4.1 3.0 | 2.5 | | 40-44 | 3.7 25.9 24.9 * | 3.0 18.3 21.2 * | 2.4 15.8 16.4 52.6 | 4.6 3.5 | 2.9 | | 45-49 | 4.4 32.8 31.5 * | 3.8 21.6 28.4 * | 2.9 19.6 21.7 * | 5.8 4.3 | 3.6 | | 50-54 | 6.0 37.1 36.4 * | 4.8 27.9 44.0 * | 3.8 23.2 28.6 * | 7.0 5.6 | 4.5 | | 55-59 | 8.4 54.7 52.1 * | 7.0 37.4 50.5 * | 5.5 33.0 37.1 118.8 | 10.1 7.9 | 6.4 | | 60-64 | 11.6 62.0 89.6 * | 8.8 43.7 78.1 * | 7.2 37.7 59.4 135.1 | 12.9 9.7 | 8.0 | | 65-69 | 14.2 68.8 129.3 386.4 | 10.8 52.6 79.8 * | 8.9 43.1 76.5 233.4 | 15.7 11.8 | 9.8 | | 70-74 | 20.7 91.5 140.0 * | 12.5 71.5 131.2 * | 12.0 57.8 96.4 236.2 | 21.5 14.8 | 13.0 | | 75-79 | 27.8 121.4 278.4 * | 15.3 78.4 156.4 * | 15.6 71.8 161.8 326.5 | 29.9 17.4 | 17.1 | | 80-84 | 39.1 180.9 369.1 * | 19.4 106.5 266.7 * | 21.5 103.6 229.1 * | 41.9 23.5 | 23.7 | | 85 plus | 43.7 172.7 388.7 0.0 | 16.6 97.5 * * | 22.8 97.6 216.5 * | 44.1 20.2 | 23.9 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.7 8.7 14.4 29.8 | 1.1 5.9 10.7 23.7 | 1.0 5.0 8.6 18.8 | 1.8 1.2 | 1.0 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0- 4 | 1.6 * * 0.0 | 1.5 * * 0.0 | 1.1 2.6 * 0.0 | 1.5 1.4 | 1.0 | | 5- 9 | 1.6 * * 0.0 | 1.4 * * 0.0 | 1.1 2.7 * 0.0 | 1.5 1.3 | 1.0 | | 10-14 | 1.9 6.4 0.0 * | 1.6 5.8 * 0.0 | 1.2 4.3 * * | 1.8 1.6 | 1.2 | | 15-19 | 2.4 8.3 * 0.0 | 1.8 8.7 * * | 1.5 6.0 * * | 2.2 1.9 | 1.5 | | 20-24 | 2.7 12.6 * * | 2.3 11.0 * 0.0 | 1.8 8.4 10.7 * | 2.9 2.5 | 1.9 | | 25-29 | 3.1 18.5 * * | 3.0 14.6 * * | 2.2 11.7 11.9 * | 3.5 3.2 | 2.4 | | 30-34 | 3.3 20.9 * * | 3.2 13.9 * * | 2.3 12.5 10.4 * | 3.9 3.2 | 2.5 | | 35-39 | 3.6 23.7 23.1 * | 2.8 17.1 * * | 2.3 14.5 13.2 * | 4.3 3.2 | 2.7 | | 40-44 | 4.1 29.5 22.9 * | 3.3 20.0 * 0.0 | 2.6 17.3 12.9 * | 5.0 3.7 | 3.1 | | 45-49 | 5.1 42.5 28.0 * | 4.0 25.5 25.4 * | 3.2 23.8 18.8 * | 6.8 4.6 | 4.0 | | 50-54 | 6.6 48.9 39.9 * | 5.2 33.4 37.4 * | 4.1 29.0 26.2 78.2 | 8.3 6.1 | 5.1 | | 55-59 | 8.0 61.0 * * | 6.0 47.8 * * | 4.9 38.3 23.6 * | 10.3 7.8 | 6.4 | | 60-64 | 10.1 80.2 78.2 * | 8.6 61.6 * * | 6.6 50.3 43.0 * | 13.5 10.8 | 8.6 | | 65-69 | 12.8 72.5 78.7 * | 9.8 63.2 64.3 * | 8.0 48.0 51.0 * | 14.4 11.9 | 9.3 | | 70-74 | 15.8 95.3 * * | 10.3 72.7 * * | 9.4 59.6 53.6 * | 18.2 12.9 | 11.0 | | 75-79 | 21.2 109.0 * * | 12.0 79.6 * * | 11.9 66.9 75.7 * | 22.7 14.6 | 13.4 | | 80-84 | 26.2 157.5 * * | 12.7 101.8 * 0.0 | 14.2 92.8 * * | 30.1 17.1 | 17.1 | | 85 plus | 29.4 158.6 * * | 10.4 87.2 * 0.0 | 15.1 89.4 * * | 32.7 14.8 | 17.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.4 9.1 9.0 19.0 | 1.0 6.6 6.3 19.6 | 0.8 5.5 5.3 13.5 | 1.6 1.1 | 0.9 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Incident cases for 1994 through 1997 are combined to produce larger cell sizes. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.13 Median Age at Start of ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD ---------------------------------------------------------------------------------------------------------- | | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | |----------------------------------+------+------+------+------+------+------+------+------+------+------| |Age 0-19 | 15.0| 15.0| 14.0| 14.0| 15.0| 14.0| 14.0| 14.0| 14.0| 14.0| | 20-44 | 35.0| 35.0| 35.0| 36.0| 36.0| 36.0| 36.0| 36.0| 37.0| 37.0| | 45-64 | 57.0| 57.0| 57.0| 57.0| 57.0| 56.0| 56.0| 56.0| 56.0| 56.0| | 65-74 | 69.0| 69.0| 69.0| 69.0| 69.0| 69.0| 69.0| 69.0| 70.0| 70.0| | 75 plus | 78.0| 79.0| 79.0| 79.0| 79.0| 79.0| 79.0| 79.0| 79.0| 79.0| |Disease 1 Diabetes | 59.0| 60.0| 61.0| 61.0| 62.0| 62.0| 62.0| 62.0| 63.0| 64.0| | 2 Hypertension | 67.0| 67.0| 68.0| 68.0| 68.0| 69.0| 68.0| 69.0| 69.0| 71.0| | 3 Glomeruloneph. | 52.0| 53.0| 53.0| 54.0| 53.0| 54.0| 54.0| 53.0| 54.0| 56.0| | 4 Cystic Kidney | 53.0| 53.5| 54.0| 54.0| 54.0| 53.0| 54.0| 53.0| 53.0| 54.0| | 5 Other Urologic | 68.0| 68.0| 67.0| 62.0| 64.0| 62.0| 64.0| 65.0| 66.0| 66.0| | 6 Other Cause | 56.0| 57.0| 56.0| 58.0| 58.0| 57.0| 56.0| 56.0| 57.0| 60.0| | 7 Unknown Cause | 65.0| 66.0| 65.0| 65.0| 65.0| 65.0| 65.0| 66.0| 66.0| 69.0| | 8 Missing Cause | 56.0| 62.0| 61.0| 58.0| 61.5| 68.0| 64.0| 61.0| 58.0| 58.0| |Race 1 Native Amer. | 57.0| 59.0| 57.0| 58.0| 60.0| 60.0| 58.0| 58.0| 57.0| 59.0| | 2 Asian | 58.0| 59.0| 59.0| 61.0| 60.0| 62.0| 62.0| 62.0| 64.0| 65.0| | 3 Black | 57.0| 58.0| 59.0| 59.0| 59.0| 59.0| 58.0| 57.0| 58.0| 59.0| | 4 White | 63.0| 64.0| 64.0| 65.0| 65.0| 66.0| 66.0| 65.0| 66.0| 67.0| | 5 Unknown | 40.0| 39.0| 45.0| 41.0| 39.0| 45.0| 49.0| 52.0| 56.0| 52.0| | 9 Other | 54.5| 58.0| 46.0| 50.0| 61.0| 64.0| 57.0| 57.0| 56.0| 57.0| |Sex Female | 62.0| 63.0| 63.0| 64.0| 64.0| 65.0| 64.0| 64.0| 64.0| 65.0| | Male | 60.0| 61.0| 61.0| 62.0| 62.0| 63.0| 62.0| 62.0| 62.0| 64.0| |Total Total | 61.0| 62.0| 62.0| 63.0| 63.0| 64.0| 63.0| 63.0| 63.0| 65.0| ---------------------------------------------------------------------------------------------------------- Table A.14 Mean Age at Start Of ESRD Therapy by Year, Age, Race, Sex, and Primary Disease Causing ESRD ---------------------------------------------------------------------------------------------------------- | | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | |----------------------------------+------+------+------+------+------+------+------+------+------+------| |Age 0-19 | 12.8| 12.9| 12.6| 12.3| 12.8| 12.4| 12.7| 12.2| 12.3| 12.2| | 20-44 | 34.2| 34.3| 34.6| 34.9| 34.9| 34.9| 34.9| 35.2| 35.3| 35.4| | 45-64 | 56.0| 55.9| 56.0| 56.0| 55.9| 55.7| 55.7| 55.6| 55.6| 55.7| | 65-74 | 69.3| 69.3| 69.3| 69.4| 69.4| 69.4| 69.5| 69.5| 69.6| 69.6| | 75 plus | 79.3| 79.4| 79.6| 79.5| 79.7| 79.7| 79.7| 79.8| 79.9| 80.0| |Disease 1 Diabetes | 56.8| 57.3| 58.3| 58.9| 59.3| 59.6| 60.0| 60.3| 61.0| 61.9| | 2 Hypertension | 63.5| 64.0| 64.4| 64.8| 64.8| 65.2| 65.0| 64.9| 65.3| 66.9| | 3 Glomeruloneph. | 50.6| 51.3| 51.6| 52.4| 52.1| 52.3| 52.8| 52.3| 53.2| 54.3| | 4 Cystic Kidney | 53.6| 53.5| 54.0| 53.5| 54.3| 54.1| 54.8| 53.8| 54.3| 55.1| | 5 Other Urologic | 61.3| 62.0| 60.5| 55.4| 56.7| 55.8| 56.8| 59.4| 60.0| 60.8| | 6 Other Cause | 51.8| 52.3| 51.9| 53.2| 54.0| 53.2| 53.2| 53.3| 54.2| 55.8| | 7 Unknown Cause | 60.2| 60.3| 59.7| 59.8| 59.9| 59.1| 59.1| 61.4| 61.4| 63.7| | 8 Missing Cause | 52.9| 58.0| 57.3| 55.2| 57.3| 64.2| 58.7| 57.4| 54.8| 56.3| |Race 1 Native Amer. | 54.7| 56.7| 56.2| 56.0| 58.4| 58.3| 56.3| 56.3| 56.5| 57.4| | 2 Asian | 55.9| 55.1| 56.3| 57.2| 57.1| 58.0| 58.5| 59.6| 60.5| 61.0| | 3 Black | 54.9| 55.4| 56.0| 56.2| 56.4| 56.6| 56.2| 55.7| 56.2| 57.5| | 4 White | 58.6| 59.5| 59.9| 60.5| 61.1| 61.6| 61.8| 61.8| 62.4| 63.5| | 5 Unknown | 42.8| 41.9| 44.6| 42.4| 40.4| 45.3| 47.6| 50.3| 51.7| 51.7| | 9 Other | 51.5| 53.3| 45.5| 49.2| 55.5| 58.2| 52.9| 54.3| 54.0| 54.9| |Sex Female | 58.3| 59.1| 59.6| 60.2| 60.4| 61.0| 60.8| 60.6| 61.0| 62.2| | Male | 56.5| 57.3| 57.7| 58.1| 58.7| 58.9| 59.0| 58.7| 59.4| 60.8| |Total Total | 57.3| 58.1| 58.6| 59.1| 59.5| 59.9| 59.8| 59.6| 60.2| 61.4| ---------------------------------------------------------------------------------------------------------- Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. * Values for cells with fewer than 10 patients are suppressed. Table A.15 Incidence of Reported ESRD Therapy and Median Age at Incidence by Sex, Race, One Year Transplant and Death Status and Detailed Primary Disease, for All Patients, 1993-1997 % % Tran % Died Total % Median % % % % Native First First Primary Disease Groups Patients Incid Age Males White Black Asian Amer. Year Year All ESRD, (reference) 357,051 100.0 64 53.3 63.9 29.5 3.3 1.5 6.0 22.3 Diabetes 143,448 41.7 63 47.6 63.7 28.5 3.5 2.3 3.8 21.5 . Type 1, juvenile type 41,318 12.0 56 49.9 70.3 24.6 2.4 1.5 8.8 19.2 . Type 2, adult-onset or unspec. type 102,130 29.7 64 46.7 61.0 30.0 3.9 2.7 1.8 22.5 Glomerulonephritis 37,463 10.9 54 60.7 67.5 23.9 5.3 1.2 12.7 12.8 . Focal glomerulosclerosis, focal GN 7,294 2.1 46 62.3 58.6 36.5 2.5 0.9 15.4 9.2 . Membranous nephropathy 1,708 0.5 59 65.4 70.7 24.8 2.3 0.9 11.6 11.1 . Membranoproliferative GN, types 1&2 1,380 0.4 46 58.8 74.3 16.5 5.1 2.0 21.2 9.1 . IgA nephropathy, Bergers disease 1,618 0.5 41 68.4 75.8 7.4 11.2 1.7 28.1 4.8 . IgM nephropathy 175 0.1 43 68.6 77.7 8.0 10.3 0.6 31.4 5.1 . Rapidly progressive GN 1,450 0.4 62 51.3 80.5 12.3 3.9 1.7 9.2 15.8 . Goodpastures Syndrome 659 0.2 62 46.9 88.9 7.0 2.1 1.2 6.7 23.8 . Post infectious GN, SBE 258 0.1 55 61.2 77.5 16.3 3.1 1.6 9.3 15.1 . Glomerulonephritis (GN) 21,809 6.3 58 60.5 67.2 23.1 6.1 1.3 10.3 14.5 . Other proliferative GN 1,112 0.3 53 58.1 73.9 18.1 5.3 1.4 15.8 13.5 Secondary GN/Vasculitis 8,522 2.5 46 32.4 63.2 30.4 3.3 1.2 8.0 18.3 . Lupus erythematosus, (SLE nephritis) 4,301 1.3 38 18.7 47.3 44.1 4.8 1.1 9.9 11.9 . Polyarteritis 188 0.1 64 48.4 83.5 10.6 5.3 0.5 4.3 21.8 . Wegeners granulomatosis 945 0.3 64 58.8 91.9 5.2 1.3 1.0 6.0 23.5 . Henoch-Schonlein syndrome 142 0.0 25 56.3 82.4 7.0 6.3 2.8 29.6 7.0 . Vasculitis and its derivatives 695 0.2 68 47.3 87.5 7.6 1.6 2.0 2.7 26.5 . Scleroderma 756 0.2 57 22.2 77.8 18.8 1.5 1.1 2.1 35.8 . Hemolytic uremic syndrome 718 0.2 49 35.2 80.1 17.4 1.3 0.7 9.6 21.3 . Nephropathy from heroin /related abuse 530 0.2 53 62.8 54.5 40.2 2.3 1.9 5.7 20.4 . Secondary GN, other 247 0.1 52 58.7 58.7 34.8 2.0 2.0 6.5 21.9 Interstitial Nephritis/Pyelonephritis 14,784 4.3 65 56.5 78.8 16.1 2.8 0.9 8.6 21.1 . Chronic pyelonephritis, reflux neph. 1,975 0.6 49 39.2 84.0 10.4 3.3 1.1 18.2 12.6 . Analgesic abuse 567 0.2 66 36.0 76.9 18.7 2.5 0.7 4.1 17.5 . Nephropathy caused by other agents 1,765 0.5 65 66.2 77.4 18.1 2.2 0.6 7.0 26.9 . Nephrolithiasis, Obstruction, Gouty 4,441 1.3 68 73.3 78.3 16.1 3.1 0.7 5.7 24.7 . Nephrocalcinosis 180 0.1 68 52.8 76.7 16.7 3.9 0.6 8.3 21.7 . Chronic interstitial nephritis 5,420 1.6 64 48.6 77.8 17.2 2.7 1.1 8.9 19.0 . Acute interstitial nephritis 436 0.1 68 49.1 82.1 14.4 2.1 0.2 3.0 31.9 Hypertensive/large vessel disease 96,538 28.1 69 57.0 58.3 37.1 2.8 0.7 2.2 25.0 . Hypertension, (no primary ren. dis.) 87,564 25.5 69 56.7 54.8 40.4 2.9 0.7 2.4 23.8 . Renal artery stenosis or occlusion 6,696 1.9 73 57.8 92.3 5.6 1.2 0.5 0.8 36.8 . Cholesterol emboli, renal emboli 2,278 0.7 72 66.1 94.9 3.3 1.1 0.4 0.3 37.1 Cystic/Heriditary/Congenital Diseases 12,027 3.5 51 56.3 81.3 13.7 2.6 0.8 23.6 6.7 . Polycystic kidneys, adult (dominant) 8,788 2.6 54 52.6 82.5 13.1 2.6 0.6 19.0 6.7 . Polycystic, infantile (recessive) 108 0.0 22 47.2 81.5 16.7 1.9 0.0 25.9 11.1 . Medullary cystic, inc nephronophthisis 132 0.0 24 52.3 81.8 12.1 0.8 2.3 43.2 4.5 . Alports, other hereditary/familial dis 781 0.2 33 70.2 84.4 11.0 1.9 1.2 34.4 2.3 . Tuberous sclerosis 125 0.0 60 44.8 76.8 18.4 2.4 1.6 8.8 21.6 . Cystinosis 54 0.0 15 53.7 88.9 7.4 0.0 1.9 53.7 3.7 . Primary oxalosis 86 0.0 53 51.2 90.7 7.0 2.3 0.0 24.4 11.6 . Fabrys disease 71 0.0 41 88.7 90.1 5.6 0.0 2.8 23.9 4.2 . Congenital nephrotic syndrome 130 0.0 21 51.5 65.4 18.5 10.0 2.3 34.6 10.8 . Drash syndrome, mesangial sclerosis 20 0.0 35 60.0 65.0 25.0 0.0 5.0 20.0 0.0 . Congenital obstructive uropathy 917 0.3 26 76.0 75.1 17.2 3.2 0.9 37.0 9.3 . Renal hypoplasia, dysplasia 734 0.2 14 59.4 74.0 19.1 2.0 1.4 43.3 4.6 . Prune belly syndrome 81 0.0 11 97.5 77.8 18.5 1.2 0.0 43.2 3.7 Neoplasms/Tumors 5,971 1.7 68 62.0 78.1 18.7 1.5 0.9 1.0 46.7 . Renal or Urological Neoplasms 1,662 0.5 68 72.6 79.7 17.1 1.3 1.1 1.3 38.1 . Multiple myeloma 2,993 0.9 69 59.2 75.7 20.8 1.7 0.9 0.2 53.6 . Light chain nephropathy 252 0.1 71 61.5 77.0 18.3 3.2 0.4 0.8 42.1 . Amyloidosis 1,064 0.3 66 53.7 82.3 15.0 1.0 0.8 2.9 41.4 Miscellaneous Conditions 10,814 3.1 53 65.3 55.2 41.4 1.1 0.7 3.4 37.4 . Complication post bone marr/other txp 196 0.1 54 62.8 86.2 10.7 1.0 1.0 18.9 24.5 . Sickle cell disease/anemia or trait 374 0.1 38 52.4 5.1 93.0 0.3 1.1 1.6 16.8 . AIDS nephropathy 3,622 1.1 38 74.9 9.1 87.6 0.2 0.6 0.1 43.7 . Traumatic/surgical loss of kidney(s) 247 0.1 66 70.0 81.8 13.0 2.0 1.2 3.2 22.7 . Hepatorenal syndrome 424 0.1 56 69.1 82.5 10.8 1.7 2.6 15.6 49.8 . Tubular necrosis (no recovery) 3,796 1.1 69 59.9 84.1 13.2 1.3 0.4 2.0 37.2 . Post-Partum Fail, Oth Renal Disorders 2,155 0.6 66 60.0 79.3 16.4 2.3 0.7 8.1 31.0 Etiology Uncertain 14,069 4.1 66 57.3 70.3 23.1 3.8 1.0 7.0 25.3 Missing 13,415 . 63 54.8 60.2 30.7 2.1 0.7 20.3 30.0 * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.16 Incidence of Reported ESRD Therapy by Detailed Primary Disease and Race for All Patients, 1993-1997 # Native Total # # # Native White Black Asian Amer. Primary Disease Groups Patients White Black Asian Amer. (%) (%) (%) (%) All ESRD, (reference) 357,051 228,332 105,177 11,654 5,182 100.0 100.0 100.0 100.0 Diabetes 143,448 91,309 40,855 4,954 3,366 41.5 40.4 43.5 66.1 . Type 1, juvenile type 41,318 29,028 10,171 976 622 13.2 10.1 8.6 12.2 . Type 2, adult-onset or unspec. type 102,130 62,281 30,684 3,978 2,744 28.3 30.4 35.0 53.9 Glomerulonephritis 37,463 25,304 8,951 1,972 466 11.5 8.9 17.3 9.2 . Focal glomerulosclerosis, focal GN 7,294 4,274 2,661 184 67 1.9 2.6 1.6 1.3 . Membranous nephropathy 1,708 1,207 424 40 16 0.5 0.4 0.4 0.3 . Membranoproliferative GN, types 1&2 1,380 1,026 228 71 28 0.5 0.2 0.6 0.6 . IgA nephropathy, Bergers disease 1,618 1,226 120 182 27 0.6 0.1 1.6 0.5 . IgM nephropathy 175 136 14 18 * 0.1 0.0 0.2 0.0 . Rapidly progressive GN 1,450 1,167 178 56 25 0.5 0.2 0.5 0.5 . Goodpastures Syndrome 659 586 46 14 * 0.3 0.0 0.1 0.2 . Post infectious GN, SBE 258 200 42 * * 0.1 0.0 0.1 0.1 . Glomerulonephritis (GN) 21,809 14,660 5,037 1,340 274 6.7 5.0 11.8 5.4 . Other proliferative GN 1,112 822 201 59 16 0.4 0.2 0.5 0.3 Secondary GN/Vasculitis 8,522 5,383 2,594 285 104 2.4 2.6 2.5 2.0 . Lupus erythematosus, (SLE nephritis) 4,301 2,036 1,896 206 48 0.9 1.9 1.8 0.9 . Polyarteritis 188 157 20 10 * 0.1 0.0 0.1 0.0 . Wegeners granulomatosis 945 868 49 12 * 0.4 0.0 0.1 0.2 . Henoch-Schonlein syndrome 142 117 10 * * 0.1 0.0 0.1 0.1 . Vasculitis and its derivatives 695 608 53 11 14 0.3 0.1 0.1 0.3 . Scleroderma 756 588 142 11 * 0.3 0.1 0.1 0.2 . Hemolytic uremic syndrome 718 575 125 * * 0.3 0.1 0.1 0.1 . Nephropathy from heroin /related abuse 530 289 213 12 10 0.1 0.2 0.1 0.2 . Secondary GN, other 247 145 86 * * 0.1 0.1 0.0 0.1 Interstitial Nephritis/Pyelonephritis 14,784 11,653 2,373 420 127 5.3 2.3 3.7 2.5 . Chronic pyelonephritis, reflux neph. 1,975 1,659 205 65 21 0.8 0.2 0.6 0.4 . Analgesic abuse 567 436 106 14 * 0.2 0.1 0.1 0.1 . Nephropathy caused by other agents 1,765 1,366 320 39 10 0.6 0.3 0.3 0.2 . Nephrolithiasis, Obstruction, Gouty 4,441 3,479 715 139 33 1.6 0.7 1.2 0.6 . Nephrocalcinosis 180 138 30 * * 0.1 0.0 0.1 0.0 . Chronic interstitial nephritis 5,420 4,217 934 147 57 1.9 0.9 1.3 1.1 . Acute interstitial nephritis 436 358 63 * * 0.2 0.1 0.1 0.0 Hypertensive/large vessel disease 96,538 56,313 35,810 2,689 670 25.6 35.4 23.6 13.2 . Hypertension, (no primary ren. dis.) 87,564 47,972 35,356 2,582 629 21.8 35.0 22.7 12.4 . Renal artery stenosis or occlusion 6,696 6,180 378 83 31 2.8 0.4 0.7 0.6 . Cholesterol emboli, renal emboli 2,278 2,161 76 24 10 1.0 0.1 0.2 0.2 Cystic/Heriditary/Congenital Diseases 12,027 9,780 1,647 309 93 4.4 1.6 2.7 1.8 . Polycystic kidneys, adult (dominant) 8,788 7,246 1,148 228 54 3.3 1.1 2.0 1.1 . Polycystic, infantile (recessive) 108 88 18 * 0 0.0 0.0 0.0 0.0 . Medullary cystic, inc nephronophthisis 132 108 16 * * 0.0 0.0 0.0 0.1 . Alports, other hereditary/familial dis 781 659 86 15 * 0.3 0.1 0.1 0.2 . Tuberous sclerosis 125 96 23 * * 0.0 0.0 0.0 0.0 . Cystinosis 54 48 * 0 * 0.0 0.0 0.0 0.0 . Primary oxalosis 86 78 * * 0 0.0 0.0 0.0 0.0 . Fabrys disease 71 64 * 0 * 0.0 0.0 0.0 0.0 . Congenital nephrotic syndrome 130 85 24 13 * 0.0 0.0 0.1 0.1 . Drash syndrome, mesangial sclerosis 20 13 * 0 * 0.0 0.0 0.0 0.0 . Congenital obstructive uropathy 917 689 158 29 * 0.3 0.2 0.3 0.2 . Renal hypoplasia, dysplasia 734 543 140 15 10 0.2 0.1 0.1 0.2 . Prune belly syndrome 81 63 15 * 0 0.0 0.0 0.0 0.0 Neoplasms/Tumors 5,971 4,662 1,114 92 53 2.1 1.1 0.8 1.0 . Renal or Urological Neoplasms 1,662 1,325 285 22 18 0.6 0.3 0.2 0.4 . Multiple myeloma 2,993 2,267 623 51 26 1.0 0.6 0.4 0.5 . Light chain nephropathy 252 194 46 * * 0.1 0.0 0.1 0.0 . Amyloidosis 1,064 876 160 11 * 0.4 0.2 0.1 0.2 Miscellaneous Conditions 10,814 5,968 4,475 119 72 2.7 4.4 1.0 1.4 . Complication post bone marr/other txp 196 169 21 * * 0.1 0.0 0.0 0.0 . Sickle cell disease/anemia or trait 374 19 348 * * 0.0 0.3 0.0 0.1 . AIDS nephropathy 3,622 328 3,173 * 21 0.1 3.1 0.1 0.4 . Traumatic/surgical loss of kidney(s) 247 202 32 * * 0.1 0.0 0.0 0.1 . Hepatorenal syndrome 424 350 46 * 11 0.2 0.0 0.1 0.2 . Tubular necrosis (no recovery) 3,796 3,192 501 48 16 1.4 0.5 0.4 0.3 . Post-Partum Fail, Oth Renal Disorders 2,155 1,708 354 49 15 0.8 0.4 0.4 0.3 Etiology Uncertain 14,069 9,889 3,244 536 138 4.5 3.2 4.7 2.7 Missing 13,415 8,071 4,114 278 93 . . . . * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.17 Incidence of Reported ESRD Therapy and Median Age at Incidence by Sex, Race, One Year Transplant and Death Status, and Detailed Primary Disease, for Patients Age 65 and Over, 1993-1997 % % Tran % Died Total % Median % % % % Native First First Primary Disease Groups Patients Incid Age Males White Black Asian Amer. Year Year All ESRD, (reference) 170,127 100.0 73 51.1 72.5 22.1 3.2 1.0 0.4 33.1 Diabetes 63,441 38.7 71 43.5 66.9 25.6 4.1 1.8 0.2 30.8 . Type 1, juvenile type 12,437 7.6 71 42.2 70.5 24.0 3.4 1.1 0.2 31.9 . Type 2, adult-onset or unspec. type 51,004 31.1 71 43.9 66.0 26.0 4.3 1.9 0.2 30.5 Glomerulonephritis 12,977 7.9 73 59.6 83.0 11.3 4.1 0.8 1.1 26.0 . Focal glomerulosclerosis, focal GN 1,756 1.1 72 64.5 83.9 12.6 2.6 0.4 1.9 21.8 . Membranous nephropathy 639 0.4 73 63.4 81.4 14.7 2.7 0.5 1.4 19.9 . Membranoproliferative GN, types 1&2 303 0.2 72 56.8 86.8 9.6 2.0 1.3 3.0 22.1 . IgA nephropathy, Bergers disease 230 0.1 72 71.7 90.4 3.5 4.8 0.4 1.7 21.7 . IgM nephropathy 27 0.0 71 77.8 92.6 3.7 3.7 0.0 3.7 14.8 . Rapidly progressive GN 656 0.4 73 48.3 90.7 5.9 1.8 0.9 0.3 28.7 . Goodpastures Syndrome 304 0.2 73 44.1 93.1 4.6 1.0 1.0 0.3 37.8 . Post infectious GN, SBE 83 0.1 74 62.7 90.4 6.0 2.4 0.0 0.0 27.7 . Glomerulonephritis (GN) 8,637 5.3 74 59.4 81.4 11.9 5.0 0.9 1.0 26.8 . Other proliferative GN 342 0.2 72 57.9 86.5 9.4 3.2 0.6 0.6 29.8 Secondary GN/Vasculitis 2,029 1.2 72 43.2 87.3 9.8 1.6 0.7 0.4 36.8 . Lupus erythematosus, (SLE nephritis) 378 0.2 70 24.6 71.4 24.9 1.9 0.3 0.5 33.1 . Polyarteritis 91 0.1 74 41.8 90.1 6.6 3.3 0.0 1.1 29.7 . Wegeners granulomatosis 466 0.3 72 56.4 96.4 2.1 0.9 0.6 0.2 36.7 . Henoch-Schonlein syndrome 12 0.0 74 50.0 83.3 8.3 8.3 0.0 0.0 33.3 . Vasculitis and its derivatives 403 0.2 74 49.6 92.8 3.5 1.7 1.5 0.5 33.5 . Scleroderma 244 0.1 71 23.8 89.3 7.8 2.0 0.4 0.0 51.6 . Hemolytic uremic syndrome 171 0.1 72 34.5 89.5 9.4 0.0 0.6 0.0 40.9 . Nephropathy from heroin /related abuse 185 0.1 75 61.6 80.0 17.3 1.6 1.1 0.0 31.9 . Secondary GN, other 79 0.0 73 58.2 86.1 8.9 3.8 1.3 2.5 36.7 Interstitial Nephritis/Pyelonephritis 7,430 4.5 74 59.9 83.5 12.7 2.6 0.5 0.8 31.0 . Chronic pyelonephritis, reflux neph. 589 0.4 74 37.0 85.4 10.0 3.4 0.5 1.0 30.2 . Analgesic abuse 318 0.2 73 38.7 82.1 13.2 3.1 0.6 1.3 23.0 . Nephropathy caused by other agents 900 0.5 74 68.6 82.2 14.1 2.3 0.3 0.8 36.2 . Nephrolithiasis, Obstruction, Gouty 2,639 1.6 75 77.1 82.0 13.6 2.6 0.6 0.5 33.3 . Nephrocalcinosis 96 0.1 75 56.3 80.2 15.6 3.1 0.0 2.1 31.3 . Chronic interstitial nephritis 2,630 1.6 74 48.4 84.7 12.0 2.4 0.4 1.1 27.1 . Acute interstitial nephritis 258 0.2 75 50.0 88.0 9.3 2.3 0.0 0.4 42.2 Hypertensive/large vessel disease 60,192 36.7 75 54.4 71.4 24.8 2.6 0.5 0.3 33.8 . Hypertension, (no primary ren. dis.) 52,731 32.2 75 53.6 68.1 27.7 2.9 0.5 0.3 33.0 . Renal artery stenosis or occlusion 5,550 3.4 74 57.7 93.6 4.6 1.2 0.3 0.1 39.4 . Cholesterol emboli, renal emboli 1,911 1.2 74 65.1 95.4 2.9 1.0 0.4 0.1 39.1 Cystic/Heriditary/Congenital Diseases 2,748 1.7 72 51.3 83.8 12.5 2.6 0.4 2.5 17.4 . Polycystic kidneys, adult (dominant) 2,355 1.4 72 49.8 83.9 12.4 2.6 0.4 2.9 15.9 . Polycystic, infantile (recessive) * 0.0 72 55.6 77.8 22.2 0.0 0.0 0.0 11.1 . Medullary cystic, inc nephronophthisis 17 0.0 73 58.8 82.4 11.8 5.9 0.0 0.0 29.4 . Alports, other hereditary/familial dis 64 0.0 72 48.4 95.3 3.1 1.6 0.0 3.1 10.9 . Tuberous sclerosis 52 0.0 73 55.8 88.5 7.7 1.9 1.9 0.0 36.5 . Cystinosis * 0.0 75 0.0 50.0 50.0 0.0 0.0 0.0 50.0 . Primary oxalosis 21 0.0 70 47.6 85.7 14.3 0.0 0.0 0.0 23.8 . Fabrys disease * 0.0 71 50.0 50.0 50.0 0.0 0.0 0.0 0.0 . Congenital nephrotic syndrome 19 0.0 77 42.1 84.2 5.3 10.5 0.0 0.0 42.1 . Drash syndrome, mesangial sclerosis * 0.0 72 50.0 83.3 16.7 0.0 0.0 0.0 0.0 . Congenital obstructive uropathy 155 0.1 75 74.8 76.1 18.1 3.2 0.6 0.0 32.3 . Renal hypoplasia, dysplasia 44 0.0 75 50.0 84.1 15.9 0.0 0.0 0.0 18.2 . Prune belly syndrome * 0.0 80 100.0 100.0 0.0 0.0 0.0 0.0 50.0 Neoplasms/Tumors 3,731 2.3 73 62.6 81.5 15.9 1.4 0.6 0.1 52.6 . Renal or Urological Neoplasms 1,034 0.6 74 75.0 82.5 14.8 1.4 1.0 0.1 43.8 . Multiple myeloma 1,939 1.2 73 58.9 79.3 17.9 1.5 0.6 0.0 58.4 . Light chain nephropathy 166 0.1 75 62.0 83.7 14.5 1.8 0.0 0.0 47.6 . Amyloidosis 592 0.4 72 53.0 86.3 11.8 1.2 0.2 0.5 50.3 Miscellaneous Conditions 3,833 2.3 74 60.6 87.8 9.6 1.6 0.4 0.3 45.0 . Complication post bone marr/other txp 34 0.0 67 67.6 97.1 0.0 0.0 2.9 17.6 26.5 . Sickle cell disease/anemia or trait 21 0.0 71 42.9 19.0 81.0 0.0 0.0 0.0 42.9 . AIDS nephropathy 39 0.0 71 69.2 33.3 61.5 2.6 0.0 0.0 38.5 . Traumatic/surgical loss of kidney(s) 132 0.1 75 70.5 87.9 7.6 2.3 1.5 0.0 36.4 . Hepatorenal syndrome 112 0.1 70 66.1 82.1 9.8 0.9 5.4 2.7 65.2 . Tubular necrosis (no recovery) 2,345 1.4 74 57.7 89.7 8.1 1.4 0.2 0.1 46.0 . Post-Partum Fail, Oth Renal Disorders 1,150 0.7 75 64.8 87.1 10.0 2.0 0.3 0.2 42.9 Etiology Uncertain 7,566 4.6 75 55.9 80.4 15.0 3.1 0.7 0.3 37.5 Missing 6,180 . 73 51.8 70.5 22.7 1.3 0.6 1.9 48.6 * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.18 Incidence of Reported ESRD Therapy by Detailed Primary Disease and Race for Patients Age 65 and Over, 1993-1997 # Native Total # # # Native White Black Asian Amer. Primary Disease Groups Patients White Black Asian Amer. (%) (%) (%) (%) All ESRD, (reference) 170,127 123,283 37,651 5,453 1,727 100.0 100.0 100.0 100.0 Diabetes 63,441 42,432 16,261 2,593 1,124 35.7 44.9 48.3 66.5 . Type 1, juvenile type 12,437 8,763 2,986 422 141 7.4 8.2 7.9 8.3 . Type 2, adult-onset or unspec. type 51,004 33,669 13,275 2,171 983 28.3 36.6 40.4 58.2 Glomerulonephritis 12,977 10,772 1,467 537 105 9.1 4.0 10.0 6.2 . Focal glomerulosclerosis, focal GN 1,756 1,474 221 45 * 1.2 0.6 0.8 0.4 . Membranous nephropathy 639 520 94 17 * 0.4 0.3 0.3 0.2 . Membranoproliferative GN, types 1&2 303 263 29 * * 0.2 0.1 0.1 0.2 . IgA nephropathy, Bergers disease 230 208 * 11 * 0.2 0.0 0.2 0.1 . IgM nephropathy 27 25 * * 0 0.0 0.0 0.0 0.0 . Rapidly progressive GN 656 595 39 12 * 0.5 0.1 0.2 0.4 . Goodpastures Syndrome 304 283 14 * * 0.2 0.0 0.1 0.2 . Post infectious GN, SBE 83 75 * * 0 0.1 0.0 0.0 0.0 . Glomerulonephritis (GN) 8,637 7,033 1,024 429 79 5.9 2.8 8.0 4.7 . Other proliferative GN 342 296 32 11 * 0.2 0.1 0.2 0.1 Secondary GN/Vasculitis 2,029 1,772 199 33 15 1.5 0.5 0.6 0.9 . Lupus erythematosus, (SLE nephritis) 378 270 94 * * 0.2 0.3 0.1 0.1 . Polyarteritis 91 82 * * 0 0.1 0.0 0.1 0.0 . Wegeners granulomatosis 466 449 10 * * 0.4 0.0 0.1 0.2 . Henoch-Schonlein syndrome 12 10 * * 0 0.0 0.0 0.0 0.0 . Vasculitis and its derivatives 403 374 14 * * 0.3 0.0 0.1 0.4 . Scleroderma 244 218 19 * * 0.2 0.1 0.1 0.1 . Hemolytic uremic syndrome 171 153 16 0 * 0.1 0.0 0.0 0.1 . Nephropathy from heroin /related abuse 185 148 32 * * 0.1 0.1 0.1 0.1 . Secondary GN, other 79 68 * * * 0.1 0.0 0.1 0.1 Interstitial Nephritis/Pyelonephritis 7,430 6,201 942 190 36 5.2 2.6 3.5 2.1 . Chronic pyelonephritis, reflux neph. 589 503 59 20 * 0.4 0.2 0.4 0.2 . Analgesic abuse 318 261 42 10 * 0.2 0.1 0.2 0.1 . Nephropathy caused by other agents 900 740 127 21 * 0.6 0.4 0.4 0.2 . Nephrolithiasis, Obstruction, Gouty 2,639 2,165 359 68 17 1.8 1.0 1.3 1.0 . Nephrocalcinosis 96 77 15 * 0 0.1 0.0 0.1 0.0 . Chronic interstitial nephritis 2,630 2,228 316 62 11 1.9 0.9 1.2 0.7 . Acute interstitial nephritis 258 227 24 * 0 0.2 0.1 0.1 0.0 Hypertensive/large vessel disease 60,192 42,955 14,935 1,593 307 36.1 41.2 29.7 18.2 . Hypertension, (no primary ren. dis.) 52,731 35,935 14,626 1,506 282 30.2 40.4 28.0 16.7 . Renal artery stenosis or occlusion 5,550 5,197 254 67 18 4.4 0.7 1.2 1.1 . Cholesterol emboli, renal emboli 1,911 1,823 55 20 * 1.5 0.2 0.4 0.4 Cystic/Heriditary/Congenital Diseases 2,748 2,303 343 72 12 1.9 0.9 1.3 0.7 . Polycystic kidneys, adult (dominant) 2,355 1,977 291 62 10 1.7 0.8 1.2 0.6 . Polycystic, infantile (recessive) * * * 0 0 0.0 0.0 0.0 0.0 . Medullary cystic, inc nephronophthisis 17 14 * * 0 0.0 0.0 0.0 0.0 . Alports, other hereditary/familial dis 64 61 * * 0 0.1 0.0 0.0 0.0 . Tuberous sclerosis 52 46 * * * 0.0 0.0 0.0 0.1 . Cystinosis * * * 0 0 0.0 0.0 0.0 0.0 . Primary oxalosis 21 18 * 0 0 0.0 0.0 0.0 0.0 . Fabrys disease * * * 0 0 0.0 0.0 0.0 0.0 . Congenital nephrotic syndrome 19 16 * * 0 0.0 0.0 0.0 0.0 . Drash syndrome, mesangial sclerosis * * * 0 0 0.0 0.0 0.0 0.0 . Congenital obstructive uropathy 155 118 28 * * 0.1 0.1 0.1 0.1 . Renal hypoplasia, dysplasia 44 37 * 0 0 0.0 0.0 0.0 0.0 . Prune belly syndrome * * 0 0 0 0.0 0.0 0.0 0.0 Neoplasms/Tumors 3,731 3,041 595 53 22 2.6 1.6 1.0 1.3 . Renal or Urological Neoplasms 1,034 853 153 14 10 0.7 0.4 0.3 0.6 . Multiple myeloma 1,939 1,538 348 29 11 1.3 1.0 0.5 0.7 . Light chain nephropathy 166 139 24 * 0 0.1 0.1 0.1 0.0 . Amyloidosis 592 511 70 * * 0.4 0.2 0.1 0.1 Miscellaneous Conditions 3,833 3,364 368 61 17 2.8 1.0 1.1 1.0 . Complication post bone marr/other txp 34 33 0 0 * 0.0 0.0 0.0 0.1 . Sickle cell disease/anemia or trait 21 * 17 0 0 0.0 0.0 0.0 0.0 . AIDS nephropathy 39 13 24 * 0 0.0 0.1 0.0 0.0 . Traumatic/surgical loss of kidney(s) 132 116 10 * * 0.1 0.0 0.1 0.1 . Hepatorenal syndrome 112 92 11 * * 0.1 0.0 0.0 0.4 . Tubular necrosis (no recovery) 2,345 2,104 191 33 * 1.8 0.5 0.6 0.3 . Post-Partum Fail, Oth Renal Disorders 1,150 1,002 115 23 * 0.8 0.3 0.4 0.2 Etiology Uncertain 7,566 6,085 1,136 238 51 5.1 3.1 4.4 3.0 Missing 6,180 4,358 1,405 83 38 . . . . * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.19 Incidence of Reported ESRD Therapy and Median Age at Incidence by Sex, Race, One Year Transplant and Death Status, and Detailed Primary Disease, for Adult Patients Age 20-64, 1993-1997 % % Tran % Died Total % Median % % % % Native First First Primary Disease Groups Patients Incid Age Males White Black Asian Amer. Year Year All ESRD, (reference) 181,493 100.0 51 55.2 56.0 36.4 3.3 1.9 10.0 12.8 Diabetes 79,918 45.7 54 50.9 61.1 30.7 2.9 2.8 6.7 14.2 . Type 1, juvenile type 28,838 16.5 48 53.2 70.2 24.8 1.9 1.7 12.5 13.7 . Type 2, adult-onset or unspec. type 51,080 29.2 56 49.6 56.0 34.1 3.5 3.4 3.4 14.5 Glomerulonephritis 22,866 13.1 44 61.8 59.5 30.4 5.9 1.5 17.5 6.2 . Focal glomerulosclerosis, focal GN 4,983 2.9 42 61.7 51.0 43.9 2.5 1.1 17.6 5.6 . Membranous nephropathy 1,040 0.6 49 67.2 64.8 30.3 2.2 1.3 17.5 6.0 . Membranoproliferative GN, types 1&2 939 0.5 43 61.3 71.1 17.9 6.5 2.3 23.9 6.2 . IgA nephropathy, Bergers disease 1,302 0.7 39 67.7 73.4 7.8 12.8 1.6 31.6 2.2 . IgM nephropathy 141 0.1 40 68.8 75.2 7.8 12.1 0.7 36.9 3.5 . Rapidly progressive GN 681 0.4 49 55.9 73.3 17.5 5.4 1.8 12.8 5.9 . Goodpastures Syndrome 318 0.2 48 49.4 84.9 9.1 3.1 1.6 11.6 12.9 . Post infectious GN, SBE 163 0.1 45 62.0 71.2 20.9 3.7 2.5 13.5 9.2 . Glomerulonephritis (GN) 12,610 7.2 45 61.5 57.9 30.5 6.9 1.5 15.5 6.6 . Other proliferative GN 689 0.4 44 58.6 68.8 21.5 6.2 2.0 20.0 6.8 Secondary GN/Vasculitis 6,008 3.4 41 28.5 55.1 37.8 3.6 1.4 9.5 13.0 . Lupus erythematosus, (SLE nephritis) 3,671 2.1 37 17.8 45.1 46.4 4.8 1.2 10.9 10.1 . Polyarteritis 88 0.1 47 60.2 80.7 12.5 5.7 1.1 5.7 13.6 . Wegeners granulomatosis 439 0.3 53 62.4 87.9 8.2 1.4 1.4 10.0 11.4 . Henoch-Schonlein syndrome 85 0.0 33 60.0 78.8 10.6 7.1 3.5 23.5 5.9 . Vasculitis and its derivatives 279 0.2 53 44.1 81.0 12.5 1.4 2.5 5.0 17.6 . Scleroderma 511 0.3 49 21.5 72.4 23.9 1.2 1.4 3.1 28.4 . Hemolytic uremic syndrome 441 0.3 46 30.6 76.0 21.8 1.4 0.5 7.5 17.2 . Nephropathy from heroin /related abuse 333 0.2 44 64.3 39.9 53.5 2.4 2.4 7.5 14.7 . Secondary GN, other 161 0.1 44 59.6 44.1 49.1 1.2 2.5 8.1 15.5 Interstitial Nephritis/Pyelonephritis 6,860 3.9 49 52.4 74.0 19.6 3.1 1.3 13.9 11.7 . Chronic pyelonephritis, reflux neph. 1,239 0.7 41 39.7 83.8 10.2 3.4 1.4 22.8 5.4 . Analgesic abuse 246 0.1 53 32.5 70.3 25.6 1.6 0.8 7.7 10.6 . Nephropathy caused by other agents 817 0.5 51 63.5 72.0 22.9 2.1 0.7 11.3 18.0 . Nephrolithiasis, Obstruction, Gouty 1,626 0.9 53 67.2 72.6 19.7 4.2 0.9 9.3 13.0 . Nephrocalcinosis 83 0.0 50 49.4 72.3 18.1 4.8 1.2 15.7 10.8 . Chronic interstitial nephritis 2,684 1.5 48 48.3 71.2 22.4 2.9 1.7 14.5 11.7 . Acute interstitial nephritis 165 0.1 52 47.3 75.8 20.0 1.2 0.6 5.5 18.2 Hypertensive/large vessel disease 36,084 20.7 51 61.3 36.8 57.5 3.0 1.0 5.3 10.4 . Hypertension, (no primary ren. dis.) 34,589 19.8 51 61.3 34.6 59.5 3.1 1.0 5.4 9.8 . Renal artery stenosis or occlusion 1,128 0.6 60 58.2 86.0 10.7 1.4 1.1 3.5 24.2 . Cholesterol emboli, renal emboli 367 0.2 61 70.8 92.1 5.7 1.1 0.8 1.4 26.7 Cystic/Heriditary/Congenital Diseases 7,869 4.5 48 56.1 82.1 13.2 2.5 0.8 25.6 3.5 . Polycystic kidneys, adult (dominant) 6,323 3.6 50 53.8 82.1 13.2 2.5 0.7 24.5 3.3 . Polycystic, infantile (recessive) 47 0.0 44 51.1 85.1 14.9 0.0 0.0 27.7 10.6 . Medullary cystic, inc nephronophthisis 55 0.0 33 50.9 83.6 10.9 0.0 1.8 40.0 0.0 . Alports, other hereditary/familial dis 569 0.3 36 68.2 86.8 9.1 1.9 0.7 33.2 1.8 . Tuberous sclerosis 68 0.0 42 35.3 70.6 25.0 1.5 1.5 13.2 11.8 . Cystinosis 14 0.0 42 42.9 92.9 0.0 0.0 7.1 21.4 7.1 . Primary oxalosis 46 0.0 53 54.3 95.7 4.3 0.0 0.0 23.9 10.9 . Fabrys disease 68 0.0 41 89.7 91.2 4.4 0.0 2.9 25.0 4.4 . Congenital nephrotic syndrome 47 0.0 33 66.0 57.4 29.8 10.6 2.1 40.4 2.1 . Drash syndrome, mesangial sclerosis * 0.0 40 60.0 40.0 40.0 0.0 20.0 20.0 0.0 . Congenital obstructive uropathy 400 0.2 34 71.8 77.8 15.3 3.8 1.5 28.0 5.8 . Renal hypoplasia, dysplasia 209 0.1 33 56.9 79.9 18.2 0.5 0.5 31.6 2.4 . Prune belly syndrome 18 0.0 26 100.0 83.3 16.7 0.0 0.0 27.8 0.0 Neoplasms/Tumors 2,202 1.3 56 61.3 72.5 23.2 1.7 1.3 2.1 37.1 . Renal or Urological Neoplasms 591 0.3 56 69.7 75.8 20.8 1.2 1.0 2.0 29.3 . Multiple myeloma 1,054 0.6 57 59.7 69.2 26.1 2.1 1.4 0.5 44.9 . Light chain nephropathy 86 0.0 56 60.5 64.0 25.6 5.8 1.2 2.3 31.4 . Amyloidosis 471 0.3 55 54.6 77.3 19.1 0.8 1.5 5.9 30.4 Miscellaneous Conditions 6,777 3.9 42 68.3 36.7 59.6 0.8 0.8 4.3 34.0 . Complication post bone marr/other txp 152 0.1 52 62.5 83.6 13.2 1.3 0.7 16.4 25.7 . Sickle cell disease/anemia or trait 336 0.2 38 52.7 4.2 93.8 0.3 1.2 1.5 16.1 . AIDS nephropathy 3,560 2.0 38 75.1 8.8 87.9 0.2 0.6 0.1 43.8 . Traumatic/surgical loss of kidney(s) 109 0.1 44 71.6 76.1 18.3 1.8 0.9 7.3 6.4 . Hepatorenal syndrome 310 0.2 51 70.0 82.9 11.0 1.9 1.6 20.0 44.5 . Tubular necrosis (no recovery) 1,396 0.8 54 63.9 75.1 21.5 1.0 0.8 4.3 23.8 . Post-Partum Fail, Oth Renal Disorders 914 0.5 49 54.8 70.7 24.0 2.7 1.1 13.9 18.6 Etiology Uncertain 6,116 3.5 47 59.5 58.4 32.8 4.6 1.3 13.2 11.9 Missing 6,793 . 48 57.2 50.9 38.2 2.6 0.8 33.0 14.8 * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.20 Incidence of Reported ESRD Therapy by Detailed Primary Disease and Race for Adult Patients Age 20-64, 1993-1997 # Native Total # # # Native White Black Asian Amer. Primary Disease Groups Patients White Black Asian Amer. (%) (%) (%) (%) All ESRD, (reference) 181,493 101,661 66,054 5,980 3,378 100.0 100.0 100.0 100.0 Diabetes 79,918 48,832 24,559 2,357 2,240 49.7 38.7 40.6 67.4 . Type 1, juvenile type 28,838 20,244 7,166 552 481 20.6 11.3 9.5 14.5 . Type 2, adult-onset or unspec. type 51,080 28,588 17,393 1,805 1,759 29.1 27.4 31.1 52.9 Glomerulonephritis 22,866 13,612 6,958 1,356 333 13.9 11.0 23.4 10.0 . Focal glomerulosclerosis, focal GN 4,983 2,543 2,189 124 55 2.6 3.4 2.1 1.7 . Membranous nephropathy 1,040 674 315 23 13 0.7 0.5 0.4 0.4 . Membranoproliferative GN, types 1&2 939 668 168 61 22 0.7 0.3 1.1 0.7 . IgA nephropathy, Bergers disease 1,302 956 102 167 21 1.0 0.2 2.9 0.6 . IgM nephropathy 141 106 11 17 * 0.1 0.0 0.3 0.0 . Rapidly progressive GN 681 499 119 37 12 0.5 0.2 0.6 0.4 . Goodpastures Syndrome 318 270 29 10 * 0.3 0.0 0.2 0.2 . Post infectious GN, SBE 163 116 34 * * 0.1 0.1 0.1 0.1 . Glomerulonephritis (GN) 12,610 7,306 3,843 868 186 7.4 6.1 15.0 5.6 . Other proliferative GN 689 474 148 43 14 0.5 0.2 0.7 0.4 Secondary GN/Vasculitis 6,008 3,313 2,269 218 83 3.4 3.6 3.8 2.5 . Lupus erythematosus, (SLE nephritis) 3,671 1,654 1,703 175 45 1.7 2.7 3.0 1.4 . Polyarteritis 88 71 11 * * 0.1 0.0 0.1 0.0 . Wegeners granulomatosis 439 386 36 * * 0.4 0.1 0.1 0.2 . Henoch-Schonlein syndrome 85 67 * * * 0.1 0.0 0.1 0.1 . Vasculitis and its derivatives 279 226 35 * * 0.2 0.1 0.1 0.2 . Scleroderma 511 370 122 * * 0.4 0.2 0.1 0.2 . Hemolytic uremic syndrome 441 335 96 * * 0.3 0.2 0.1 0.1 . Nephropathy from heroin /related abuse 333 133 178 * * 0.1 0.3 0.1 0.2 . Secondary GN, other 161 71 79 * * 0.1 0.1 0.0 0.1 Interstitial Nephritis/Pyelonephritis 6,860 5,074 1,345 216 87 5.2 2.1 3.7 2.6 . Chronic pyelonephritis, reflux neph. 1,239 1,038 126 42 17 1.1 0.2 0.7 0.5 . Analgesic abuse 246 173 63 * * 0.2 0.1 0.1 0.1 . Nephropathy caused by other agents 817 588 187 17 * 0.6 0.3 0.3 0.2 . Nephrolithiasis, Obstruction, Gouty 1,626 1,180 320 69 15 1.2 0.5 1.2 0.5 . Nephrocalcinosis 83 60 15 * * 0.1 0.0 0.1 0.0 . Chronic interstitial nephritis 2,684 1,910 601 78 45 1.9 0.9 1.3 1.4 . Acute interstitial nephritis 165 125 33 * * 0.1 0.1 0.0 0.0 Hypertensive/large vessel disease 36,084 13,261 20,733 1,088 357 13.5 32.7 18.8 10.7 . Hypertension, (no primary ren. dis.) 34,589 11,953 20,591 1,068 342 12.2 32.4 18.4 10.3 . Renal artery stenosis or occlusion 1,128 970 121 16 12 1.0 0.2 0.3 0.4 . Cholesterol emboli, renal emboli 367 338 21 * * 0.3 0.0 0.1 0.1 Cystic/Heriditary/Congenital Diseases 7,869 6,460 1,042 193 61 6.6 1.6 3.3 1.8 . Polycystic kidneys, adult (dominant) 6,323 5,191 837 160 43 5.3 1.3 2.8 1.3 . Polycystic, infantile (recessive) 47 40 * 0 0 0.0 0.0 0.0 0.0 . Medullary cystic, inc nephronophthisis 55 46 * 0 * 0.0 0.0 0.0 0.0 . Alports, other hereditary/familial dis 569 494 52 11 * 0.5 0.1 0.2 0.1 . Tuberous sclerosis 68 48 17 * * 0.0 0.0 0.0 0.0 . Cystinosis 14 13 0 0 * 0.0 0.0 0.0 0.0 . Primary oxalosis 46 44 * 0 0 0.0 0.0 0.0 0.0 . Fabrys disease 68 62 * 0 * 0.1 0.0 0.0 0.1 . Congenital nephrotic syndrome 47 27 14 * * 0.0 0.0 0.1 0.0 . Drash syndrome, mesangial sclerosis * * * 0 * 0.0 0.0 0.0 0.0 . Congenital obstructive uropathy 400 311 61 15 * 0.3 0.1 0.3 0.2 . Renal hypoplasia, dysplasia 209 167 38 * * 0.2 0.1 0.0 0.0 . Prune belly syndrome 18 15 * 0 0 0.0 0.0 0.0 0.0 Neoplasms/Tumors 2,202 1,596 510 38 29 1.6 0.8 0.7 0.9 . Renal or Urological Neoplasms 591 448 123 * * 0.5 0.2 0.1 0.2 . Multiple myeloma 1,054 729 275 22 15 0.7 0.4 0.4 0.5 . Light chain nephropathy 86 55 22 * * 0.1 0.0 0.1 0.0 . Amyloidosis 471 364 90 * * 0.4 0.1 0.1 0.2 Miscellaneous Conditions 6,777 2,487 4,038 56 53 2.5 6.4 1.0 1.6 . Complication post bone marr/other txp 152 127 20 * * 0.1 0.0 0.0 0.0 . Sickle cell disease/anemia or trait 336 14 315 * * 0.0 0.5 0.0 0.1 . AIDS nephropathy 3,560 312 3,130 * 21 0.3 4.9 0.1 0.6 . Traumatic/surgical loss of kidney(s) 109 83 20 * * 0.1 0.0 0.0 0.0 . Hepatorenal syndrome 310 257 34 * * 0.3 0.1 0.1 0.2 . Tubular necrosis (no recovery) 1,396 1,048 300 14 11 1.1 0.5 0.2 0.3 . Post-Partum Fail, Oth Renal Disorders 914 646 219 25 10 0.7 0.3 0.4 0.3 Etiology Uncertain 6,116 3,570 2,003 280 82 3.6 3.2 4.8 2.5 Missing 6,793 3,456 2,597 178 53 . . . . * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.21 Incidence of Reported ESRD Therapy and Median Age at Incidence by Sex, Race, One Year Transplant and Death Status, and Detailed Primary Disease, for Pediatric Patients Age < 20, 1993-1997 % % Tran % Died Total % Median % % % % Native First First Primary Disease Groups Patients Incid Age Males White Black Asian Amer. Year Year All ESRD, (reference) 5,431 100.0 14 57.1 62.4 27.1 4.1 1.4 44.4 3.2 Diabetes 89 1.8 16 42.7 50.6 39.3 4.5 2.2 12.4 2.2 . Type 1, juvenile type 43 0.9 17 39.5 48.8 44.2 4.7 0.0 18.6 2.3 . Type 2, adult-onset or unspec. type 46 0.9 6 45.7 52.2 34.8 4.3 4.3 6.5 2.2 Glomerulonephritis 1,620 32.5 16 55.2 56.8 32.5 4.9 1.7 38.0 1.5 . Focal glomerulosclerosis, focal GN 555 11.1 15 60.5 46.3 45.2 2.7 0.9 37.8 1.8 . Membranous nephropathy 29 0.6 16 44.8 44.8 51.7 0.0 0.0 24.1 3.4 . Membranoproliferative GN, types 1&2 138 2.8 16 46.4 68.8 22.5 2.9 1.4 42.8 0.0 . IgA nephropathy, Bergers disease 86 1.7 17 68.6 72.1 11.6 4.7 5.8 44.2 0.0 . IgM nephropathy * 0.1 19 28.6 71.4 28.6 0.0 0.0 28.6 0.0 . Rapidly progressive GN 113 2.3 14 40.7 64.6 17.7 6.2 6.2 38.9 0.9 . Goodpastures Syndrome 37 0.7 16 48.6 89.2 8.1 2.7 0.0 16.2 2.7 . Post infectious GN, SBE 12 0.2 14 41.7 75.0 25.0 0.0 0.0 16.7 8.3 . Glomerulonephritis (GN) 562 11.3 16 54.8 57.1 30.2 7.7 1.6 37.5 1.6 . Other proliferative GN 81 1.6 16 54.3 64.2 25.9 6.2 0.0 44.4 1.2 Secondary GN/Vasculitis 485 9.7 15 35.9 61.4 26.0 7.0 1.2 21.4 6.2 . Lupus erythematosus, (SLE nephritis) 252 5.1 17 23.4 44.4 39.3 9.5 0.8 9.1 7.5 . Polyarteritis * 0.2 14 0.0 44.4 33.3 22.2 0.0 22.2 22.2 . Wegeners granulomatosis 40 0.8 16 47.5 82.5 7.5 5.0 0.0 30.0 2.5 . Henoch-Schonlein syndrome 45 0.9 14 51.1 88.9 0.0 4.4 2.2 48.9 2.2 . Vasculitis and its derivatives 13 0.3 17 46.2 61.5 30.8 0.0 7.7 23.1 0.0 . Scleroderma * 0.0 17 0.0 0.0 100.0 0.0 0.0 0.0 0.0 . Hemolytic uremic syndrome 106 2.1 8 55.7 82.1 12.3 2.8 1.9 34.0 6.6 . Nephropathy from heroin /related abuse 12 0.2 15 41.7 66.7 25.0 8.3 0.0 41.7 0.0 . Secondary GN, other * 0.1 17 42.9 85.7 0.0 0.0 0.0 14.3 0.0 Interstitial Nephritis/Pyelonephritis 494 9.9 14 61.3 76.5 17.4 2.8 0.8 50.0 2.6 . Chronic pyelonephritis, reflux neph. 147 2.9 14 44.2 80.3 13.6 2.0 0.7 47.6 2.0 . Analgesic abuse * 0.1 17 33.3 66.7 33.3 0.0 0.0 0.0 0.0 . Nephropathy caused by other agents 48 1.0 15 68.8 79.2 12.5 2.1 2.1 52.1 2.1 . Nephrolithiasis, Obstruction, Gouty 176 3.5 12 74.4 76.1 20.5 1.1 0.6 49.4 2.8 . Nephrocalcinosis * 0.0 15 0.0 100.0 0.0 0.0 0.0 0.0 0.0 . Chronic interstitial nephritis 106 2.1 15 62.3 74.5 16.0 6.6 0.9 58.5 3.8 . Acute interstitial nephritis 13 0.3 17 53.8 46.2 46.2 7.7 0.0 23.1 0.0 Hypertensive/large vessel disease 262 5.3 17 57.3 37.0 54.2 3.1 2.3 26.0 4.6 . Hypertension, (no primary ren. dis.) 244 4.9 18 58.6 34.4 57.0 3.3 2.0 25.0 4.5 . Renal artery stenosis or occlusion 18 0.4 10 38.9 72.2 16.7 0.0 5.6 38.9 5.6 . Cholesterol emboli, renal emboli 0 . . . . . . . . . Cystic/Heriditary/Congenital Diseases 1,410 28.3 10 67.5 72.1 18.6 3.1 1.4 53.7 3.6 . Polycystic kidneys, adult (dominant) 110 2.2 10 47.3 70.9 18.2 5.5 0.9 48.2 2.7 . Polycystic, infantile (recessive) 52 1.0 4 42.3 78.8 17.3 3.8 0.0 28.8 11.5 . Medullary cystic, inc nephronophthisis 60 1.2 13 51.7 80.0 13.3 0.0 3.3 58.3 1.7 . Alports, other hereditary/familial dis 148 3.0 16 87.2 70.3 21.6 2.0 3.4 52.7 0.7 . Tuberous sclerosis * 0.1 18 60.0 40.0 40.0 20.0 0.0 40.0 0.0 . Cystinosis 38 0.8 12 60.5 89.5 7.9 0.0 0.0 68.4 0.0 . Primary oxalosis 19 0.4 3 47.4 84.2 5.3 10.5 0.0 52.6 0.0 . Fabrys disease * 0.0 19 100.0 100.0 0.0 0.0 0.0 0.0 0.0 . Congenital nephrotic syndrome 64 1.3 2 43.8 65.6 14.1 9.4 3.1 40.6 7.8 . Drash syndrome, mesangial sclerosis * 0.2 0 66.7 66.7 22.2 0.0 0.0 33.3 0.0 . Congenital obstructive uropathy 362 7.3 11 81.2 71.8 19.1 2.5 0.3 62.7 3.3 . Renal hypoplasia, dysplasia 481 9.6 8 61.3 70.5 19.8 2.9 1.9 52.4 4.4 . Prune belly syndrome 61 1.2 7 96.7 75.4 19.7 1.6 0.0 49.2 3.3 Neoplasms/Tumors 38 0.8 7 47.4 65.8 23.7 2.6 5.3 23.7 21.1 . Renal or Urological Neoplasms 37 0.7 6 48.6 64.9 24.3 2.7 5.4 24.3 21.6 . Multiple myeloma 0 . . . . . . . . . . Light chain nephropathy 0 . . . . . . . . . . Amyloidosis * 0.0 11 0.0 100.0 0.0 0.0 0.0 0.0 0.0 Miscellaneous Conditions 204 4.1 12 54.4 57.4 33.8 1.0 1.0 33.3 8.3 . Complication post bone marr/other txp 10 0.2 16 50.0 90.0 10.0 0.0 0.0 60.0 0.0 . Sickle cell disease/anemia or trait 17 0.3 19 58.8 5.9 94.1 0.0 0.0 5.9 0.0 . AIDS nephropathy 23 0.5 16 65.2 13.0 82.6 0.0 0.0 0.0 30.4 . Traumatic/surgical loss of kidney(s) * 0.1 14 33.3 50.0 33.3 0.0 0.0 0.0 16.7 . Hepatorenal syndrome * 0.0 13 100.0 50.0 50.0 0.0 0.0 50.0 0.0 . Tubular necrosis (no recovery) 55 1.1 7 52.7 72.7 18.2 1.8 0.0 27.3 7.3 . Post-Partum Fail, Oth Renal Disorders 91 1.8 11 52.7 65.9 22.0 1.1 2.2 49.5 5.5 Etiology Uncertain 387 7.8 15 50.4 60.5 27.1 4.7 1.3 42.4 1.3 Missing 442 . 13 59.5 58.1 25.3 3.8 0.5 82.8 2.5 * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.22 Incidence of Reported ESRD Therapy by Detailed Primary Disease and Race for Pediatric Patients Age < 20, 1993-1997 # Native Total # # # Native White Black Asian Amer. Primary Disease Groups Patients White Black Asian Amer. (%) (%) (%) (%) All ESRD, (reference) 5,431 3,388 1,472 221 77 100.0 100.0 100.0 100.0 Diabetes 89 45 35 * * 1.4 2.6 2.0 2.7 . Type 1, juvenile type 43 21 19 * 0 0.7 1.4 1.0 0.0 . Type 2, adult-onset or unspec. type 46 24 16 * * 0.8 1.2 1.0 2.7 Glomerulonephritis 1,620 920 526 79 28 29.4 38.7 38.7 37.3 . Focal glomerulosclerosis, focal GN 555 257 251 15 * 8.2 18.5 7.4 6.7 . Membranous nephropathy 29 13 15 0 0 0.4 1.1 0.0 0.0 . Membranoproliferative GN, types 1&2 138 95 31 * * 3.0 2.3 2.0 2.7 . IgA nephropathy, Bergers disease 86 62 10 * * 2.0 0.7 2.0 6.7 . IgM nephropathy * * * 0 0 0.2 0.1 0.0 0.0 . Rapidly progressive GN 113 73 20 * * 2.3 1.5 3.4 9.3 . Goodpastures Syndrome 37 33 * * 0 1.1 0.2 0.5 0.0 . Post infectious GN, SBE 12 * * 0 0 0.3 0.2 0.0 0.0 . Glomerulonephritis (GN) 562 321 170 43 * 10.3 12.5 21.1 12.0 . Other proliferative GN 81 52 21 * 0 1.7 1.5 2.5 0.0 Secondary GN/Vasculitis 485 298 126 34 * 9.5 9.3 16.7 8.0 . Lupus erythematosus, (SLE nephritis) 252 112 99 24 * 3.6 7.3 11.8 2.7 . Polyarteritis * * * * 0 0.1 0.2 1.0 0.0 . Wegeners granulomatosis 40 33 * * 0 1.1 0.2 1.0 0.0 . Henoch-Schonlein syndrome 45 40 0 * * 1.3 0.0 1.0 1.3 . Vasculitis and its derivatives 13 * * 0 * 0.3 0.3 0.0 1.3 . Scleroderma * 0 * 0 0 0.0 0.1 0.0 0.0 . Hemolytic uremic syndrome 106 87 13 * * 2.8 1.0 1.5 2.7 . Nephropathy from heroin /related abuse 12 * * * 0 0.3 0.2 0.5 0.0 . Secondary GN, other * * 0 0 0 0.2 0.0 0.0 0.0 Interstitial Nephritis/Pyelonephritis 494 378 86 14 * 12.1 6.3 6.9 5.3 . Chronic pyelonephritis, reflux neph. 147 118 20 * * 3.8 1.5 1.5 1.3 . Analgesic abuse * * * 0 0 0.1 0.1 0.0 0.0 . Nephropathy caused by other agents 48 38 * * * 1.2 0.4 0.5 1.3 . Nephrolithiasis, Obstruction, Gouty 176 134 36 * * 4.3 2.6 1.0 1.3 . Nephrocalcinosis * * 0 0 0 0.0 0.0 0.0 0.0 . Chronic interstitial nephritis 106 79 17 * * 2.5 1.3 3.4 1.3 . Acute interstitial nephritis 13 * * * 0 0.2 0.4 0.5 0.0 Hypertensive/large vessel disease 262 97 142 * * 3.1 10.4 3.9 8.0 . Hypertension, (no primary ren. dis.) 244 84 139 * * 2.7 10.2 3.9 6.7 . Renal artery stenosis or occlusion 18 13 * 0 * 0.4 0.2 0.0 1.3 . Cholesterol emboli, renal emboli 0 0 0 0 0 . . . . Cystic/Heriditary/Congenital Diseases 1,410 1,017 262 44 20 32.5 19.3 21.6 26.7 . Polycystic kidneys, adult (dominant) 110 78 20 * * 2.5 1.5 2.9 1.3 . Polycystic, infantile (recessive) 52 41 * * 0 1.3 0.7 1.0 0.0 . Medullary cystic, inc nephronophthisis 60 48 * 0 * 1.5 0.6 0.0 2.7 . Alports, other hereditary/familial dis 148 104 32 * * 3.3 2.4 1.5 6.7 . Tuberous sclerosis * * * * 0 0.1 0.1 0.5 0.0 . Cystinosis 38 34 * 0 0 1.1 0.2 0.0 0.0 . Primary oxalosis 19 16 * * 0 0.5 0.1 1.0 0.0 . Fabrys disease * * 0 0 0 0.0 0.0 0.0 0.0 . Congenital nephrotic syndrome 64 42 * * * 1.3 0.7 2.9 2.7 . Drash syndrome, mesangial sclerosis * * * 0 0 0.2 0.1 0.0 0.0 . Congenital obstructive uropathy 362 260 69 * * 8.3 5.1 4.4 1.3 . Renal hypoplasia, dysplasia 481 339 95 14 * 10.8 7.0 6.9 12.0 . Prune belly syndrome 61 46 12 * 0 1.5 0.9 0.5 0.0 Neoplasms/Tumors 38 25 * * * 0.8 0.7 0.5 2.7 . Renal or Urological Neoplasms 37 24 * * * 0.8 0.7 0.5 2.7 . Multiple myeloma 0 0 0 0 0 . . . . . Light chain nephropathy 0 0 0 0 0 . . . . . Amyloidosis * * 0 0 0 0.0 0.0 0.0 0.0 Miscellaneous Conditions 204 117 69 * * 3.7 5.1 1.0 2.7 . Complication post bone marr/other txp 10 * * 0 0 0.3 0.1 0.0 0.0 . Sickle cell disease/anemia or trait 17 * 16 0 0 0.0 1.2 0.0 0.0 . AIDS nephropathy 23 * 19 0 0 0.1 1.4 0.0 0.0 . Traumatic/surgical loss of kidney(s) * * * 0 0 0.1 0.1 0.0 0.0 . Hepatorenal syndrome * * * 0 0 0.0 0.1 0.0 0.0 . Tubular necrosis (no recovery) 55 40 10 * 0 1.3 0.7 0.5 0.0 . Post-Partum Fail, Oth Renal Disorders 91 60 20 * * 1.9 1.5 0.5 2.7 Etiology Uncertain 387 234 105 18 * 7.5 7.7 8.8 6.7 Missing 442 257 112 17 * . . . . * Values for cells with fewer than 10 patients are suppressed. Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories. Table A.23 Incidence Counts of Reported ESRD Therapy by State after Dropping Territories and Unknown States All Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 743 956 845 1,012 1,142 1,092 1,236 1,367 1,479 1,594 Alaska 37 46 36 49 59 52 202 348 70 77 Arizona 571 680 698 779 958 919 1,095 1,164 1,251 1,324 Arkansas 378 379 411 502 522 560 675 728 717 806 California 4,328 5,010 5,423 5,866 5,933 6,210 7,592 8,070 8,320 8,905 Colorado 309 402 407 464 506 511 551 543 659 669 Connecticut 471 547 602 651 688 682 782 900 937 923 Delaware 128 124 143 162 194 176 200 232 221 215 District of Columbia 187 313 289 313 334 355 304 424 441 414 Florida 2,303 2,652 2,835 3,157 3,507 3,530 3,798 4,142 4,696 4,883 Georgia 1,131 1,361 1,379 1,625 1,817 1,813 2,072 2,266 2,435 2,363 Hawaii 214 232 278 274 300 322 420 391 388 413 Idaho 102 124 142 132 127 138 181 183 197 229 Illinois 1,787 1,998 2,316 2,655 2,770 3,024 3,399 3,656 3,633 3,781 Indiana 805 863 927 989 1,150 1,233 1,147 1,505 1,533 1,538 Iowa 319 380 415 446 526 506 571 543 585 618 Kansas 291 365 399 401 424 425 491 498 561 653 Kentucky 475 543 590 693 755 801 743 951 947 1,050 Louisiana 863 996 1,026 1,177 1,308 1,321 1,467 1,619 1,609 1,802 Maine 112 108 147 134 160 153 198 230 210 260 Maryland 739 934 1,050 1,152 1,241 1,291 1,276 1,696 1,846 1,813 Massachusetts 770 865 915 1,009 1,166 1,181 1,358 1,433 1,513 1,546 Michigan 1,408 1,635 1,754 1,852 2,103 2,194 2,458 2,605 2,896 2,902 Minnesota 499 563 622 660 730 740 874 853 934 993 Mississippi 476 557 576 636 748 785 907 914 1,015 1,043 Missouri 775 883 980 1,065 1,140 1,214 1,325 1,463 1,498 1,589 Montana 71 110 113 139 127 136 148 165 139 143 Nebraska 188 221 219 242 292 271 320 343 356 408 Nevada 152 170 166 233 236 247 324 340 357 385 New Hampshire 105 123 139 145 152 138 166 187 159 194 New Jersey 1,383 1,572 1,758 1,920 2,093 2,168 2,443 2,670 2,710 2,849 New Mexico 249 245 259 331 315 319 360 432 477 477 New York 2,805 3,203 3,519 3,721 4,235 4,392 5,000 5,356 5,638 5,855 North Carolina 1,073 1,298 1,362 1,536 1,750 1,862 2,110 2,087 2,364 2,471 North Dakota 73 102 104 94 127 122 145 131 139 139 Ohio 1,655 1,849 1,952 2,040 2,363 2,451 2,569 3,139 3,404 3,323 Oklahoma 467 481 576 537 643 680 728 806 810 939 Oregon 344 395 413 481 466 538 581 561 583 640 Pennsylvania 1,957 2,271 2,626 2,641 2,903 2,826 3,445 3,772 3,838 4,115 Rhode Island 138 162 188 202 206 229 236 245 265 256 South Carolina 672 806 865 918 1,017 1,030 1,282 1,233 1,355 1,395 South Dakota 92 86 93 101 112 121 140 193 191 190 Tennessee 702 983 945 1,097 1,176 1,137 1,380 1,478 1,535 1,675 Texas 2,677 3,023 3,354 3,627 4,121 4,197 4,627 4,926 5,439 5,620 Utah 183 180 179 185 194 255 237 257 244 271 Vermont 53 63 67 91 62 75 79 111 94 118 Virginia 964 1,091 1,184 1,399 1,519 1,536 1,599 1,876 2,067 2,234 Washington 495 640 684 734 744 795 919 964 998 1,030 West Virginia 297 281 315 349 372 404 425 514 537 615 Wisconsin 673 745 757 832 947 925 1,036 1,080 1,158 1,209 Wyoming 50 44 35 49 40 53 45 68 70 76 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 37,739 43,660 47,077 51,499 56,520 58,135 65,666 71,658 75,518 79,030 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Table A.23(Continued) Incidence Counts of Reported ESRD Therapy by State after Dropping Territories and Unknown States Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 180 253 217 312 395 377 469 523 578 691 Alaska 9 22 12 15 19 24 60 122 31 44 Arizona 241 291 285 368 476 457 528 603 610 674 Arkansas 103 121 128 168 169 178 227 270 304 304 California 1,380 1,822 2,005 2,287 2,326 2,374 3,050 3,398 3,613 4,046 Colorado 133 165 169 201 207 228 227 258 331 308 Connecticut 137 171 191 218 244 241 285 364 357 401 Delaware 49 52 46 58 57 56 67 74 80 71 District of Columbia 47 72 90 92 118 123 89 131 177 147 Florida 610 742 832 934 1,086 1,105 1,280 1,391 1,667 1,795 Georgia 306 410 459 505 626 605 725 881 1,042 960 Hawaii 99 109 142 147 146 181 239 232 237 232 Idaho 37 46 50 40 56 54 79 72 78 97 Illinois 510 608 697 859 843 919 1,198 1,352 1,424 1,356 Indiana 235 241 326 361 409 413 426 638 648 600 Iowa 98 128 123 152 188 197 208 225 243 244 Kansas 92 106 128 159 146 155 199 193 229 261 Kentucky 140 161 191 242 251 279 275 370 397 432 Louisiana 265 331 323 443 488 443 558 614 702 777 Maine 31 33 37 41 54 58 59 81 74 95 Maryland 216 295 375 418 468 470 477 607 690 723 Massachusetts 184 260 285 342 392 397 492 525 593 550 Michigan 468 570 659 742 831 809 1,002 1,081 1,280 1,248 Minnesota 169 220 231 259 270 284 340 333 351 362 Mississippi 135 157 163 225 271 268 338 372 443 421 Missouri 239 276 318 356 419 453 497 592 632 709 Montana 32 52 53 60 69 57 67 82 64 64 Nebraska 64 84 80 93 114 109 117 171 157 163 Nevada 37 58 66 92 84 78 110 157 132 171 New Hampshire 31 38 43 46 37 42 45 70 56 71 New Jersey 408 454 610 657 678 734 902 1,084 1,105 1,147 New Mexico 119 117 107 187 188 184 197 250 286 264 New York 874 955 1,151 1,257 1,415 1,476 1,735 1,959 2,250 2,307 North Carolina 294 398 468 555 616 670 842 855 1,006 1,057 North Dakota 31 46 48 35 60 48 61 55 52 58 Ohio 568 619 683 708 924 906 1,030 1,332 1,470 1,451 Oklahoma 199 180 243 238 311 294 333 392 376 431 Oregon 106 135 144 160 179 187 216 217 225 242 Pennsylvania 614 718 878 960 1,059 990 1,282 1,528 1,477 1,575 Rhode Island 47 43 59 53 69 70 71 86 99 103 South Carolina 199 245 293 330 372 349 473 488 577 566 South Dakota 41 31 32 54 55 58 61 101 94 88 Tennessee 199 279 259 349 401 411 494 590 608 654 Texas 960 1,254 1,436 1,544 1,711 1,902 2,122 2,374 2,689 2,816 Utah 80 62 79 80 82 109 114 132 117 121 Vermont 15 23 22 34 17 28 38 56 32 50 Virginia 280 348 360 456 518 551 630 675 792 905 Washington 189 219 240 285 299 311 354 378 418 429 West Virginia 92 92 114 122 150 143 161 220 233 258 Wisconsin 204 265 292 330 383 353 392 437 478 513 Wyoming 15 21 12 15 11 22 23 40 30 36 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 11,811 14,398 16,254 18,644 20,757 21,230 25,264 29,031 31,634 33,088 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Table A.23(Continued) Incidence Counts of Reported ESRD Therapy by State after Dropping Territories and Unknown States Non-Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 556 619 475 661 730 661 748 812 873 834 Alaska 26 24 24 34 40 28 142 223 38 31 Arizona 300 359 372 398 466 425 543 538 620 592 Arkansas 268 253 274 328 349 364 443 453 404 465 California 2,710 2,952 3,198 3,450 3,476 3,526 4,359 4,384 4,442 4,458 Colorado 173 230 219 255 286 264 319 277 315 334 Connecticut 323 362 397 419 431 413 476 516 568 461 Delaware 74 61 86 95 130 100 128 144 126 119 District of Columbia 115 195 185 197 191 197 181 233 225 237 Florida 1,636 1,852 1,958 2,199 2,388 2,268 2,460 2,483 2,843 2,833 Georgia 756 872 882 1,083 1,155 1,124 1,282 1,316 1,355 1,276 Hawaii 113 119 133 124 151 134 176 154 144 162 Idaho 64 76 89 90 70 82 101 109 115 117 Illinois 1,207 1,275 1,423 1,634 1,821 1,850 2,085 2,182 2,084 2,132 Indiana 554 575 573 592 688 727 639 796 835 840 Iowa 209 236 285 288 334 289 351 302 329 332 Kansas 196 240 260 241 271 253 285 303 328 367 Kentucky 308 340 376 419 474 447 400 532 502 549 Louisiana 579 652 690 722 806 838 895 977 894 964 Maine 79 73 104 89 105 95 134 144 135 154 Maryland 458 587 645 708 746 777 737 965 1,010 962 Massachusetts 521 565 604 653 753 750 819 842 898 873 Michigan 914 1,035 1,046 1,081 1,245 1,275 1,426 1,485 1,595 1,561 Minnesota 324 330 380 395 450 419 522 504 558 583 Mississippi 312 368 323 383 462 488 542 514 546 569 Missouri 515 560 641 701 714 720 806 848 842 814 Montana 37 52 60 76 57 76 81 80 72 75 Nebraska 120 133 134 148 177 151 197 167 194 223 Nevada 109 103 91 136 149 159 205 176 219 200 New Hampshire 70 79 94 97 111 92 114 114 102 109 New Jersey 936 1,074 1,108 1,224 1,401 1,321 1,499 1,544 1,569 1,591 New Mexico 117 114 135 139 124 122 161 171 180 196 New York 1,810 2,123 2,303 2,386 2,739 2,707 3,175 3,218 3,282 3,289 North Carolina 738 856 866 964 1,101 1,101 1,232 1,193 1,327 1,293 North Dakota 42 53 56 57 66 70 84 74 86 72 Ohio 1,024 1,111 1,204 1,230 1,330 1,383 1,407 1,688 1,779 1,643 Oklahoma 267 295 329 293 321 362 391 404 417 468 Oregon 236 257 263 317 284 336 359 334 354 368 Pennsylvania 1,250 1,346 1,654 1,599 1,753 1,656 2,069 2,104 2,194 2,311 Rhode Island 90 117 125 147 132 147 157 154 164 137 South Carolina 443 538 547 574 624 629 786 708 750 738 South Dakota 49 53 58 47 57 63 76 90 97 95 Tennessee 476 645 558 724 762 662 870 858 895 933 Texas 1,611 1,646 1,857 2,029 2,349 2,155 2,440 2,429 2,643 2,485 Utah 102 115 92 102 109 140 122 116 119 130 Vermont 37 39 45 56 41 42 38 51 59 62 Virginia 621 702 798 908 973 938 909 1,069 1,157 1,181 Washington 300 405 436 438 439 460 557 569 573 567 West Virginia 193 176 193 224 212 250 252 267 279 311 Wisconsin 441 464 458 493 557 539 630 628 669 653 Wyoming 35 22 22 34 29 29 22 25 40 36 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 24,444 27,328 29,128 31,681 34,629 34,104 38,832 40,267 41,844 41,785 Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Table A.24 Incidence Rates per Million Population of Reported ESRD Therapy by State Adjusted for Age, Race and Sex All Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 164.08 198.52 162.05 194.69 222.21 204.18 237.59 259.16 275.58 287.60 Alaska 109.39 178.42 123.31 145.99 186.38 190.39 717.19 1159.64 219.02 254.32 Arizona 194.03 222.66 209.19 240.47 286.12 252.01 290.08 294.49 315.72 315.52 Arkansas 159.50 156.39 159.99 199.90 202.31 213.82 250.45 278.52 262.54 298.10 California 178.76 203.83 218.07 231.65 228.24 230.63 278.69 287.30 287.95 304.84 Colorado 118.12 169.72 159.23 186.79 184.23 185.47 195.49 190.83 219.16 224.32 Connecticut 164.53 184.25 195.20 212.60 226.49 219.30 255.72 290.20 301.33 290.88 Delaware 186.31 177.89 216.15 237.09 280.74 232.25 257.26 297.55 279.58 274.92 District of Columbia 216.51 218.33 190.01 169.63 184.57 222.60 203.75 289.72 257.77 257.23 Florida 166.98 186.79 192.80 208.28 225.22 223.11 229.05 249.90 276.38 273.15 Georgia 158.88 182.89 179.85 211.55 232.25 226.25 252.99 330.63 358.46 270.36 Hawaii 104.74 226.17 149.45 131.22 167.06 160.95 185.62 172.90 146.45 177.57 Idaho 101.71 170.44 144.86 172.32 253.20 257.77 297.17 197.96 231.13 391.80 Illinois 159.58 175.68 202.76 228.81 240.12 255.75 285.14 305.46 302.22 312.67 Indiana 168.10 184.23 190.20 198.02 232.12 252.63 228.91 298.22 304.75 289.72 Iowa 159.88 190.38 214.77 214.80 261.38 230.42 296.17 256.36 334.38 279.93 Kansas 142.79 171.13 194.85 197.36 202.45 208.57 228.16 244.91 280.49 310.97 Kentucky 156.98 176.98 185.33 213.64 246.30 240.20 220.40 283.85 275.81 292.79 Louisiana 184.54 194.16 208.14 241.02 261.74 259.90 284.55 303.06 297.21 329.33 Maine 367.49 145.75 158.59 180.74 135.40 104.82 302.89 291.66 307.57 255.13 Maryland 138.71 167.64 193.09 206.74 219.82 222.40 214.13 276.82 294.15 291.18 Massachusetts 155.16 163.48 174.57 189.28 219.87 217.54 256.22 271.80 285.39 276.88 Michigan 159.62 182.84 192.90 201.13 224.80 230.12 260.41 271.41 293.51 293.32 Minnesota 180.36 184.31 211.18 207.41 219.54 226.81 271.32 284.22 291.27 283.64 Mississippi 158.15 161.84 169.77 198.66 222.12 217.54 269.94 277.78 282.14 295.66 Missouri 162.30 185.66 196.05 214.59 228.27 243.68 258.28 284.56 303.08 301.86 Montana 157.12 124.07 309.82 264.67 140.21 145.75 311.61 393.38 140.39 144.46 Nebraska 169.92 193.05 179.83 214.18 236.10 227.16 272.85 263.59 298.89 307.46 Nevada 169.21 203.17 167.91 213.77 197.26 205.59 254.40 248.08 235.48 242.72 New Hampshire 202.14 185.06 206.53 169.91 159.34 153.17 202.75 175.33 193.50 207.30 New Jersey 174.72 197.44 219.92 236.28 255.55 260.85 289.35 313.02 314.85 326.22 New Mexico 192.12 199.07 203.75 230.08 221.44 214.64 229.01 274.46 291.97 301.12 New York 149.68 168.39 183.37 193.92 218.16 223.79 252.10 266.15 279.81 289.16 North Carolina 143.14 169.45 173.65 195.73 216.24 227.38 249.90 271.66 302.14 277.54 North Dakota 111.35 821.46 195.26 135.39 202.86 791.32 421.09 862.72 196.35 347.24 Ohio 167.17 183.35 189.00 193.13 223.49 227.11 232.36 285.19 312.95 302.50 Oklahoma 159.02 163.23 190.68 178.80 207.67 224.04 231.61 253.39 251.13 287.25 Oregon 158.37 195.83 169.43 223.04 186.22 220.59 254.66 233.36 236.83 216.45 Pennsylvania 167.94 190.83 217.95 217.58 236.69 227.44 282.06 311.66 310.68 324.94 Rhode Island 158.18 213.35 232.79 217.88 224.58 234.96 277.89 290.98 312.26 284.81 South Carolina 159.53 186.59 200.61 203.96 243.07 226.17 273.77 396.09 457.55 283.03 South Dakota 154.07 111.49 482.05 445.54 139.71 147.77 190.47 264.77 273.39 261.71 Tennessee 156.12 191.26 188.53 215.54 229.63 213.17 255.25 275.11 274.56 297.08 Texas 196.91 209.55 228.08 243.68 268.95 268.48 289.42 305.25 330.21 332.83 Utah 199.50 128.56 120.21 180.66 163.61 313.27 184.10 190.63 213.80 206.58 Vermont 272.56 608.79 107.29 265.27 101.21 181.52 133.84 273.14 274.36 320.95 Virginia 153.49 167.01 180.70 208.84 222.35 222.62 223.87 258.85 280.24 301.93 Washington 136.14 171.37 186.99 190.16 202.76 202.09 216.72 228.83 231.39 226.71 West Virginia 188.76 167.97 210.74 222.05 222.00 239.30 252.99 325.39 329.32 348.29 Wisconsin 184.25 194.99 202.11 211.76 250.60 239.57 255.32 278.30 289.89 286.98 Wyoming 178.15 169.75 123.36 308.21 132.77 248.01 127.58 151.87 295.01 233.48 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.24(Continued) Incidence Rates per Million Population of Reported ESRD Therapy by State Adjusted for Age, Race and Sex Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 40.73 51.91 38.19 55.21 72.69 66.90 89.17 97.13 106.22 121.11 Alaska 22.33 93.05 43.11 40.22 52.17 95.84 260.24 367.53 85.48 153.88 Arizona 84.19 94.97 77.18 112.81 142.25 125.53 136.35 150.32 147.49 163.05 Arkansas 42.75 49.99 50.52 65.98 66.78 68.05 87.66 104.32 112.44 111.08 California 56.54 73.22 80.24 89.83 89.16 88.17 111.52 120.20 124.22 138.09 Colorado 50.71 72.76 65.48 81.12 73.57 78.82 83.63 90.33 110.19 97.33 Connecticut 46.78 56.76 61.37 71.85 83.53 79.47 96.47 119.40 118.90 130.83 Delaware 71.93 78.99 67.38 79.39 79.90 72.81 86.63 92.45 102.84 91.01 District of Columbia 39.44 48.51 42.58 37.43 54.56 65.68 42.00 93.31 98.41 92.44 Florida 46.35 55.11 59.72 63.96 73.25 72.48 80.19 86.79 101.20 102.60 Georgia 38.06 54.21 60.69 67.37 79.44 73.99 88.55 126.25 151.79 108.47 Hawaii 24.57 123.42 59.94 55.03 61.85 47.29 100.70 91.73 70.51 84.63 Idaho 40.19 93.92 56.15 39.91 62.27 133.20 93.19 66.58 117.55 164.36 Illinois 44.25 53.03 61.14 73.40 72.31 77.28 99.98 112.73 118.44 112.18 Indiana 48.93 48.52 64.31 69.64 82.97 85.67 85.52 124.06 130.53 114.05 Iowa 58.30 63.41 68.62 80.37 87.77 94.35 116.77 115.23 157.93 133.16 Kansas 47.25 51.45 63.11 82.38 72.58 77.74 96.75 102.65 118.66 133.46 Kentucky 47.15 52.65 63.16 75.19 81.41 87.18 80.96 109.25 113.63 121.16 Louisiana 50.87 61.65 66.07 83.00 92.21 87.47 103.22 112.44 123.86 134.55 Maine 101.44 26.97 26.50 98.10 61.78 39.59 50.31 158.35 122.75 97.49 Maryland 40.06 53.88 64.78 73.10 82.49 79.81 79.43 96.82 110.07 113.73 Massachusetts 39.37 48.83 55.65 65.18 74.89 75.23 94.22 103.91 113.00 100.74 Michigan 51.36 61.59 70.95 79.82 88.50 84.40 105.10 113.10 130.63 127.31 Minnesota 70.40 76.60 85.64 84.17 86.47 100.83 111.06 111.61 114.83 117.27 Mississippi 47.36 47.11 53.25 69.32 84.09 68.92 104.59 123.18 121.64 121.02 Missouri 49.21 60.04 63.82 73.33 86.85 87.72 96.94 116.13 125.86 135.38 Montana 112.48 59.57 243.29 178.21 77.85 61.95 98.31 208.13 64.92 65.95 Nebraska 70.47 80.80 64.50 88.48 104.53 107.06 101.59 151.14 136.98 143.90 Nevada 39.69 65.32 66.45 77.83 67.27 64.47 81.90 113.02 82.35 105.04 New Hampshire 49.30 43.63 78.35 42.87 46.71 72.69 60.49 73.84 81.78 59.53 New Jersey 50.11 55.95 75.33 79.52 81.83 87.68 105.94 126.75 128.15 131.21 New Mexico 82.09 80.11 79.17 123.69 120.00 115.16 120.75 152.79 162.18 159.82 New York 45.51 49.43 59.35 64.51 72.08 74.20 86.96 97.04 110.71 113.47 North Carolina 38.46 52.86 60.26 71.49 76.01 81.57 99.08 111.05 126.22 114.08 North Dakota 49.81 408.79 76.22 57.58 98.42 690.50 260.17 586.18 79.16 239.88 Ohio 57.06 59.26 65.66 65.10 85.89 83.87 91.41 118.14 133.37 133.35 Oklahoma 64.20 55.52 73.91 76.49 96.95 92.62 100.57 121.01 112.45 123.34 Oregon 45.18 79.17 57.67 74.29 74.24 75.37 110.60 93.32 101.84 85.98 Pennsylvania 52.69 58.89 70.19 77.79 86.65 78.61 103.79 124.62 118.08 123.21 Rhode Island 46.38 63.84 80.66 55.23 85.54 76.37 89.46 113.46 128.90 112.58 South Carolina 45.31 51.16 65.37 74.55 82.96 75.03 103.11 148.23 176.76 107.44 South Dakota 55.54 42.24 41.05 319.60 69.21 73.23 77.38 123.48 113.72 145.48 Tennessee 49.88 54.16 52.17 68.20 78.19 76.26 92.54 109.26 108.20 113.37 Texas 72.41 85.72 97.59 103.42 111.48 121.34 132.11 148.16 164.18 166.06 Utah 113.06 43.97 54.85 71.08 72.41 132.89 75.77 104.16 87.11 103.30 Vermont 108.94 312.77 35.11 137.68 28.29 42.78 58.39 177.94 49.29 150.52 Virginia 42.81 49.79 51.33 64.19 73.69 76.77 85.69 91.52 105.15 119.93 Washington 49.55 63.24 74.89 82.34 88.66 86.30 80.16 96.21 98.99 97.13 West Virginia 62.21 62.98 71.60 85.10 85.92 87.36 93.30 143.42 139.31 138.62 Wisconsin 54.93 74.55 80.32 85.43 96.83 96.18 98.34 116.90 128.16 129.32 Wyoming 37.53 58.61 73.43 31.57 29.13 76.14 80.27 88.57 69.82 138.68 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.24(Continued) Incidence Rates per Million Population of Reported ESRD Therapy by State Adjusted for Age, Race and Sex Non-Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 121.27 126.61 93.79 131.35 144.50 124.82 145.33 154.04 163.31 152.11 Alaska 82.78 85.37 80.21 105.77 134.22 94.54 456.95 775.42 130.57 96.43 Arizona 100.58 119.52 116.73 124.26 138.82 116.85 147.87 138.88 162.85 137.68 Arkansas 113.93 102.67 106.19 131.42 134.11 136.15 161.15 172.52 146.98 172.57 California 112.66 121.10 129.06 137.01 134.08 130.31 160.55 156.75 155.19 153.79 Colorado 66.16 93.61 86.16 102.12 105.42 97.80 110.06 97.86 103.71 118.81 Connecticut 113.48 122.88 129.36 136.19 139.21 130.70 152.30 163.28 178.41 139.32 Delaware 108.16 84.65 135.32 139.81 191.60 135.40 164.96 185.18 158.09 152.69 District of Columbia 133.88 136.82 129.34 120.62 101.31 125.32 127.03 157.01 119.25 135.69 Florida 116.18 127.44 129.34 142.63 149.59 141.71 145.26 144.72 162.62 154.45 Georgia 111.12 116.89 113.31 139.08 148.05 140.31 155.69 195.86 202.24 147.73 Hawaii 50.79 96.35 58.89 70.38 102.64 81.68 80.53 72.25 70.80 78.11 Idaho 60.62 74.52 86.01 130.66 190.05 122.91 203.17 129.68 110.73 215.01 Illinois 108.75 112.19 124.67 141.52 158.65 156.77 175.31 182.21 173.25 175.53 Indiana 116.10 122.93 119.96 119.51 135.35 147.33 126.83 157.42 165.18 156.68 Iowa 97.74 121.88 141.19 130.59 172.56 130.44 169.86 133.92 171.27 128.38 Kansas 94.37 110.15 126.43 114.66 126.76 123.83 128.45 140.49 159.75 166.98 Kentucky 101.74 105.46 114.64 126.79 152.25 129.05 118.06 157.16 144.36 152.46 Louisiana 128.25 129.64 139.82 155.14 164.87 162.32 177.68 184.53 170.02 185.73 Maine 264.80 117.16 116.95 79.95 73.00 65.23 249.24 126.77 184.15 126.20 Maryland 86.88 104.04 122.15 128.60 132.45 134.59 124.97 158.59 162.32 156.32 Massachusetts 102.97 106.31 114.00 120.47 140.41 135.74 150.92 153.96 167.53 154.16 Michigan 105.35 117.98 116.34 117.67 132.86 133.96 151.49 153.33 160.78 155.99 Minnesota 108.22 98.54 121.98 121.35 130.60 113.41 156.99 167.60 164.01 156.75 Mississippi 99.01 106.30 87.59 114.64 131.44 140.04 153.46 144.69 153.90 152.98 Missouri 107.52 114.50 128.22 139.26 139.90 145.81 157.21 163.38 172.71 153.94 Montana 42.55 57.88 66.53 83.35 61.21 80.42 213.30 182.35 72.31 74.32 Nebraska 94.35 110.00 110.20 125.14 131.06 109.80 163.04 106.53 157.42 151.04 Nevada 122.07 127.41 92.82 132.21 127.24 132.92 166.20 130.86 149.94 129.62 New Hampshire 149.49 136.65 126.48 125.08 109.25 77.01 132.79 99.13 110.99 134.37 New Jersey 119.60 135.89 139.49 152.00 171.94 159.40 178.50 181.37 182.42 182.15 New Mexico 101.15 109.62 114.34 102.89 99.30 87.54 107.55 112.11 119.44 130.46 New York 97.95 112.44 120.75 125.29 141.97 138.77 160.70 160.05 163.92 163.02 North Carolina 99.38 111.45 109.89 122.04 135.85 134.68 146.11 155.90 171.60 149.97 North Dakota 61.54 408.22 119.03 75.48 103.16 95.53 160.92 274.12 116.27 95.86 Ohio 104.02 110.30 115.25 116.64 126.81 127.07 128.59 155.75 165.08 146.91 Oklahoma 94.50 105.77 115.03 100.02 107.72 125.10 130.07 129.29 133.64 151.17 Oregon 109.81 115.77 110.02 147.58 110.98 138.57 142.43 134.42 133.79 118.47 Pennsylvania 107.60 113.85 140.05 131.44 141.71 134.39 169.80 173.61 176.48 182.26 Rhode Island 110.98 147.83 148.57 161.18 135.07 146.53 177.56 170.97 181.57 152.37 South Carolina 105.56 128.18 129.19 125.68 153.90 139.49 166.05 237.63 274.27 155.36 South Dakota 95.97 66.41 437.90 125.94 70.50 74.55 109.37 138.88 159.67 108.00 Tennessee 101.11 126.41 111.45 140.63 148.90 124.28 159.88 159.21 160.93 166.17 Texas 117.41 114.35 125.95 136.47 153.10 137.65 153.04 149.03 159.29 147.50 Utah 85.98 82.18 59.73 107.64 89.15 158.32 91.40 80.98 121.55 91.68 Vermont 162.48 294.76 72.18 126.01 66.76 130.51 70.82 88.68 187.66 161.05 Virginia 100.35 110.70 125.06 139.10 144.06 138.41 129.52 150.11 159.31 161.93 Washington 84.45 104.72 110.57 104.98 111.90 111.18 135.11 128.83 130.57 123.40 West Virginia 120.68 97.98 126.74 135.69 130.14 142.64 153.33 161.34 162.40 181.99 Wisconsin 120.25 116.33 119.81 124.10 151.94 133.54 153.38 158.77 159.11 146.90 Wyoming 140.62 55.57 44.81 276.64 103.64 167.37 47.31 52.53 225.18 86.26 Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.25 Standard Errors for Incidence Rates per Million Population of Reported ESRD Therapy by State Adjusted for Age, Race and Sex All Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 8.40 8.30 6.35 6.88 7.93 7.17 8.14 8.51 8.69 8.37 Alaska 27.23 39.15 32.25 31.96 31.11 32.85 70.14 85.57 37.97 37.15 Arizona 10.72 11.13 9.93 11.28 12.07 10.38 10.93 10.69 11.22 10.75 Arkansas 9.70 9.08 8.26 9.77 9.44 9.76 10.22 11.44 10.34 11.48 California 2.88 3.04 3.13 3.19 3.13 3.11 3.40 3.42 3.39 3.46 Colorado 7.72 10.20 9.26 10.36 9.53 9.62 9.73 9.46 9.84 10.05 Connecticut 8.59 8.39 8.46 8.91 9.25 8.94 9.69 10.19 10.39 10.05 Delaware 17.33 16.72 19.19 20.50 22.00 17.92 18.93 20.25 19.50 19.74 District of Columbia 29.30 26.72 24.68 22.16 23.46 27.30 27.13 29.96 25.63 26.29 Florida 3.77 3.94 3.93 4.02 4.07 4.06 3.92 4.13 4.25 4.09 Georgia 5.81 5.66 5.53 6.19 6.25 6.03 6.44 8.99 9.22 6.34 Hawaii 31.21 70.59 41.94 22.38 31.69 33.59 27.51 28.49 21.48 23.73 Idaho 10.54 43.46 13.02 50.54 118.22 88.49 85.91 42.70 40.49 93.05 Illinois 3.87 4.01 4.30 4.51 4.65 4.71 4.94 5.10 5.06 5.13 Indiana 6.49 7.45 6.90 6.86 7.67 8.26 7.50 8.64 8.72 7.89 Iowa 15.48 17.18 19.09 17.56 19.82 17.29 21.53 18.74 23.14 18.84 Kansas 9.64 10.17 11.09 11.17 11.08 11.46 11.46 12.29 13.21 13.50 Kentucky 9.47 10.35 9.84 9.62 11.56 9.89 9.33 10.87 10.16 9.77 Louisiana 7.78 7.15 7.66 8.44 8.58 8.43 8.73 9.03 8.84 9.09 Maine 144.64 54.18 46.21 51.14 23.98 8.49 81.00 69.43 97.13 42.63 Maryland 5.60 5.97 6.48 6.66 6.79 6.74 6.56 7.38 7.54 7.52 Massachusetts 6.55 6.44 6.65 6.87 7.34 7.15 7.82 8.06 8.21 7.83 Michigan 4.55 4.76 4.87 4.88 5.09 5.13 5.50 5.56 5.59 5.62 Minnesota 14.32 12.68 14.58 12.93 13.32 13.55 14.18 15.28 14.12 13.35 Mississippi 11.43 9.45 10.10 11.62 10.82 9.58 13.20 13.13 12.00 12.32 Missouri 6.42 6.94 6.65 7.17 7.29 7.66 7.49 7.95 8.67 8.03 Montana 75.26 11.91 179.62 109.50 12.50 12.55 88.99 155.42 12.00 12.23 Nebraska 16.48 17.52 15.85 18.07 18.10 17.94 19.63 17.82 20.02 18.85 Nevada 15.79 17.79 14.78 15.97 13.78 14.23 15.38 14.38 13.06 13.01 New Hampshire 54.30 48.34 40.66 38.54 22.24 40.03 35.08 20.80 35.35 31.20 New Jersey 4.78 5.05 5.32 5.45 5.63 5.64 5.88 6.08 6.07 6.13 New Mexico 16.82 19.07 18.63 16.83 16.35 16.53 15.59 17.17 17.18 17.86 New York 2.89 3.03 3.15 3.24 3.41 3.43 3.62 3.70 3.79 3.84 North Carolina 4.83 5.11 5.13 5.55 5.67 5.80 5.97 6.84 7.09 6.05 North Dakota 13.71 385.09 46.22 14.49 21.71 436.63 170.42 461.27 16.98 145.26 Ohio 5.01 4.81 4.79 4.66 5.05 4.96 4.83 5.34 5.78 5.65 Oklahoma 8.03 8.03 8.55 8.27 8.74 9.24 9.14 9.51 9.41 9.97 Oregon 14.31 16.86 13.41 16.74 14.16 15.84 17.88 16.04 16.12 12.99 Pennsylvania 4.45 4.45 4.68 4.68 4.75 4.60 5.20 5.49 5.40 5.36 Rhode Island 17.02 21.93 22.10 19.35 19.58 18.65 22.20 22.65 23.07 21.18 South Carolina 7.64 8.69 9.70 9.02 11.55 9.52 10.09 18.73 21.40 9.68 South Dakota 35.76 12.18 252.01 242.45 13.33 13.55 24.05 31.39 44.27 43.86 Tennessee 8.35 6.32 7.13 7.45 7.78 6.99 7.54 8.25 7.62 7.99 Texas 4.09 3.91 4.05 4.14 4.26 4.22 4.32 4.43 4.54 4.50 Utah 35.94 10.05 9.25 31.80 24.09 52.25 23.32 22.01 29.14 29.21 Vermont 72.63 251.92 13.21 85.07 12.91 53.94 18.19 84.12 65.53 96.16 Virginia 5.34 5.38 5.64 5.94 6.04 5.99 5.90 6.31 6.48 6.71 Washington 8.21 9.22 9.82 9.48 10.25 9.59 9.35 9.67 9.49 9.19 West Virginia 15.01 13.08 17.70 15.55 14.38 15.88 15.74 19.52 18.54 18.37 Wisconsin 9.21 9.04 9.36 9.14 10.26 9.80 9.74 10.32 10.39 9.87 Wyoming 69.18 56.89 45.55 113.06 44.53 73.62 35.79 19.58 86.34 67.47 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.25(Continued) Standard Errors for Incidence Rates per Million Population of Reported ESRD Therapy by State Adjusted for Age, Race and Sex Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 3.89 4.15 2.82 3.39 4.32 3.73 5.03 5.28 5.28 5.65 Alaska 8.74 31.74 18.88 14.06 13.73 24.49 48.17 48.60 24.34 28.18 Arizona 7.26 7.24 5.24 7.64 8.55 7.47 7.32 7.61 7.42 7.97 Arkansas 4.92 4.99 4.88 5.39 5.40 5.32 6.37 7.13 6.74 6.81 California 1.61 1.80 1.89 1.98 1.95 1.92 2.14 2.21 2.22 2.33 Colorado 5.01 6.98 6.02 7.16 5.89 6.13 6.79 6.54 7.13 6.40 Connecticut 4.67 4.62 4.69 5.14 5.82 5.61 6.13 6.63 6.63 6.88 Delaware 10.84 11.73 10.26 10.82 11.04 10.00 11.03 10.89 11.91 11.40 District of Columbia 11.88 12.28 10.13 9.43 12.25 14.13 10.15 18.00 17.05 16.42 Florida 2.02 2.22 2.24 2.22 2.38 2.32 2.35 2.47 2.61 2.52 Georgia 2.43 2.97 3.29 3.79 3.62 3.34 3.73 5.48 5.94 4.01 Hawaii 7.13 57.40 27.37 14.65 14.24 10.36 22.38 20.68 15.75 16.59 Idaho 7.20 42.54 8.87 6.80 9.24 78.76 20.20 8.43 37.75 52.22 Illinois 2.00 2.20 2.38 2.54 2.53 2.58 2.92 3.10 3.17 3.07 Indiana 3.43 3.32 3.80 3.82 4.56 4.95 4.65 5.55 5.89 5.06 Iowa 10.15 9.96 11.39 11.36 10.92 11.47 14.07 13.08 16.83 14.36 Kansas 5.57 5.76 6.29 7.47 6.82 6.97 7.69 8.27 8.76 9.17 Kentucky 5.35 5.66 6.29 6.05 6.78 6.40 5.68 6.49 6.66 6.52 Louisiana 3.65 3.86 4.57 4.78 4.96 4.96 5.14 5.49 5.73 5.59 Maine 73.79 5.41 4.40 47.59 22.89 5.21 8.78 65.17 70.60 24.11 Maryland 3.00 3.36 3.62 3.85 4.13 3.99 3.95 4.29 4.60 4.64 Massachusetts 3.45 3.51 3.86 4.09 4.34 4.33 4.79 5.12 5.19 4.77 Michigan 2.52 2.70 2.89 3.09 3.21 3.11 3.48 3.63 3.77 3.75 Minnesota 9.60 8.40 9.53 8.65 8.62 9.99 9.47 9.46 9.33 9.58 Mississippi 6.74 5.93 6.37 6.85 7.33 5.22 9.02 9.78 8.07 8.40 Missouri 3.50 4.10 3.79 4.29 4.65 4.32 4.57 5.12 5.43 5.41 Montana 74.91 8.32 179.41 109.06 9.42 8.24 28.38 117.46 8.16 8.31 Nebraska 11.47 11.95 9.46 12.18 12.74 13.12 12.00 14.64 13.73 14.07 Nevada 7.53 9.82 9.21 9.11 7.77 8.06 8.38 9.64 7.50 8.51 New Hampshire 24.68 14.34 27.94 7.70 17.34 39.17 24.88 17.76 29.09 8.03 New Jersey 2.53 2.66 3.10 3.13 3.17 3.26 3.55 3.87 3.87 3.89 New Mexico 9.64 10.67 11.42 11.26 10.70 11.22 11.33 12.44 11.91 12.82 New York 1.57 1.63 1.78 1.85 1.95 1.96 2.12 2.23 2.38 2.41 North Carolina 2.51 2.90 3.08 3.48 3.38 3.51 3.78 4.42 4.57 3.81 North Dakota 9.43 304.41 11.53 10.25 13.25 436.46 162.36 433.01 11.20 144.76 Ohio 3.00 2.64 2.83 2.61 3.10 3.09 2.98 3.36 3.75 3.84 Oklahoma 5.08 4.51 5.17 5.38 5.96 5.92 5.96 6.64 6.28 6.42 Oregon 6.72 11.76 7.40 9.82 8.95 9.01 13.20 10.43 11.33 8.69 Pennsylvania 2.46 2.42 2.52 2.78 2.93 2.70 3.14 3.43 3.29 3.28 Rhode Island 7.58 12.91 13.79 9.44 13.18 11.34 13.11 15.12 15.81 13.00 South Carolina 3.78 3.71 5.01 6.54 6.11 5.19 6.91 11.18 12.56 5.62 South Dakota 8.77 7.69 7.32 233.96 9.42 9.67 9.94 12.33 11.78 42.30 Tennessee 5.72 3.37 3.71 4.07 4.68 4.00 4.84 5.28 4.80 4.81 Texas 2.55 2.47 2.65 2.69 2.74 2.83 2.90 3.09 3.22 3.17 Utah 32.68 6.11 6.38 18.01 18.07 32.44 7.30 18.15 13.15 23.41 Vermont 58.66 188.23 7.54 74.58 6.87 8.11 9.50 82.60 8.73 74.54 Virginia 2.73 2.80 2.82 3.16 3.41 3.43 3.58 3.70 3.92 4.17 Washington 5.04 6.00 7.00 7.07 7.24 6.91 5.60 6.88 6.58 6.22 West Virginia 8.71 9.17 8.61 10.14 8.40 9.71 9.30 13.37 11.93 10.60 Wisconsin 4.95 5.93 5.96 5.90 6.13 6.37 6.09 6.84 7.21 6.91 Wyoming 10.20 14.31 44.22 8.24 9.70 30.55 34.21 14.99 13.51 64.08 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.25(Continued) Standard Errors for Incidence Rates per Million Population of Reported ESRD Therapy by State Adjusted for Age, Race and Sex Non-Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 State Alabama 7.40 6.49 5.03 5.83 6.29 5.66 6.36 6.37 6.74 5.78 Alaska 25.60 22.92 26.15 28.70 27.92 21.90 51.22 70.11 29.00 24.06 Arizona 7.63 8.32 7.78 8.26 8.34 6.95 8.00 7.40 8.31 6.84 Arkansas 8.29 7.16 6.57 8.09 7.71 7.56 7.97 8.92 7.77 8.84 California 2.29 2.35 2.41 2.46 2.41 2.34 2.59 2.53 2.49 2.46 Colorado 5.82 7.30 6.72 7.36 7.30 7.02 6.93 6.76 6.57 7.57 Connecticut 7.08 6.89 6.93 7.17 7.11 6.72 7.34 7.54 7.91 6.77 Delaware 13.22 11.09 15.69 15.60 18.70 13.85 15.17 16.22 14.65 14.73 District of Columbia 22.87 21.19 20.66 19.29 16.84 20.46 22.66 21.60 15.73 18.18 Florida 3.13 3.21 3.16 3.33 3.27 3.24 3.10 3.08 3.21 3.04 Georgia 5.13 4.53 4.33 4.82 5.02 4.79 5.10 7.04 7.02 4.69 Hawaii 12.97 41.18 14.78 16.42 28.20 22.77 15.70 17.56 14.16 15.89 Idaho 7.64 8.77 9.41 50.07 117.86 40.33 83.50 41.85 14.57 76.94 Illinois 3.21 3.20 3.37 3.55 3.80 3.69 3.88 3.94 3.83 3.83 Indiana 5.45 6.03 5.63 5.39 5.50 6.10 5.53 6.12 6.31 5.68 Iowa 11.63 13.94 14.96 13.18 16.54 12.88 15.61 13.05 15.77 11.33 Kansas 7.84 7.98 8.97 8.29 8.64 8.89 8.41 9.01 9.83 9.64 Kentucky 7.64 6.90 7.39 6.87 8.82 6.53 6.74 7.94 6.95 6.85 Louisiana 6.73 5.94 6.11 6.88 6.80 6.59 6.95 7.03 6.67 7.03 Maine 124.40 53.89 45.12 18.69 7.15 6.70 80.51 23.59 66.70 25.05 Maryland 4.46 4.70 5.25 5.33 5.29 5.28 5.05 5.63 5.64 5.55 Massachusetts 5.26 5.18 5.32 5.40 5.82 5.55 5.90 5.93 6.26 5.82 Michigan 3.74 3.87 3.83 3.68 3.87 3.90 4.19 4.11 4.10 4.04 Minnesota 10.60 8.80 10.93 9.59 10.13 8.60 10.50 11.89 9.96 9.21 Mississippi 8.30 7.14 5.77 8.01 7.31 7.81 8.83 8.37 8.61 7.52 Missouri 5.15 5.18 5.39 5.67 5.59 5.98 5.87 5.95 6.70 5.72 Montana 7.07 8.08 8.66 9.61 8.13 9.26 84.34 101.76 8.60 8.72 Nebraska 11.36 12.76 12.35 13.34 12.85 11.50 14.87 9.64 14.35 12.26 Nevada 13.49 14.22 11.15 13.01 11.25 11.40 12.72 10.55 10.62 9.61 New Hampshire 48.35 46.12 29.58 37.73 13.83 8.07 24.26 10.75 20.11 29.84 New Jersey 3.98 4.21 4.25 4.39 4.64 4.41 4.63 4.63 4.62 4.58 New Mexico 13.56 15.60 14.51 12.41 12.33 10.98 10.71 10.98 11.65 11.95 New York 2.35 2.48 2.56 2.61 2.75 2.71 2.90 2.87 2.91 2.89 North Carolina 4.03 4.13 4.04 4.29 4.46 4.44 4.55 5.15 5.35 4.53 North Dakota 9.95 304.36 44.76 10.11 17.15 11.68 51.80 158.95 12.73 11.40 Ohio 3.92 3.67 3.60 3.58 3.80 3.57 3.61 4.00 4.21 3.81 Oklahoma 6.21 6.59 6.75 6.20 6.32 6.97 6.90 6.72 6.91 7.31 Oregon 12.25 12.08 11.17 13.55 10.96 12.72 12.05 11.75 11.47 8.96 Pennsylvania 3.62 3.41 3.85 3.56 3.59 3.52 4.03 4.09 4.05 4.01 Rhode Island 15.22 17.70 17.20 16.86 14.37 14.17 17.38 16.48 16.77 15.68 South Carolina 6.41 7.21 8.20 6.13 9.54 7.77 7.27 14.86 17.38 7.37 South Dakota 34.62 9.24 251.90 63.58 9.43 9.50 21.80 28.82 42.67 11.17 Tennessee 6.02 5.15 5.67 5.78 6.18 5.31 5.73 6.15 5.84 5.95 Texas 3.11 2.88 2.99 3.10 3.22 3.02 3.15 3.08 3.14 2.99 Utah 14.95 7.86 6.39 26.27 15.88 36.57 14.32 12.31 25.95 17.27 Vermont 43.82 167.42 10.85 40.89 10.48 53.20 15.28 15.58 55.00 60.64 Virginia 4.37 4.46 4.81 4.93 4.90 4.77 4.54 4.86 4.93 4.97 Washington 6.38 6.95 6.87 6.23 7.14 6.59 7.47 6.68 6.80 6.67 West Virginia 12.10 9.06 12.64 11.77 11.48 11.44 12.52 13.14 12.27 14.05 Wisconsin 7.47 6.71 7.16 6.91 8.19 7.12 7.51 7.69 7.43 6.78 Wyoming 68.43 12.81 9.66 112.76 43.46 66.90 10.55 10.74 85.28 20.67 Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.26 Incidence Counts of Reported ESRD Therapy by Network Before Dropping Territories and Unknown Networks Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 1,649 1,868 2,058 2,232 2,434 2,458 2,819 3,106 3,178 3,297 (NY) Net. of N.Y. 2,805 3,203 3,519 3,721 4,235 4,392 5,000 5,356 5,638 5,855 (NJ) Trans-Atlantic R. C. 1,874 2,142 2,331 2,543 2,823 2,854 3,317 3,551 3,678 3,878 (PA) ESRD Net. Org. #4 2,085 2,395 2,769 2,803 3,097 3,002 3,645 4,004 4,059 4,330 (VA) Mid Atlantic R. C. 2,187 2,619 2,838 3,213 3,466 3,586 3,604 4,510 4,891 5,076 (NC) Southeastern Kidney Council 2,876 3,465 3,606 4,079 4,584 4,705 5,464 5,586 6,154 6,229 (FL) ESRD Net. of Florida 2,303 2,652 2,835 3,157 3,507 3,530 3,798 4,142 4,696 4,883 (MS) Network 8 1,921 2,496 2,366 2,745 3,066 3,014 3,523 3,759 4,029 4,312 (IN) Tri-state R. N. 2,935 3,255 3,469 3,722 4,268 4,485 4,459 5,595 5,884 5,911 (IL) Renal Net. of Illinois 1,787 1,998 2,316 2,655 2,770 3,024 3,399 3,656 3,633 3,781 (MN) Renal Net. of upper midwest 2,745 3,131 3,330 3,539 4,019 4,102 4,653 4,862 5,318 5,433 (MO) ESRD net. #12 1,573 1,849 2,013 2,154 2,382 2,416 2,707 2,847 3,000 3,268 (OK) ESRD net. #13 1,708 1,856 2,013 2,216 2,473 2,561 2,870 3,153 3,136 3,547 (TX) Net. of Texas 2,677 3,023 3,354 3,627 4,121 4,197 4,627 4,926 5,439 5,620 (CO) Inter-mountain ESRD net. 1,514 1,721 1,744 2,041 2,249 2,304 2,612 2,804 3,058 3,202 (WA) Northwest Renal Net. 1,049 1,315 1,388 1,535 1,523 1,659 2,031 2,221 1,987 2,119 (N-CA) Trans-pacific ESRD Net. 1,947 2,139 2,390 2,510 2,580 2,755 3,235 3,378 3,560 3,736 (S-CA) Southern California Net. 2,624 3,129 3,345 3,664 3,703 3,821 4,829 5,153 5,231 5,676 Unknown Network 173 193 189 259 310 513 1,157 351 147 95 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 38,432 44,449 47,873 52,415 57,610 59,378 67,749 72,960 76,716 80,248 Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories for Table A.26. Includes residents of 50 states and District of Columbia only for Table A.27. * Values for cells with fewer than 10 patients are suppressed. Table A.27 Incidence Counts of Reported ESRD Therapy by Network after Dropping Territories and Unknown Networks All Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 1,649 1,868 2,058 2,232 2,434 2,458 2,819 3,106 3,178 3,297 (NY) Net. of N.Y. 2,805 3,203 3,519 3,721 4,235 4,392 5,000 5,356 5,638 5,855 (NJ) Trans-Atlantic R. C. 1,383 1,572 1,758 1,920 2,093 2,168 2,443 2,670 2,710 2,849 (PA) ESRD Net. Org. #4 2,085 2,395 2,769 2,803 3,097 3,002 3,645 4,004 4,059 4,330 (VA) Mid Atlantic R. C. 2,187 2,619 2,838 3,213 3,466 3,586 3,604 4,510 4,891 5,076 (NC) Southeastern Kidney Council 2,876 3,465 3,606 4,079 4,584 4,705 5,464 5,586 6,154 6,229 (FL) ESRD Net. of Florida 2,303 2,652 2,835 3,157 3,507 3,530 3,798 4,142 4,696 4,883 (MS) Network 8 1,921 2,496 2,366 2,745 3,066 3,014 3,523 3,759 4,029 4,312 (IN) Tri-state R. N. 2,935 3,255 3,469 3,722 4,268 4,485 4,459 5,595 5,884 5,911 (IL) Renal Net. of Illinois 1,787 1,998 2,316 2,655 2,770 3,024 3,399 3,656 3,633 3,781 (MN) Renal Net. of upper midwest 2,745 3,131 3,330 3,539 4,019 4,102 4,653 4,862 5,318 5,433 (MO) ESRD net. #12 1,573 1,849 2,013 2,154 2,382 2,416 2,707 2,847 3,000 3,268 (OK) ESRD net. #13 1,708 1,856 2,013 2,216 2,473 2,561 2,870 3,153 3,136 3,547 (TX) Net. of Texas 2,677 3,023 3,354 3,627 4,121 4,197 4,627 4,926 5,439 5,620 (CO) Inter-mountain ESRD net. 1,514 1,721 1,744 2,041 2,249 2,304 2,612 2,804 3,058 3,202 (WA) Northwest Renal Net. 1,049 1,315 1,388 1,535 1,523 1,659 2,031 2,221 1,987 2,119 (N-CA) Trans-pacific ESRD Net. 1,918 2,113 2,356 2,476 2,530 2,711 3,183 3,308 3,477 3,642 (S-CA) Southern California Net. 2,624 3,129 3,345 3,664 3,703 3,821 4,829 5,153 5,231 5,676 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 37,739 43,660 47,077 51,499 56,520 58,135 65,666 71,658 75,518 79,030 (CONTINUED) Table A.27(Continued) Incidence Counts of Reported ESRD Therapy by Network after Dropping Territories and Unknown Networks Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 445 568 637 734 813 836 990 1,182 1,211 1,270 (NY) Net. of N.Y. 874 955 1,151 1,257 1,415 1,476 1,735 1,959 2,250 2,307 (NJ) Trans-Atlantic R. C. 408 454 610 657 678 734 902 1,084 1,105 1,147 (PA) ESRD Net. Org. #4 663 770 924 1,018 1,116 1,046 1,349 1,602 1,557 1,646 (VA) Mid Atlantic R. C. 635 807 939 1,088 1,254 1,287 1,357 1,633 1,892 2,033 (NC) Southeastern Kidney Council 799 1,053 1,220 1,390 1,614 1,624 2,040 2,224 2,625 2,583 (FL) ESRD Net. of Florida 610 742 832 934 1,086 1,105 1,280 1,391 1,667 1,795 (MS) Network 8 514 689 639 886 1,067 1,056 1,301 1,485 1,629 1,766 (IN) Tri-state R. N. 943 1,021 1,200 1,311 1,584 1,598 1,731 2,340 2,515 2,483 (IL) Renal Net. of Illinois 510 608 697 859 843 919 1,198 1,352 1,424 1,356 (MN) Renal Net. of upper midwest 913 1,132 1,262 1,420 1,599 1,552 1,856 2,007 2,255 2,269 (MO) ESRD net. #12 493 594 649 760 867 914 1,021 1,181 1,261 1,377 (OK) ESRD net. #13 567 632 694 849 968 915 1,118 1,276 1,382 1,512 (TX) Net. of Texas 960 1,254 1,436 1,544 1,711 1,902 2,122 2,374 2,689 2,816 (CO) Inter-mountain ESRD net. 625 714 718 943 1,048 1,078 1,199 1,440 1,506 1,574 (WA) Northwest Renal Net. 373 474 499 560 622 633 776 871 816 876 (N-CA) Trans-pacific ESRD Net. 619 799 892 943 997 1,075 1,352 1,448 1,600 1,693 (S-CA) Southern California Net. 860 1,132 1,255 1,491 1,475 1,480 1,937 2,182 2,250 2,585 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 11,811 14,398 16,254 18,644 20,757 21,230 25,264 29,031 31,634 33,088 (CONTINUED) Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories for Table A.26. Includes residents of 50 states and District of Columbia only for Table A.27. * Values for cells with fewer than 10 patients are suppressed. Table A.27(Continued) Incidence Counts of Reported ESRD Therapy by Network after Dropping Territories and Unknown Networks Non-Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 1,120 1,235 1,369 1,461 1,573 1,539 1,738 1,821 1,926 1,796 (NY) Net. of N.Y. 1,810 2,123 2,303 2,386 2,739 2,707 3,175 3,218 3,282 3,289 (NJ) Trans-Atlantic R. C. 936 1,074 1,108 1,224 1,401 1,321 1,499 1,544 1,569 1,591 (PA) ESRD Net. Org. #4 1,324 1,407 1,740 1,694 1,883 1,756 2,197 2,248 2,320 2,430 (VA) Mid Atlantic R. C. 1,387 1,660 1,821 2,037 2,122 2,162 2,079 2,534 2,671 2,691 (NC) Southeastern Kidney Council 1,937 2,266 2,295 2,621 2,880 2,854 3,300 3,217 3,432 3,307 (FL) ESRD Net. of Florida 1,636 1,852 1,958 2,199 2,388 2,268 2,460 2,483 2,843 2,833 (MS) Network 8 1,344 1,632 1,356 1,768 1,954 1,811 2,160 2,184 2,314 2,336 (IN) Tri-state R. N. 1,886 2,026 2,153 2,241 2,492 2,557 2,446 3,016 3,116 3,032 (IL) Renal Net. of Illinois 1,207 1,275 1,423 1,634 1,821 1,850 2,085 2,182 2,084 2,132 (MN) Renal Net. of upper midwest 1,770 1,935 1,998 2,073 2,375 2,366 2,738 2,781 3,005 2,964 (MO) ESRD net. #12 1,040 1,169 1,320 1,378 1,496 1,413 1,639 1,620 1,693 1,736 (OK) ESRD net. #13 1,114 1,200 1,293 1,343 1,476 1,564 1,729 1,834 1,715 1,897 (TX) Net. of Texas 1,611 1,646 1,857 2,029 2,349 2,155 2,440 2,429 2,643 2,485 (CO) Inter-mountain ESRD net. 836 943 931 1,064 1,163 1,139 1,372 1,303 1,493 1,488 (WA) Northwest Renal Net. 663 814 872 955 890 982 1,240 1,315 1,152 1,158 (N-CA) Trans-pacific ESRD Net. 1,226 1,255 1,416 1,507 1,503 1,538 1,787 1,811 1,831 1,828 (S-CA) Southern California Net. 1,597 1,816 1,915 2,067 2,124 2,122 2,748 2,727 2,755 2,792 -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- 24,444 27,328 29,128 31,681 34,629 34,104 38,832 40,267 41,844 41,785 Includes all patients: residents of the 50 states, the District of Columbia, Puerto Rico and the Territories for Table A.26. Includes residents of 50 states and District of Columbia only for Table A.27. * Values for cells with fewer than 10 patients are suppressed. Table A.28 Incidence Rates per Million Population of Reported ESRD Therapy by Network Adjusted for Age, Race and Sex All Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 158.03 173.08 184.45 196.78 215.38 211.52 251.31 275.05 281.64 277.52 (NY) Net. of N.Y. 149.68 168.39 183.37 193.92 218.16 223.79 252.10 266.15 279.81 289.16 (NJ) Trans-Atlantic R. C. 174.72 197.44 219.92 236.28 255.55 260.85 289.35 313.02 314.85 326.22 (PA) ESRD Net. Org. #4 169.25 190.00 218.32 219.05 239.80 227.68 281.27 310.01 308.73 321.85 (VA) Mid Atlantic R. C. 151.83 172.10 187.50 208.00 221.71 226.65 223.86 274.62 293.03 306.62 (NC) Southeastern Kidney Council 151.94 177.32 180.42 203.05 224.64 225.96 255.00 306.06 337.19 274.92 (FL) ESRD Net. of Florida 166.98 186.79 192.80 208.28 225.22 223.11 229.05 249.90 276.38 273.15 (MS) Network 8 158.87 187.63 175.38 203.35 224.72 210.33 250.49 267.31 275.73 291.62 (IN) Tri-state R. N. 164.66 182.00 188.06 197.43 228.90 235.68 228.35 287.94 304.07 297.27 (IL) Renal Net. of Illinois 159.58 175.68 202.76 228.81 240.12 255.75 285.14 305.46 302.22 312.67 (MN) Renal Net. of upper midwest 167.36 188.79 197.10 203.50 230.36 232.66 260.82 272.85 289.46 290.43 (MO) ESRD net. #12 158.02 181.98 193.52 208.71 229.05 231.89 255.30 267.49 293.11 299.52 (OK) ESRD net. #13 168.71 178.29 194.54 209.70 231.30 235.38 259.79 281.32 276.37 309.39 (TX) Net. of Texas 196.91 209.55 228.08 243.68 268.95 268.48 289.42 305.25 330.21 332.83 (CO) Inter-mountain ESRD net. 167.42 198.71 181.55 215.60 222.77 222.96 242.36 249.80 262.60 266.68 (WA) Northwest Renal Net. 141.57 176.53 180.60 196.17 196.80 209.73 259.93 290.36 228.35 225.98 (N-CA) Trans-pacific ESRD Net. 178.70 198.82 217.34 221.73 219.36 229.20 256.51 257.84 266.38 280.13 (S-CA) Southern California Net. 176.40 205.18 216.77 237.61 233.96 231.60 292.08 304.05 299.83 319.81 (CONTINUED) Table A.28(Continued) Incidence Rates per Million Population of Reported ESRD Therapy by Network Adjusted for Age, Race and Sex Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 42.57 52.37 58.86 66.53 75.03 73.71 91.03 108.62 111.67 110.91 (NY) Net. of N.Y. 45.51 49.43 59.35 64.51 72.08 74.20 86.96 97.04 110.71 113.47 (NJ) Trans-Atlantic R. C. 50.11 55.95 75.33 79.52 81.83 87.68 105.94 126.75 128.15 131.21 (PA) ESRD Net. Org. #4 53.83 60.11 70.19 78.49 86.46 78.49 102.98 122.49 117.26 121.55 (VA) Mid Atlantic R. C. 42.76 51.77 58.76 67.55 78.88 79.10 82.93 98.33 111.80 120.72 (NC) Southeastern Kidney Council 39.89 53.26 61.60 70.27 78.16 77.31 95.31 120.29 140.56 110.26 (FL) ESRD Net. of Florida 46.35 55.11 59.72 63.96 73.25 72.48 80.19 86.79 101.20 102.60 (MS) Network 8 45.46 52.00 47.26 64.09 77.67 71.98 92.87 106.54 110.21 117.51 (IN) Tri-state R. N. 53.11 55.03 64.54 67.97 84.02 84.50 87.42 117.89 128.87 126.13 (IL) Renal Net. of Illinois 44.25 53.03 61.14 73.40 72.31 77.28 99.98 112.73 118.44 112.18 (MN) Renal Net. of upper midwest 57.46 69.81 76.77 83.39 94.20 90.49 106.07 115.11 125.11 124.10 (MO) ESRD net. #12 50.09 60.99 63.63 76.92 88.11 88.14 98.15 116.03 126.63 133.11 (OK) ESRD net. #13 56.93 61.34 69.01 80.15 91.06 85.98 101.88 114.84 121.23 131.55 (TX) Net. of Texas 72.41 85.72 97.59 103.42 111.48 121.34 132.11 148.16 164.18 166.06 (CO) Inter-mountain ESRD net. 68.99 81.30 72.88 96.96 102.23 102.19 108.80 126.50 124.82 129.27 (WA) Northwest Renal Net. 47.52 70.53 71.37 78.41 84.35 85.40 97.42 111.09 96.99 97.85 (N-CA) Trans-pacific ESRD Net. 55.72 72.65 79.58 80.38 84.51 87.94 103.91 106.86 115.88 125.90 (S-CA) Southern California Net. 56.89 73.63 80.62 96.37 92.66 89.34 117.22 128.96 129.51 146.23 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.28(Continued) Incidence Rates per Million Population of Reported ESRD Therapy by Network Adjusted for Age, Race and Sex Non-Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 107.44 114.52 120.77 126.32 136.23 130.16 151.07 155.80 165.74 145.96 (NY) Net. of N.Y. 97.95 112.44 120.75 125.29 141.97 138.77 160.70 160.05 163.92 163.02 (NJ) Trans-Atlantic R. C. 119.60 135.89 139.49 152.00 171.94 159.40 178.50 181.37 182.42 182.15 (PA) ESRD Net. Org. #4 107.83 111.98 139.90 131.74 144.95 133.97 169.94 174.12 175.36 180.13 (VA) Mid Atlantic R. C. 97.72 110.63 122.97 134.88 137.03 138.70 130.85 156.25 162.13 164.04 (NC) Southeastern Kidney Council 104.43 116.37 113.93 129.15 141.59 137.17 153.40 178.79 191.82 149.76 (FL) ESRD Net. of Florida 116.18 127.44 129.34 142.63 149.59 141.71 145.26 144.72 162.62 154.45 (MS) Network 8 108.14 122.21 100.18 130.20 142.64 126.90 152.73 152.97 159.63 157.07 (IN) Tri-state R. N. 105.93 112.70 116.17 118.69 132.99 132.91 125.97 156.51 161.65 149.98 (IL) Renal Net. of Illinois 108.75 112.19 124.67 141.52 158.65 156.77 175.31 182.21 173.25 175.53 (MN) Renal Net. of upper midwest 106.19 115.20 116.37 117.14 133.33 132.06 151.21 153.38 161.02 155.74 (MO) ESRD net. #12 103.55 112.04 125.58 130.13 139.08 134.55 152.57 147.00 162.27 152.87 (OK) ESRD net. #13 109.08 114.57 123.19 127.34 137.21 141.39 155.80 162.60 151.31 166.09 (TX) Net. of Texas 117.41 114.35 125.95 136.47 153.10 137.65 153.04 149.03 159.29 147.50 (CO) Inter-mountain ESRD net. 93.06 110.31 98.49 115.27 116.38 111.38 129.90 118.32 132.48 126.47 (WA) Northwest Renal Net. 91.36 103.32 107.67 115.43 110.68 119.86 161.22 174.30 129.30 120.21 (N-CA) Trans-pacific ESRD Net. 116.16 120.62 133.40 138.96 132.40 131.84 149.45 147.01 146.90 145.11 (S-CA) Southern California Net. 108.46 119.78 124.78 134.82 134.75 128.32 166.19 160.76 158.59 157.94 Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.29 Standard Errors for Incidence Rates per Million Population of Reported ESRD Therapy by Network Adjusted for Age, Race and Sex All Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 4.74 4.78 4.81 4.91 5.11 4.94 5.47 5.67 5.72 5.49 (NY) Net. of N.Y. 2.89 3.03 3.15 3.24 3.41 3.43 3.62 3.70 3.79 3.84 (NJ) Trans-Atlantic R. C. 4.78 5.05 5.32 5.45 5.63 5.64 5.88 6.08 6.07 6.13 (PA) ESRD Net. Org. #4 4.30 4.28 4.54 4.55 4.67 4.43 5.00 5.26 5.18 5.16 (VA) Mid Atlantic R. C. 3.54 3.62 3.79 3.94 4.03 4.04 3.98 4.37 4.47 4.58 (NC) Southeastern Kidney Council 3.31 3.42 3.44 3.72 3.84 3.78 3.96 5.13 5.36 3.94 (FL) ESRD Net. of Florida 3.77 3.94 3.93 4.02 4.07 4.06 3.92 4.13 4.25 4.09 (MS) Network 8 5.12 4.49 4.30 4.70 4.89 4.39 5.10 5.36 5.09 5.18 (IN) Tri-state R. N. 3.66 3.73 3.62 3.55 3.94 3.91 3.67 4.16 4.34 4.16 (IL) Renal Net. of Illinois 3.87 4.01 4.30 4.51 4.65 4.71 4.94 5.10 5.06 5.13 (MN) Renal Net. of upper midwest 3.48 3.65 3.68 3.63 3.87 3.85 4.03 4.13 4.15 4.11 (MO) ESRD net. #12 4.63 4.85 4.90 5.12 5.31 5.35 5.46 5.60 6.03 5.82 (OK) ESRD net. #13 4.24 4.29 4.49 4.60 4.79 4.79 4.99 5.16 5.08 5.35 (TX) Net. of Texas 4.09 3.91 4.05 4.14 4.26 4.22 4.32 4.43 4.54 4.50 (CO) Inter-mountain ESRD net. 5.44 6.21 5.42 6.05 5.80 5.75 5.78 5.69 5.68 5.63 (WA) Northwest Renal Net. 6.67 7.51 7.44 7.58 7.82 7.82 8.61 9.02 7.51 7.08 (N-CA) Trans-pacific ESRD Net. 4.58 4.83 5.00 5.03 4.95 5.01 5.23 5.19 5.25 5.34 (S-CA) Southern California Net. 3.63 3.85 3.94 4.09 4.02 3.94 4.42 4.47 4.39 4.49 (CONTINUED) Table A.29(Continued) Standard Errors for Incidence Rates per Million Population of Reported ESRD Therapy by Network Adjusted for Age, Race and Sex Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 2.49 2.63 2.80 2.92 3.11 2.98 3.37 3.65 3.70 3.55 (NY) Net. of N.Y. 1.57 1.63 1.78 1.85 1.95 1.96 2.12 2.23 2.38 2.41 (NJ) Trans-Atlantic R. C. 2.53 2.66 3.10 3.13 3.17 3.26 3.55 3.87 3.87 3.89 (PA) ESRD Net. Org. #4 2.39 2.38 2.45 2.70 2.84 2.61 3.02 3.27 3.16 3.16 (VA) Mid Atlantic R. C. 1.84 1.93 2.03 2.17 2.38 2.35 2.39 2.59 2.74 2.84 (NC) Southeastern Kidney Council 1.63 1.84 2.04 2.32 2.24 2.21 2.44 3.23 3.43 2.45 (FL) ESRD Net. of Florida 2.02 2.22 2.24 2.22 2.38 2.32 2.35 2.47 2.61 2.52 (MS) Network 8 3.01 2.42 2.23 2.58 2.92 2.44 3.27 3.54 3.21 3.32 (IN) Tri-state R. N. 2.13 1.94 2.12 2.02 2.36 2.41 2.26 2.61 2.84 2.78 (IL) Renal Net. of Illinois 2.00 2.20 2.38 2.54 2.53 2.58 2.92 3.10 3.17 3.07 (MN) Renal Net. of upper midwest 2.12 2.30 2.37 2.39 2.54 2.47 2.63 2.74 2.78 2.74 (MO) ESRD net. #12 2.60 2.96 2.84 3.18 3.43 3.29 3.42 3.81 4.03 4.01 (OK) ESRD net. #13 2.50 2.54 2.71 2.85 3.02 2.93 3.14 3.31 3.36 3.49 (TX) Net. of Texas 2.55 2.47 2.65 2.69 2.74 2.83 2.90 3.09 3.22 3.17 (CO) Inter-mountain ESRD net. 3.47 3.95 3.35 3.96 3.85 3.83 3.83 4.03 3.81 3.90 (WA) Northwest Renal Net. 3.75 5.19 5.18 5.35 5.32 5.39 5.40 5.79 5.19 4.92 (N-CA) Trans-pacific ESRD Net. 2.54 2.88 3.02 2.99 3.05 3.10 3.30 3.33 3.45 3.58 (S-CA) Southern California Net. 2.05 2.29 2.40 2.60 2.52 2.43 2.79 2.91 2.88 3.04 (CONTINUED) Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.29(Continued) Standard Errors for Incidence Rates per Million Population of Reported ESRD Therapy by Network Adjusted for Age, Race and Sex Non-Diabetes Patients Year 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Network (CT) Net. of New England 3.90 3.89 3.83 3.87 4.00 3.81 4.16 4.17 4.31 3.89 (NY) Net. of N.Y. 2.35 2.48 2.56 2.61 2.75 2.71 2.90 2.87 2.91 2.89 (NJ) Trans-Atlantic R. C. 3.98 4.21 4.25 4.39 4.64 4.41 4.63 4.63 4.62 4.58 (PA) ESRD Net. Org. #4 3.48 3.26 3.73 3.46 3.57 3.38 3.89 3.94 3.88 3.85 (VA) Mid Atlantic R. C. 2.87 2.94 3.11 3.22 3.19 3.18 3.07 3.32 3.35 3.37 (NC) Southeastern Kidney Council 2.79 2.77 2.71 2.87 3.05 2.95 3.05 3.94 4.09 2.94 (FL) ESRD Net. of Florida 3.13 3.21 3.16 3.33 3.27 3.24 3.10 3.08 3.21 3.04 (MS) Network 8 4.06 3.55 3.23 3.61 3.76 3.40 3.80 3.87 3.86 3.63 (IN) Tri-state R. N. 2.92 2.85 2.78 2.72 2.94 2.82 2.73 3.06 3.15 2.86 (IL) Renal Net. of Illinois 3.21 3.20 3.37 3.55 3.80 3.69 3.88 3.94 3.83 3.83 (MN) Renal Net. of upper midwest 2.72 2.79 2.77 2.70 2.88 2.85 3.02 3.04 3.05 2.97 (MO) ESRD net. #12 3.73 3.66 3.93 3.98 4.03 4.04 4.20 4.03 4.44 4.05 (OK) ESRD net. #13 3.39 3.43 3.54 3.58 3.68 3.68 3.86 3.91 3.76 3.93 (TX) Net. of Texas 3.11 2.88 2.99 3.10 3.22 3.02 3.15 3.08 3.14 2.99 (CO) Inter-mountain ESRD net. 4.11 4.65 4.05 4.53 4.25 4.09 4.27 3.95 4.13 3.93 (WA) Northwest Renal Net. 5.40 5.41 5.33 5.33 5.66 5.61 6.70 6.78 5.39 4.98 (N-CA) Trans-pacific ESRD Net. 3.71 3.79 3.93 4.00 3.87 3.79 4.02 3.93 3.90 3.85 (S-CA) Southern California Net. 2.86 2.96 3.00 3.10 3.06 2.93 3.33 3.25 3.19 3.16 Includes residents of 50 states and District of Columbia only. * Values for cells with fewer than 10 patients are suppressed. Rates per million based on July 1, U.S. resident population by state or ESRD Network. The standard population is July 1, 1996, U.S. resident population by 5-year age groups, sex, and white/non-white race groups. Table A.30 Incidence Counts of Reported ESRD Therapy by Age, Sex, and Race 1992-1994 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 1006 436 59 21 1522| 826 314 60 22 1222| 1832 750 119 43 2744| | 20-44 | 10514 7747 576 233 19070| 7403 4978 516 182 13079| 17917 12725 1092 415 32149| | 45-64 | 20083 10507 927 595 32112| 16158 10608 835 630 28231| 36241 21115 1762 1225 60343| | 65-74 | 19928 5079 738 259 26004| 16884 7711 726 375 25696| 36812 12790 1464 634 51700| | 75 plus | 14457 2556 463 118 17594| 11652 4232 423 159 16466| 26109 6788 886 277 34060| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 65988 26325 2763 1226 96302| 52923 27843 2560 1368 84694|118911 54168 5323 2594 180996| ----------------------------------------------------------------------------------------------------------------------- 1995-1997 ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 1212 548 62 19 1841| 882 399 73 24 1378| 2094 947 135 43 3219| | 20-44 | 11302 8962 585 328 21177| 7598 6518 579 277 14972| 18900 15480 1164 605 36149| | 45-64 | 24600 13439 1347 774 40160| 19765 13449 1188 889 35291| 44365 26888 2535 1663 75451| | 65-74 | 23787 5949 974 288 30998| 19431 9032 1074 507 30044| 43218 14981 2048 795 61042| | 75 plus | 19801 3395 797 125 24118| 15723 5565 758 200 22246| 35524 8960 1555 325 46364| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 80702 32293 3765 1534 118294| 63399 34963 3672 1897 103931|144101 67256 7437 3431 222225| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.31 Incidence Rates per Million Population of Reported ESRD Therapy Specific Rates by Sex, Race, and Age, and Rates Adjusted for Age, Race, and Sex 1992-1994 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 11 25 14 16 | * 18 15 18 | 11 23 15 18 | 13 11 | 12 | | 20-44 | 83 417 103 176 | 60 242 87 139 | 70 339 96 168 | 129 84 | 106 | | 45-64 | 321 1569 448 1263 | 246 1275 351 1233 | 301 1507 440 1401 | 524 415 | 468 | | 65-74 | 902 2584 1520 2400 | 612 2780 1135 2812 | 760 2696 1333 2610 | 1160 927 | 1042 | | 75 plus | 1050 2330 1809 2000 | 471 2024 1297 1670 | 702 2035 1450 1680 | 1157 666 | 906 | | All Age | 209 575 218 377 | 161 549 192 415 | 185 561 205 396 | 255 214 | 234 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 221 808 346 623 | 144 667 262 610 | 177 735 298 616 | 287 201 | 238 | ------------------------------------------------------------------------------------------------------------------------- 1995-1997 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 13 30 13 14 | 10 23 16 18 | 12 27 15 17 | 15 12 | 14 | | 20-44 | 90 472 97 240 | 62 311 90 207 | 73 393 94 232 | 139 94 | 116 | | 45-64 | 364 1802 540 1485 | 280 1451 415 1572 | 353 1773 554 1712 | 616 490 | 551 | | 65-74 | 1071 2905 1766 2487 | 713 3165 1419 3595 | 895 3071 1610 3046 | 1355 1080 | 1215 | | 75 plus | 1311 2869 2577 1791 | 601 2516 1806 1792 | 899 2551 2079 1658 | 1471 858 | 1158 | | All Age | 249 677 267 450 | 189 662 245 549 | 219 669 256 500 | 304 256 | 279 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 261 935 427 691 | 168 793 331 776 | 207 862 371 739 | 336 236 | 279 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.32 Standard Errors for Adjusted Incidence Rates per Million Population of Reported ESRD Therapy by Sex, Race, and Age, Adjusted for Age, Race, and Sex 1992-1994 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.3 1.2 1.8 3.5 | 0.3 1.0 1.9 3.7 | 0.2 0.8 1.4 2.7 | 0.3 0.3 | 0.2 | | 20-44 | 0.8 4.7 4.3 11.6 | 0.7 3.4 3.8 10.3 | 0.5 3.0 2.9 8.3 | 0.9 0.7 | 0.6 | | 45-64 | 2.3 15.3 14.7 51.8 | 1.9 12.4 12.2 49.1 | 1.6 10.6 10.9 41.3 | 3.0 2.5 | 2.0 | | 65-74 | 6.4 36.3 56.0 149.1 | 4.7 31.7 42.1 145.2 | 4.0 24.3 35.5 105.1 | 7.5 6.0 | 4.8 | | 75 plus | 8.7 46.1 84.1 184.1 | 4.4 31.1 63.0 132.4 | 4.8 27.2 52.7 107.6 | 9.9 5.7 | 5.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 0.9 5.2 7.1 19.0 | 0.6 4.0 5.5 16.9 | 0.5 3.2 4.4 12.6 | 0.9 0.7 | 0.6 | ------------------------------------------------------------------------------------------------------------------------- 1995-1997 ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.4 1.3 1.7 3.3 | 0.3 1.1 1.9 3.8 | 0.3 0.9 1.3 2.5 | 0.4 0.3 | 0.2 | | 20-44 | 0.8 5.0 4.0 13.3 | 0.7 3.8 3.7 12.4 | 0.5 3.2 2.8 9.5 | 1.0 0.8 | 0.6 | | 45-64 | 2.3 15.5 14.7 53.4 | 2.0 12.5 12.0 52.7 | 1.7 11.2 11.4 43.5 | 3.2 2.7 | 2.1 | | 65-74 | 6.9 37.7 56.6 146.5 | 5.1 33.3 43.3 159.7 | 4.3 25.6 36.2 109.0 | 8.0 6.4 | 5.1 | | 75 plus | 9.3 49.2 91.3 160.2 | 4.8 33.7 65.6 126.7 | 5.2 29.5 56.5 96.5 | 10.7 6.3 | 6.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 0.9 5.4 7.5 18.6 | 0.7 4.3 5.7 18.2 | 0.5 3.4 4.6 13.1 | 1.0 0.7 | 0.6 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.33 Incidence Counts of Reported ESRD Therapy by Age, Sex, Race, and Primary Disease Causing ESRD 1992-1994 Diabetes ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | * * 0 * 16| 14 12 * * 28| 22 19 * * 44| | 20-44 | 4287 1172 92 99 5650| 3124 1166 74 85 4449| 7411 2338 166 184 10099| | 45-64 | 9108 4023 462 412 14005| 8364 5490 390 508 14752| 17472 9513 852 920 28757| | 65-74 | 6428 1851 336 145 8760| 7649 3781 392 271 12093| 14077 5632 728 416 20853| | 75 plus | 2438 565 132 39 3174| 2954 1306 159 83 4502| 5392 1871 291 122 7676| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 22269 7618 1022 696 31605| 22105 11755 1016 948 35824| 44374 19373 2038 1644 67429| ----------------------------------------------------------------------------------------------------------------------- Hypertension ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 31 57 * * 92| 37 27 * * 68| 68 84 * * 160| | 20-44 | 1174 3124 112 41 4451| 614 1397 85 16 2112| 1788 4521 197 57 6563| | 45-64 | 3926 4232 195 65 8418| 2428 3252 162 42 5884| 6354 7484 357 107 14302| | 65-74 | 7277 2218 221 58 9774| 4658 2876 177 47 7758| 11935 5094 398 105 17532| | 75 plus | 7092 1396 209 41 8738| 5258 2220 155 42 7675| 12350 3616 364 83 16413| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 19500 11027 739 207 31473| 12995 9772 582 148 23497| 32495 20799 1321 355 54970| ----------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 279 189 25 * 500| 276 125 26 10 437| 555 314 51 17 937| | 20-44 | 2221 1468 249 41 3979| 1259 930 203 31 2423| 3480 2398 452 72 6402| | 45-64 | 2615 785 140 55 3595| 1459 553 124 24 2160| 4074 1338 264 79 5755| | 65-74 | 2088 254 90 24 2456| 1302 243 59 16 1620| 3390 497 149 40 4076| | 75 plus | 1474 113 49 10 1646| 1000 148 45 12 1205| 2474 261 94 22 2851| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 8677 2809 553 137 12176| 5296 1999 457 93 7845| 13973 4808 1010 230 20021| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.33(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race, and Primary Disease Causing ESRD 1992-1994 Cystic Kidney ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 40 * * * 47| 43 10 * 0 57| 83 14 * * 104| | 20-44 | 453 60 11 * 532| 362 78 11 * 456| 815 138 22 13 988| | 45-64 | 1136 150 32 10 1328| 1092 183 25 * 1308| 2228 333 57 18 2636| | 65-74 | 361 50 15 * 429| 392 44 * * 449| 753 94 24 * 878| | 75 plus | 187 18 * * 209| 153 26 * 0 184| 340 44 * * 393| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 2177 282 62 24 2545| 2042 341 54 17 2454| 4219 623 116 41 4999| ----------------------------------------------------------------------------------------------------------------------- Other Urologic ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 107 35 * 0 148| 62 * * * 69| 169 40 * * 217| | 20-44 | 264 50 11 * 326| 223 25 * * 257| 487 75 15 * 583| | 45-64 | 290 57 10 * 360| 244 57 17 * 320| 534 114 27 * 680| | 65-74 | 382 52 * * 447| 208 33 10 0 251| 590 85 19 * 698| | 75 plus | 353 57 12 * 427| 160 21 * 0 189| 513 78 20 * 616| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 1396 251 48 13 1708| 897 141 40 * 1086| 2293 392 88 21 2794| ----------------------------------------------------------------------------------------------------------------------- Other Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 400 93 21 * 520| 275 95 14 * 391| 675 188 35 13 911| | 20-44 | 1215 1318 46 25 2604| 1211 1080 97 27 2415| 2426 2398 143 52 5019| | 45-64 | 1722 637 43 29 2431| 1592 539 58 26 2215| 3314 1176 101 55 4646| | 65-74 | 1765 271 34 13 2083| 1431 212 33 18 1694| 3196 483 67 31 3777| | 75 plus | 1375 192 20 * 1595| 952 164 20 * 1143| 2327 356 40 15 2738| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 6477 2511 164 81 9233| 5461 2090 222 85 7858| 11938 4601 386 166 17091| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.33(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race, and Primary Disease Causing ESRD 1992-1994 Unknown Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 95 28 * * 128| 80 23 * * 114| 175 51 12 * 242| | 20-44 | 629 389 38 15 1071| 404 198 35 13 650| 1033 587 73 28 1721| | 45-64 | 809 348 33 12 1202| 584 246 49 * 888| 1393 594 82 21 2090| | 65-74 | 994 172 27 11 1204| 695 218 32 * 953| 1689 390 59 19 2157| | 75 plus | 985 112 34 13 1144| 705 156 23 * 887| 1690 268 57 16 2031| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 3512 1049 135 53 4749| 2468 841 148 35 3492| 5980 1890 283 88 8241| ----------------------------------------------------------------------------------------------------------------------- Missing Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 46 23 * * 71| 39 17 * 0 58| 85 40 * * 129| | 20-44 | 271 166 17 * 457| 206 104 * 0 317| 477 270 24 * 774| | 45-64 | 477 275 12 * 773| 395 288 10 11 704| 872 563 22 20 1477| | 65-74 | 633 211 * * 851| 549 304 14 11 878| 1182 515 20 12 1729| | 75 plus | 553 103 * * 661| 470 191 * 12 681| 1023 294 12 13 1342| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 1980 778 40 15 2813| 1659 904 41 34 2638| 3639 1682 81 49 5451| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.33(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race, and Primary Disease Causing ESRD 1995-1997 Diabetes ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 16 * * 0 25| 13 13 * 0 27| 29 21 * 0 52| | 20-44 | 4520 1454 108 127 6209| 3019 1468 89 118 4694| 7539 2922 197 245 10903| | 45-64 | 12237 5668 676 563 19144| 11101 7594 608 691 19994| 23338 13262 1284 1254 39138| | 65-74 | 9312 2661 485 193 12651| 9819 5097 644 383 15943| 19131 7758 1129 576 28594| | 75 plus | 4470 1006 290 48 5814| 4703 2198 346 121 7368| 9173 3204 636 169 13182| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 30555 10797 1560 931 43843| 28655 16370 1688 1313 48026| 59210 27167 3248 2244 91869| ----------------------------------------------------------------------------------------------------------------------- Hypertension ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 21 53 * * 77| 25 32 * * 64| 46 85 * * 141| | 20-44 | 1089 3022 96 49 4256| 502 1750 75 35 2362| 1591 4772 171 84 6618| | 45-64 | 3742 4434 259 92 8527| 2261 3287 210 70 5828| 6003 7721 469 162 14355| | 65-74 | 7006 2116 248 38 9408| 4492 2748 208 65 7513| 11498 4864 456 103 16921| | 75 plus | 8318 1599 291 39 10247| 6269 2485 265 49 9068| 14587 4084 556 88 19315| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 20176 11224 896 219 32515| 13549 10302 762 222 24835| 33725 21526 1658 441 57350| ----------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 289 173 25 * 493| 254 131 21 * 415| 543 304 46 15 908| | 20-44 | 2374 1549 227 74 4224| 1320 1062 228 64 2674| 3694 2611 455 138 6898| | 45-64 | 2951 1052 197 47 4247| 1646 697 165 47 2555| 4597 1749 362 94 6802| | 65-74 | 2250 281 115 17 2663| 1308 325 83 17 1733| 3558 606 198 34 4396| | 75 plus | 1886 144 88 13 2131| 1247 191 61 10 1509| 3133 335 149 23 3640| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 9750 3199 652 157 13758| 5775 2406 558 147 8886| 15525 5605 1210 304 22644| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.33(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race, and Primary Disease Causing ESRD 1995-1997 Cystic Kidney ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 54 14 * * 71| 59 11 * 0 73| 113 25 * * 144| | 20-44 | 534 99 15 * 652| 350 82 12 * 445| 884 181 27 * 1097| | 45-64 | 1250 165 41 * 1463| 1063 183 30 * 1285| 2313 348 71 16 2748| | 65-74 | 410 51 14 * 476| 411 64 13 * 489| 821 115 27 * 965| | 75 plus | 200 45 * * 252| 194 33 * * 232| 394 78 * * 484| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 2448 374 76 16 2914| 2077 373 62 12 2524| 4525 747 138 28 5438| ----------------------------------------------------------------------------------------------------------------------- Other Urologic ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 74 21 0 0 95| 58 10 * * 71| 132 31 * * 166| | 20-44 | 307 54 10 10 381| 313 57 16 * 388| 620 111 26 12 769| | 45-64 | 468 101 18 * 595| 364 63 20 * 449| 832 164 38 10 1044| | 65-74 | 575 125 15 * 720| 282 45 19 * 348| 857 170 34 * 1068| | 75 plus | 743 84 10 * 843| 244 39 * * 293| 987 123 19 * 1136| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 2167 385 53 29 2634| 1261 214 66 * 1549| 3428 599 119 37 4183| ----------------------------------------------------------------------------------------------------------------------- Other Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 594 198 25 * 826| 339 134 30 10 513| 933 332 55 19 1339| | 20-44 | 1466 1868 45 41 3420| 1388 1567 103 41 3099| 2854 3435 148 82 6519| | 45-64 | 2379 1063 70 33 3545| 2203 867 75 42 3187| 4582 1930 145 75 6732| | 65-74 | 2517 346 46 16 2925| 1914 322 57 17 2310| 4431 668 103 33 5235| | 75 plus | 2215 248 52 12 2527| 1651 255 35 * 1949| 3866 503 87 20 4476| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 9171 3723 238 111 13243| 7495 3145 300 118 11058| 16666 6868 538 229 24301| ----------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.33(Continued) Incidence Counts of Reported ESRD Therapy by Age, Sex, Race, and Primary Disease Causing ESRD 1995-1997 Unknown Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 51 38 * * 91| 62 33 * 0 100| 113 71 * * 191| | 20-44 | 427 396 41 13 877| 282 199 30 11 522| 709 595 71 24 1399| | 45-64 | 732 336 45 16 1129| 536 272 50 16 874| 1268 608 95 32 2003| | 65-74 | 981 175 35 15 1206| 667 192 36 15 910| 1648 367 71 30 2116| | 75 plus | 1268 148 46 * 1465| 931 189 29 * 1157| 2199 337 75 11 2622| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 3459 1093 168 48 4768| 2478 885 150 50 3563| 5937 1978 318 98 8331| ----------------------------------------------------------------------------------------------------------------------- Missing Cause ----------------------------------------------------------------------------------------------------------------------- | | Males | Females | Both Sexes | |Age At ESRD|-----------------------------------+----------------------------------+----------------------------------| | | White Black Asian NatAm All| White Black Asian NatAm All| White Black Asian NatAm All| |-----------+-----------------------------------+----------------------------------+----------------------------------| | 0-19 | 113 43 * 0 163| 72 35 * * 115| 185 78 14 * 278| | 20-44 | 585 520 43 10 1158| 424 333 26 * 788| 1009 853 69 15 1946| | 45-64 | 841 620 41 * 1510| 591 486 30 12 1119| 1432 1106 71 20 2629| | 65-74 | 736 194 16 * 949| 538 239 14 * 798| 1274 433 30 10 1747| | 75 plus | 701 121 15 * 839| 484 175 * * 670| 1185 296 24 * 1509| |-----------+-----------------------------------+----------------------------------+----------------------------------| | All Age | 2976 1498 122 23 4619| 2109 1268 86 27 3490| 5085 2766 208 50 8109| ----------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. * Values for cells with fewer than 10 patients are suppressed. Table A.34 Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age and Rates Adjusted for Age, Race, and Sex 1992-1994 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * 0 * | * * * * | * * * * | * * | * | | 20-44 | 338 631 164 750 | 252 567 125 649 | 288 630 149 768 | 374 289 | 330 | | 45-64 | 1455 6006 2231 8744 | 1272 6597 1641 9944 | 1455 6827 2193 10570 | 2282 2199 | 2241 | | 65-74 | 2911 9417 6920 13435 | 2774 13633 6126 20321 | 2837 11533 6512 16784 | 3962 4410 | 4198 | | 75 plus | 1770 5150 5158 6610 | 1193 6245 4874 8717 | 1271 4965 4376 6629 | 1977 1822 | 1901 | | All Age | 721 2418 1295 3453 | 611 2853 1082 4250 | 662 2663 1182 3900 | 915 854 | 884 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 721 2418 1295 3453 | 611 2853 1082 4250 | 662 2663 1182 3900 | 915 854 | 884 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 33 * * | * 16 * * | * 26 * * | * * | * | | 20-44 | 93 1682 199 310 | 49 679 143 122 | 70 1220 174 227 | 310 135 | 219 | | 45-64 | 627 6319 942 1380 | 369 3908 682 822 | 543 5381 913 1258 | 1465 895 | 1170 | | 65-74 | 3295 11284 4552 5374 | 1689 10370 2766 3524 | 2515 10939 3702 4536 | 4445 2870 | 3642 | | 75 plus | 5150 12725 8166 6949 | 2124 10616 4752 4411 | 3439 11166 6278 5526 | 5942 3191 | 4539 | | All Age | 682 3501 1066 1207 | 334 2399 658 731 | 479 2923 824 940 | 979 538 | 726 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 682 3501 1066 1207 | 334 2399 658 731 | 479 2923 824 940 | 979 538 | 726 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 31 108 59 * | 32 74 64 80 | 32 95 65 71 | 43 40 | 42 | | 20-44 | 175 791 443 310 | 101 452 342 237 | 137 628 393 284 | 266 156 | 210 | | 45-64 | 418 1172 676 1167 | 222 665 522 470 | 333 912 603 851 | 546 300 | 420 | | 65-74 | 945 1292 1854 2224 | 472 876 922 1200 | 709 1087 1391 1712 | 1041 551 | 791 | | 75 plus | 1070 1030 1915 1695 | 404 708 1379 1260 | 671 811 1569 1402 | 1008 459 | 728 | | All Age | 286 733 566 638 | 149 434 402 368 | 210 578 476 492 | 350 191 | 263 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 286 733 566 638 | 149 434 402 368 | 210 578 476 492 | 350 191 | 263 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.34(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age and Rates Adjusted for Age, Race, and Sex 1992-1994 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * * * | * * * 0 | * * * * | * * | * | | 20-44 | 36 32 20 * | 29 38 19 * | 32 38 20 52 | 35 30 | 33 | | 45-64 | 181 224 155 212 | 166 220 105 * | 175 222 128 183 | 188 171 | 179 | | 65-74 | 163 254 309 * | 142 159 * * | 152 205 232 * | 181 146 | 163 | | 75 plus | 136 164 * * | 62 124 * 0 | 89 131 * * | 125 66 | 95 | | All Age | 71 87 68 103 | 60 81 50 67 | 65 83 59 84 | 73 62 | 67 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 71 87 68 103 | 60 81 50 67 | 65 83 59 84 | 73 62 | 67 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 12 20 * 0 | * * * * | * 11 * * | 13 * | * | | 20-44 | 21 27 20 * | 18 12 * * | 19 20 13 * | 22 17 | 19 | | 45-64 | 46 85 48 * | 37 68 72 * | 44 84 68 * | 57 44 | 50 | | 65-74 | 173 265 * * | 75 119 156 0 | 125 195 178 * | 191 84 | 137 | | 75 plus | 256 520 469 * | 65 100 * 0 | 151 320 340 * | 299 69 | 181 | | All Age | 47 83 62 89 | 25 34 43 * | 34 54 50 48 | 51 26 | 37 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 47 83 62 89 | 25 34 43 * | 34 54 50 48 | 51 26 | 37 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 44 53 50 * | 32 56 35 * | 38 56 43 54 | 46 36 | 41 | | 20-44 | 96 710 82 189 | 98 525 163 206 | 96 624 123 204 | 176 155 | 165 | | 45-64 | 275 951 208 615 | 242 648 244 509 | 274 804 249 642 | 381 307 | 343 | | 65-74 | 799 1379 700 1205 | 519 764 516 1350 | 660 1078 603 1324 | 881 559 | 716 | | 75 plus | 998 1750 781 * | 385 784 613 * | 636 1190 664 984 | 1010 423 | 710 | | All Age | 216 691 182 380 | 153 450 194 344 | 179 560 186 359 | 270 190 | 224 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 216 691 182 380 | 153 450 194 344 | 179 560 186 359 | 270 190 | 224 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.34(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age and Rates Adjusted for Age, Race, and Sex 1992-1994 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 10 16 * * | * 14 * * | 10 15 16 * | 11 11 | 11 | | 20-44 | 50 209 68 114 | 33 96 59 99 | 41 157 62 110 | 72 42 | 57 | | 45-64 | 129 520 159 255 | 89 296 206 * | 116 432 197 232 | 193 129 | 160 | | 65-74 | 450 875 556 1019 | 252 786 500 * | 354 833 538 848 | 521 335 | 426 | | 75 plus | 715 1021 1328 2203 | 285 746 705 * | 480 881 957 1040 | 765 349 | 553 | | All Age | 120 316 176 298 | 67 199 146 144 | 89 254 156 210 | 143 82 | 108 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 120 316 176 298 | 67 199 146 144 | 89 254 156 210 | 143 82 | 108 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 13 * * | * 10 * 0 | * 12 * * | * * | * | | 20-44 | 21 89 30 * | 17 51 * 0 | 19 71 22 * | 31 20 | 25 | | 45-64 | 76 411 58 * | 60 346 42 215 | 73 412 50 219 | 127 106 | 116 | | 65-74 | 287 1073 * * | 199 1096 219 825 | 243 1088 177 428 | 382 318 | 349 | | 75 plus | 402 939 * * | 190 913 * 1260 | 280 882 205 763 | 441 277 | 357 | | All Age | 68 252 42 66 | 44 221 45 173 | 54 235 45 129 | 85 61 | 71 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 68 252 42 66 | 44 221 45 173 | 54 235 45 129 | 85 61 | 71 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.34(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age and Rates Adjusted for Age, Race, and Sex 1995-1997 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * * 0 | * * * 0 | * * * 0 | * * | * | | 20-44 | 359 765 179 931 | 246 700 138 881 | 288 742 161 961 | 398 296 | 346 | | 45-64 | 1809 7602 2708 10799 | 1572 8193 2122 12215 | 1869 8939 2923 12988 | 2963 2834 | 2899 | | 65-74 | 4191 12992 8796 16664 | 3605 17861 8507 27157 | 3900 15502 8705 21885 | 5594 5795 | 5706 | | 75 plus | 2960 8501 9375 6876 | 1797 9937 8242 10843 | 2086 8310 7986 8045 | 3415 2876 | 3144 | | All Age | 960 3271 1793 4220 | 768 3785 1573 5459 | 854 3560 1673 4918 | 1219 1096 | 1153 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 960 3271 1793 4220 | 768 3785 1573 5459 | 854 3560 1673 4918 | 1219 1096 | 1153 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 29 * * | * 18 * * | * 24 * * | * * | * | | 20-44 | 87 1590 159 359 | 41 834 116 261 | 61 1217 138 323 | 283 144 | 211 | | 45-64 | 553 5947 1038 1765 | 320 3546 733 1237 | 500 5081 1034 1675 | 1392 837 | 1105 | | 65-74 | 3153 10331 4498 3281 | 1649 9630 2748 4609 | 2419 10205 3696 4041 | 4197 2762 | 3465 | | 75 plus | 5508 13511 9408 5587 | 2395 11234 6312 4391 | 3828 11989 7667 4785 | 6470 3607 | 5010 | | All Age | 680 3371 1140 1073 | 335 2389 760 964 | 477 2854 920 1016 | 964 543 | 721 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 680 3371 1140 1073 | 335 2389 760 964 | 477 2854 920 1016 | 964 543 | 721 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 31 96 53 * | 29 75 47 * | 30 87 52 56 | 41 36 | 38 | | 20-44 | 189 815 377 542 | 107 506 354 478 | 146 662 365 515 | 277 169 | 222 | | 45-64 | 436 1411 789 902 | 233 752 576 831 | 355 1090 711 923 | 607 331 | 465 | | 65-74 | 1013 1372 2086 1468 | 480 1139 1096 1205 | 747 1271 1607 1333 | 1115 595 | 850 | | 75 plus | 1249 1217 2845 1862 | 476 863 1453 896 | 811 985 2059 1202 | 1235 544 | 883 | | All Age | 311 800 635 621 | 158 500 432 520 | 226 645 519 564 | 380 207 | 285 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 311 800 635 621 | 158 500 432 520 | 226 645 519 564 | 380 207 | 285 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.34(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age and Rates Adjusted for Age, Race, and Sex 1995-1997 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * * * | * * * 0 | * * * * | * * | * | | 20-44 | 42 52 25 * | 28 39 19 * | 34 46 22 * | 42 28 | 35 | | 45-64 | 185 221 164 * | 151 197 105 * | 170 211 141 161 | 190 158 | 174 | | 65-74 | 185 249 254 * | 151 224 172 * | 167 240 214 * | 194 161 | 177 | | 75 plus | 132 380 * * | 74 149 * * | 96 258 * * | 159 80 | 119 | | All Age | 76 108 73 69 | 58 82 49 46 | 66 93 59 55 | 78 60 | 68 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 76 108 73 69 | 58 82 49 46 | 66 93 59 55 | 78 60 | 68 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 12 0 0 | * * * * | * * * * | * * | * | | 20-44 | 24 28 17 73 | 25 27 25 * | 25 28 21 43 | 25 26 | 25 | | 45-64 | 69 135 72 * | 52 68 70 * | 66 115 85 118 | 90 58 | 73 | | 65-74 | 259 610 272 * | 104 158 251 * | 182 385 264 * | 310 116 | 211 | | 75 plus | 492 710 323 * | 93 176 * * | 289 457 295 * | 526 106 | 311 | | All Age | 72 128 61 142 | 35 47 56 * | 50 81 57 81 | 77 36 | 53 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 72 128 61 142 | 35 47 56 * | 50 81 57 81 | 77 36 | 53 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 64 110 53 * | 38 77 67 77 | 51 94 62 75 | 70 45 | 57 | | 20-44 | 117 983 75 300 | 113 747 160 306 | 113 864 120 311 | 226 195 | 210 | | 45-64 | 352 1426 280 633 | 312 935 262 742 | 362 1181 298 718 | 520 414 | 465 | | 65-74 | 1133 1689 834 1381 | 703 1128 753 1205 | 920 1426 802 1278 | 1208 766 | 982 | | 75 plus | 1467 2096 1681 1719 | 631 1153 834 * | 987 1551 1188 1221 | 1478 674 | 1068 | | All Age | 296 953 258 473 | 203 647 237 422 | 242 789 241 438 | 371 257 | 305 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 296 953 258 473 | 203 647 237 422 | 242 789 241 438 | 371 257 | 305 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.34(Continued) Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD Specific Rates by Sex, Race, and Age and Rates Adjusted for Age, Race, and Sex 1995-1997 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * 21 * * | * 19 * 0 | * 20 * * | * * | * | | 20-44 | 34 208 68 95 | 23 95 47 82 | 28 151 57 91 | 58 33 | 45 | | 45-64 | 108 451 180 307 | 76 293 174 283 | 102 397 206 343 | 173 118 | 145 | | 65-74 | 442 854 635 1295 | 245 673 476 1064 | 346 777 573 1161 | 518 319 | 416 | | 75 plus | 840 1251 1487 * | 356 854 691 * | 592 1059 1105 499 | 913 435 | 669 | | All Age | 116 314 196 219 | 64 199 134 208 | 85 252 158 216 | 140 80 | 105 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 116 314 196 219 | 64 199 134 208 | 85 252 158 216 | 140 80 | 105 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 12 24 * 0 | * 20 * * | 10 22 15 * | 14 * | 12 | | 20-44 | 47 274 71 73 | 35 159 40 * | 39 216 55 54 | 76 50 | 62 | | 45-64 | 124 832 164 * | 84 524 105 212 | 110 720 143 192 | 227 152 | 188 | | 65-74 | 331 947 290 * | 198 838 185 * | 265 900 238 395 | 413 281 | 345 | | 75 plus | 464 1022 485 * | 185 791 * * | 306 901 355 * | 513 257 | 382 | | All Age | 96 410 114 93 | 57 278 66 106 | 74 341 87 100 | 129 80 | 102 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 96 410 114 93 | 57 278 66 106 | 74 341 87 100 | 129 80 | 102 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.35 Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age Adjusted for Age, Race, and Sex 1992-1994 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | * * 0.0 * | 0.4 2.0 * * | 0.3 1.3 * * | 0.3 0.5 | 0.3 | | 20-44 | 5.2 18.4 17.1 75.3 | 4.5 16.6 14.5 70.4 | 3.4 13.1 11.6 56.9 | 5.0 4.3 | 3.3 | | 45-64 | 15.2 94.7 103.8 430.8 | 13.9 89.0 83.1 441.2 | 11.1 71.3 77.4 359.3 | 20.0 18.4 | 13.6 | | 65-74 | 36.3 218.9 377.5 1115.7 | 31.7 221.7 309.4 1234.4 | 24.1 156.8 245.9 833.0 | 44.4 41.5 | 30.4 | | 75 plus | 35.9 216.7 448.9 1058.5 | 22.0 172.8 386.5 956.8 | 18.7 124.2 274.3 633.5 | 39.8 30.2 | 24.8 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.9 28.3 42.6 136.8 | 4.1 26.4 35.5 140.5 | 3.1 19.4 27.5 98.9 | 5.2 4.5 | 3.4 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.6 4.3 * * | 0.7 3.1 * * | 0.5 2.8 * * | 0.8 0.8 | 0.5 | | 20-44 | 2.7 30.1 18.8 48.5 | 2.0 18.2 15.5 30.5 | 1.7 18.3 12.4 30.3 | 4.7 3.0 | 2.7 | | 45-64 | 10.0 97.1 67.4 171.1 | 7.5 68.5 53.5 126.9 | 6.9 63.5 50.1 125.9 | 16.5 11.9 | 10.0 | | 65-74 | 38.6 239.6 306.2 705.6 | 24.8 193.4 207.9 514.1 | 23.2 156.6 188.8 448.6 | 47.0 33.6 | 28.6 | | 75 plus | 61.1 340.6 564.9 1085.3 | 29.3 225.3 381.7 680.6 | 34.0 204.5 356.8 649.7 | 72.1 39.9 | 40.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.9 34.8 42.4 90.6 | 2.9 24.4 29.0 61.4 | 2.7 20.6 24.2 52.0 | 5.6 3.5 | 3.1 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.8 7.9 11.8 * | 1.9 6.6 12.6 25.3 | 1.4 5.4 9.1 17.3 | 1.9 1.9 | 1.4 | | 20-44 | 3.7 20.6 28.1 48.5 | 2.9 14.8 24.0 42.5 | 2.3 12.9 18.5 33.6 | 4.2 3.2 | 2.6 | | 45-64 | 8.2 41.8 57.1 157.4 | 5.8 28.3 46.8 95.9 | 5.3 25.5 38.7 99.5 | 9.4 6.6 | 5.7 | | 65-74 | 20.7 81.1 195.4 453.9 | 13.1 56.2 120.0 299.9 | 12.3 49.8 115.6 275.1 | 21.9 14.1 | 12.9 | | 75 plus | 27.9 96.9 273.5 536.0 | 12.8 58.2 205.6 363.8 | 14.7 55.0 174.6 317.0 | 27.9 15.0 | 15.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.1 14.4 26.4 59.0 | 2.1 9.9 20.1 40.0 | 1.8 8.6 16.2 34.3 | 3.2 2.2 | 1.9 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.35(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age Adjusted for Age, Race, and Sex 1992-1994 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.7 * * * | 0.8 1.9 * 0.0 | 0.5 1.1 * * | 0.6 0.7 | 0.5 | | 20-44 | 1.7 4.2 5.9 * | 1.5 4.3 5.6 * | 1.1 3.2 4.3 14.5 | 1.5 1.4 | 1.0 | | 45-64 | 5.4 18.3 27.3 67.1 | 5.0 16.3 21.0 * | 3.8 12.5 17.6 44.4 | 5.3 4.8 | 3.6 | | 65-74 | 8.6 36.0 79.8 * | 7.2 23.9 * * | 5.6 21.6 48.0 * | 9.1 7.1 | 5.7 | | 75 plus | 9.9 38.7 * * | 5.0 24.4 * 0.0 | 5.3 21.6 * * | 9.5 5.3 | 5.4 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.5 5.3 9.0 22.5 | 1.3 4.4 7.2 16.7 | 1.0 3.4 5.7 13.7 | 1.5 1.3 | 0.9 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.1 3.4 * 0.0 | 0.9 * * * | 0.7 1.8 * * | 1.1 0.8 | 0.7 | | 20-44 | 1.3 3.8 5.9 * | 1.2 2.4 * * | 0.9 2.3 3.4 * | 1.2 1.1 | 0.8 | | 45-64 | 2.7 11.3 15.3 * | 2.4 9.1 17.3 * | 1.9 8.1 13.5 * | 3.1 2.5 | 2.0 | | 65-74 | 8.9 36.7 * * | 5.2 20.7 49.4 0.0 | 5.2 21.6 41.7 * | 9.4 5.5 | 5.4 | | 75 plus | 13.6 68.8 135.4 * | 5.1 21.9 * 0.0 | 7.3 39.9 83.9 * | 16.6 5.5 | 8.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.3 5.6 10.1 26.3 | 0.9 2.9 7.1 * | 0.7 2.8 5.7 11.4 | 1.3 0.8 | 0.7 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 2.2 5.5 10.9 * | 1.9 5.7 9.2 * | 1.5 4.1 7.4 15.0 | 2.0 1.8 | 1.4 | | 20-44 | 2.7 19.5 12.1 37.9 | 2.8 16.0 16.6 39.7 | 2.0 12.8 10.3 28.4 | 3.5 3.2 | 2.3 | | 45-64 | 6.6 37.7 31.7 114.3 | 6.1 27.9 32.0 99.8 | 4.8 24.0 25.6 88.8 | 8.0 6.6 | 5.1 | | 65-74 | 19.0 83.8 120.1 334.1 | 13.7 52.5 89.8 318.1 | 11.8 50.1 75.1 240.9 | 20.0 13.9 | 12.1 | | 75 plus | 26.9 126.3 174.7 * | 12.5 61.2 137.1 * | 14.5 68.8 114.2 269.0 | 28.4 13.8 | 15.5 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.7 14.5 15.7 46.4 | 2.1 10.0 13.9 39.0 | 1.6 8.5 10.3 29.6 | 2.8 2.2 | 1.7 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.35(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age Adjusted for Age, Race, and Sex 1992-1994 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.1 3.0 * * | 1.0 2.8 * * | 0.8 2.2 4.6 * | 1.0 1.0 | 0.7 | | 20-44 | 2.0 10.6 11.0 29.3 | 1.6 6.8 10.0 27.5 | 1.3 6.5 7.3 20.8 | 2.2 1.7 | 1.4 | | 45-64 | 4.5 27.9 27.7 73.5 | 3.7 18.8 29.5 * | 3.1 18.1 22.6 52.7 | 5.7 4.4 | 3.6 | | 65-74 | 14.3 66.7 107.0 307.3 | 9.6 53.2 88.4 * | 8.7 43.1 71.2 196.9 | 15.6 11.2 | 9.5 | | 75 plus | 22.8 96.5 227.8 611.1 | 10.7 59.7 147.0 * | 12.9 59.4 137.3 269.2 | 25.6 12.9 | 14.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.1 10.3 16.7 44.9 | 1.4 6.9 12.8 25.5 | 1.2 6.0 10.0 23.9 | 2.1 1.4 | 1.2 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.7 2.8 * * | 0.7 2.4 * 0.0 | 0.5 1.9 * * | 0.7 0.7 | 0.5 | | 20-44 | 1.3 6.9 7.3 * | 1.2 5.0 * 0.0 | 0.9 4.3 4.5 * | 1.4 1.1 | 0.9 | | 45-64 | 3.5 24.8 16.7 * | 3.0 20.4 13.3 64.9 | 2.5 17.7 11.1 51.1 | 4.7 4.1 | 3.1 | | 65-74 | 11.4 73.9 * * | 8.5 62.9 58.5 248.7 | 7.1 49.0 40.2 124.9 | 13.6 11.1 | 8.7 | | 75 plus | 17.1 92.5 * * | 8.8 66.1 * 363.8 | 9.7 57.0 60.8 224.2 | 19.3 11.7 | 11.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.5 9.4 7.1 18.7 | 1.1 7.4 7.6 30.1 | 0.9 5.8 5.5 19.3 | 1.6 1.2 | 1.0 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.35(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age Adjusted for Age, Race, and Sex 1995-1997 Diabetes ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.4 * * 0.0 | 0.4 2.1 * 0.0 | 0.3 1.3 * 0.0 | 0.4 0.4 | 0.3 | | 20-44 | 5.3 20.1 17.3 82.6 | 4.5 18.3 14.6 81.1 | 3.3 13.8 11.5 61.6 | 5.1 4.3 | 3.3 | | 45-64 | 16.4 101.0 104.2 455.1 | 14.9 94.0 86.0 464.7 | 12.5 79.8 84.2 379.7 | 22.3 20.5 | 15.1 | | 65-74 | 43.4 251.9 399.4 1199.5 | 36.4 250.2 335.2 1387.6 | 28.3 179.6 263.4 920.0 | 51.8 47.2 | 35.0 | | 75 plus | 44.3 268.0 550.5 992.4 | 26.2 211.9 443.1 985.7 | 23.4 159.6 339.5 641.4 | 50.7 36.7 | 31.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 5.5 32.3 47.8 143.8 | 4.6 29.7 39.6 153.5 | 3.5 21.9 30.7 106.8 | 5.9 5.0 | 3.8 | ------------------------------------------------------------------------------------------------------------------------- Hypertension ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.5 4.0 * * | 0.6 3.2 * * | 0.4 2.6 * * | 0.7 0.7 | 0.5 | | 20-44 | 2.6 28.9 16.3 51.3 | 1.8 19.9 13.4 44.2 | 1.5 17.7 10.6 35.3 | 4.4 3.0 | 2.6 | | 45-64 | 9.0 89.3 64.5 184.0 | 6.7 61.9 50.6 147.9 | 6.6 59.8 49.6 136.9 | 15.6 11.2 | 9.5 | | 65-74 | 37.7 224.6 285.6 532.2 | 24.6 183.7 190.5 571.7 | 22.7 149.5 176.1 401.2 | 45.0 32.7 | 27.6 | | 75 plus | 60.4 337.9 551.5 894.6 | 30.2 225.4 387.8 627.3 | 34.6 205.4 347.4 535.2 | 71.8 41.1 | 40.8 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 4.8 33.2 40.5 77.5 | 2.9 23.7 28.8 66.4 | 2.6 19.8 23.9 50.4 | 5.4 3.5 | 3.0 | ------------------------------------------------------------------------------------------------------------------------- Glomeruloneph. ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.8 7.3 10.6 * | 1.8 6.5 10.2 * | 1.3 5.0 7.7 14.5 | 1.8 1.8 | 1.3 | | 20-44 | 3.9 20.7 25.0 63.0 | 3.0 15.5 23.4 59.7 | 2.4 13.0 17.2 44.0 | 4.3 3.3 | 2.7 | | 45-64 | 8.0 43.5 56.2 131.5 | 5.7 28.5 44.8 121.2 | 5.4 27.1 39.1 99.8 | 9.7 6.7 | 5.8 | | 65-74 | 21.3 81.8 194.5 356.0 | 13.3 63.2 120.4 292.3 | 12.6 52.8 116.0 230.9 | 22.3 14.6 | 13.2 | | 75 plus | 28.8 101.4 303.3 516.5 | 13.5 62.5 186.0 283.4 | 15.8 59.1 181.1 261.5 | 29.9 15.3 | 16.6 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.2 14.7 27.1 53.7 | 2.1 10.3 19.2 44.3 | 1.8 8.8 15.9 34.0 | 3.3 2.2 | 1.9 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.35(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age Adjusted for Age, Race, and Sex 1995-1997 Cystic Kidney ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.8 2.1 * * | 0.9 1.9 * 0.0 | 0.6 1.4 * * | 0.7 0.8 | 0.5 | | 20-44 | 1.8 5.2 6.4 * | 1.5 4.3 5.4 * | 1.1 3.5 4.2 * | 1.6 1.3 | 1.0 | | 45-64 | 5.2 17.2 25.7 * | 4.6 14.6 19.1 * | 3.6 11.7 17.6 41.9 | 5.1 4.5 | 3.4 | | 65-74 | 9.1 34.9 67.9 * | 7.4 28.0 47.6 * | 5.9 22.8 41.8 * | 9.2 7.4 | 5.9 | | 75 plus | 9.4 56.7 * * | 5.3 26.0 * * | 5.3 31.9 * * | 11.5 5.7 | 6.3 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.5 5.8 8.9 18.7 | 1.3 4.3 6.4 13.3 | 1.0 3.5 5.3 10.7 | 1.5 1.2 | 0.9 | ------------------------------------------------------------------------------------------------------------------------- Other Urologic ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.9 2.5 0.0 0.0 | 0.9 1.8 * * | 0.6 1.6 * * | 0.8 0.8 | 0.6 | | 20-44 | 1.4 3.9 5.3 23.2 | 1.4 3.6 6.2 * | 1.0 2.7 4.1 12.5 | 1.3 1.3 | 0.9 | | 45-64 | 3.2 13.5 17.0 * | 2.7 8.6 15.6 * | 2.3 9.3 14.5 38.3 | 3.8 2.8 | 2.3 | | 65-74 | 10.8 54.6 70.2 * | 6.2 23.5 57.6 * | 6.2 30.1 45.9 * | 12.0 6.4 | 6.7 | | 75 plus | 18.1 77.4 102.2 * | 6.0 28.2 * * | 10.1 44.4 71.7 * | 20.2 6.8 | 10.4 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.6 6.8 8.9 28.5 | 1.0 3.3 7.2 * | 0.8 3.4 5.5 13.9 | 1.5 0.9 | 0.8 | ------------------------------------------------------------------------------------------------------------------------- Other Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 2.6 7.8 10.6 * | 2.1 6.6 12.1 24.4 | 1.7 5.2 8.4 17.1 | 2.4 2.0 | 1.6 | | 20-44 | 3.0 22.7 11.1 46.9 | 3.0 18.9 15.8 47.8 | 2.1 14.8 9.9 34.4 | 3.9 3.5 | 2.6 | | 45-64 | 7.2 43.7 33.5 110.2 | 6.6 31.8 30.2 114.6 | 5.5 28.0 26.0 86.6 | 9.1 7.5 | 5.8 | | 65-74 | 22.6 90.8 123.0 345.4 | 16.1 62.9 99.7 292.3 | 13.9 56.4 80.3 224.4 | 23.0 16.2 | 14.0 | | 75 plus | 31.2 133.1 233.1 496.2 | 15.5 72.2 140.9 * | 17.4 75.8 137.0 295.5 | 33.0 16.4 | 18.1 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 3.1 16.3 18.2 48.9 | 2.4 11.7 14.4 40.2 | 1.9 9.7 11.1 30.3 | 3.3 2.5 | 2.0 | ------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.35(Continued) Standard Errors for Adjusted Incidence Rates per Ten Million Population of Reported ESRD Therapy by Primary Disease Causing ESRD by Sex, Race, and Age Adjusted for Age, Race, and Sex 1995-1997 Unknown Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 0.8 3.4 * * | 0.9 3.3 * 0.0 | 0.6 2.4 * * | 0.8 0.9 | 0.6 | | 20-44 | 1.6 10.5 10.6 26.4 | 1.4 6.7 8.5 24.8 | 1.1 6.2 6.8 18.5 | 2.0 1.5 | 1.2 | | 45-64 | 4.0 24.6 26.9 76.7 | 3.3 17.8 24.7 70.7 | 2.9 16.7 22.0 63.0 | 5.3 4.1 | 3.3 | | 65-74 | 14.1 64.6 107.3 334.4 | 9.5 48.6 79.3 274.6 | 8.6 41.4 68.9 213.9 | 15.4 10.9 | 9.3 | | 75 plus | 23.6 102.8 219.3 * | 11.7 62.2 128.3 * | 13.8 63.1 135.9 151.9 | 26.7 13.9 | 14.8 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 2.0 10.0 16.4 33.2 | 1.3 6.8 11.5 30.2 | 1.1 5.8 9.5 22.7 | 2.0 1.3 | 1.1 | ------------------------------------------------------------------------------------------------------------------------- Missing Cause ------------------------------------------------------------------------------------------------------------------------- | | Specific Rates (Unadjusted) | Rates Adjusted For | | Age |---------------------------------------------------------+---------------------------------------------------| | at | Males | Females | Sex | Race | Sex | | ESRD |----------------------------+----------------------------+----------------------------+--------------| & | | | White Black Asian NatAm | White Black Asian NatAm | White Black Asian NatAm | Male Female| Race | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | 0-19 | 1.1 3.6 * 0.0 | 1.0 3.4 * * | 0.7 2.5 4.0 * | 1.1 0.9 | 0.7 | | 20-44 | 1.9 12.0 10.9 23.2 | 1.7 8.7 7.9 * | 1.2 7.4 6.7 13.9 | 2.2 1.8 | 1.4 | | 45-64 | 4.3 33.4 25.7 * | 3.4 23.8 19.1 61.2 | 3.0 22.5 18.0 44.7 | 6.1 4.7 | 3.8 | | 65-74 | 12.2 68.0 72.5 * | 8.5 54.2 49.4 * | 7.5 44.2 44.2 125.9 | 13.9 10.2 | 8.5 | | 75 plus | 17.5 92.9 125.2 * | 8.4 59.8 * * | 9.7 57.3 78.1 * | 20.0 10.8 | 11.2 | |---------+----------------------------+----------------------------+----------------------------+--------------+-------| | Age Adj | 1.8 11.1 11.3 21.0 | 1.2 7.9 7.5 21.1 | 1.0 6.6 6.5 14.8 | 1.9 1.4 | 1.1 | ------------------------------------------------------------------------------------------------------------------------- Includes residents of 50 states and District of Columbia only. Cases where race is Other or Unknown are excluded from this table. See tables A.4 and A.5 and notes at beginning of this Section. Note that rates are per TEN MILLION population rather than per million because of the small cell sizes. The population base is U.S. resident population on July 1 of each year. The standard population for adjustment is July 1, 1996, U.S. resident population. * Values for cells with fewer than 10 patients are suppressed. Table A.36 Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |ALL |906,310|181,404| 29,055| 31,678| 34,775| 38,432| 44,449| 47,873| 52,415| 57,610| 59,378| 67,750| 72,962| 76,718| 80,265| 31,546| |: ***UNRECONCILABLE CODE*** | 63,276| 38,707| 1,120| 1,324| 1,138| 1,553| 2,022| 1,761| 1,262| 1,225| 2,958| 1,548| 1,781| 1,649| 4,224| 1,004| |7900 : ***UNRECONCILABLE CODE*** | 6| .| .| .| .| .| .| .| .| .| .| .| 4| 2| .| .| |7900Z: ***UNRECONCILABLE CODE*** | 314| 106| 8| 14| 16| 28| 30| 28| 28| 19| 20| 12| 5| .| .| .| |0160Z : RENAL TUBERCULOSIS | 20| 1| .| .| .| .| .| 2| 4| 5| 6| 2| .| .| .| .| |0429 : ***UNRECONCILABLE CODE*** | 5| .| .| .| .| .| .| .| .| .| .| .| 2| 3| .| .| |0429A : AIDS nephropathy | 3,347| 2| 1| .| 1| 6| 5| 11| 18| 39| 65| 348| 943| 845| 739| 324| |0429Z : AIDS, OR HIV INFECTION WITH SPECIFIED OR MALIGNANT N| 361| 3| .| .| 1| 10| 36| 52| 74| 64| 71| 45| 5| .| .| .| |0439 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |0439D : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| 1| 1| .| .| .| |0439Z : AIDS-LIKE SYNDROME, OR HIV INFECTION WITH OTHER SPEC| 378| 2| .| 1| 1| 7| 30| 26| 33| 98| 108| 71| 1| .| .| .| |0449 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |0449Z : HIV INFECTION (DISEASE) (ILLNESS), OR OTHER HIV INFE| 860| 2| .| 1| 1| 11| 35| 81| 170| 178| 243| 133| 5| .| .| .| |0586Z : ***UNRECONCILABLE CODE*** | 1| .| .| 1| .| .| .| .| .| .| .| .| .| .| .| .| |135Z : SARCOIDOSIS | 50| 3| .| 1| 1| 2| .| 3| 12| 7| 13| 8| .| .| .| .| |18 AN : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |1890 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 2| .| 1| .| |1890B : Renal tumor (malignant) | 1,105| 33| 10| 16| 15| 23| 12| 16| 11| 20| 20| 92| 245| 225| 256| 111| |1890Z : CANCER OF KIDNEY, EXCEPT PELVIS | 726| 3| 1| 1| 4| 6| 7| 56| 163| 186| 175| 122| 2| .| .| .| |1891Z : CANCER OF RENAL PELVIS (CALYX, HILUS) | 50| .| .| .| .| .| .| 4| 14| 17| 7| 8| .| .| .| .| |1899A : Urinary tract tumor (malignant) | 313| .| .| .| .| .| .| .| .| .| .| .| 81| 95| 94| 43| |1899Z : ***UNRECONCILABLE CODE*** | 4| .| .| .| .| .| .| .| .| .| 4| .| .| .| .| .| |189Z : CANCER OF KIDNEY AND OTHER UNSPECIFIED URINARY ORGAN| 949| 204| 100| 111| 96| 125| 162| 116| 15| 7| 6| 7| .| .| .| .| |19Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| |20 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |20280A: Lymphoma of kidneys | 119| 2| 1| 3| 1| 3| 1| 4| .| 1| 1| 8| 25| 23| 34| 12| |20280Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| |20283Z: LYMPHOMA, INTRA-ABDOMINAL | 16| .| .| .| .| .| .| 1| 5| 2| 5| 3| .| .| .| .| |20285Z: LYMPHOMA, INGUINAL REGION | 12| .| .| .| .| .| .| 2| 3| 5| 1| 1| .| .| .| .| |20286Z: LYMPHOMA, INTRAPELVIC | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |2028Z : LYMPHOMAS | 65| 15| 9| 7| 10| 7| 8| 6| .| 2| 1| .| .| .| .| .| |2030 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 2| 1| .| .| |2030A : Multiple myeloma | 2,885| 101| 28| 25| 33| 36| 28| 34| 22| 39| 55| 245| 607| 669| 671| 292| |2030B : Light chain nephropathy | 293| 1| .| 1| 1| 1| 1| 1| 3| 1| 1| 1| 71| 87| 92| 31| |2030Z : MULTIPLE MYELOMA / LIGHT CHAIN DISEASE | 4,102| 673| 258| 280| 285| 310| 356| 355| 399| 449| 428| 308| 1| .| .| .| |203Z : MULTIPLE MYELOMA AND IMMUNOPROLIFERATIVE NEOPLASMS | 422| 422| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |20540Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| |20541Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |20Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| |21Z : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| 1| 1| .| .| .| .| .| .| .| |2230A : Renal tumor (benign) | 24| 1| .| .| .| .| .| .| .| .| .| 1| 5| 8| 8| 1| |2239A : Urinary tract tumor (benign) | 27| .| .| .| .| .| .| .| .| 1| 1| .| 7| 9| 5| 4| |22Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| |23 01Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |23 LU : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |23 SY : ***UNRECONCILABLE CODE*** | 1| .| .| .| 1| .| .| .| .| .| .| .| .| .| .| .| |2395A : Renal tumor (unspecified) | 55| .| .| 1| .| .| .| .| .| .| .| .| 13| 14| 23| 4| |2395B : Urinary tract tumor (unspecified) | 29| .| .| .| .| .| .| .| .| .| .| .| 5| 8| 13| 3| |25000 : ***UNRECONCILABLE CODE*** | 188| .| .| .| .| .| .| .| .| .| .| .| 104| 81| 3| .| |25000A: Type II, adult-onset type or unspecified type diabet|106,543| 2,389| 891| 1,052| 1,194| 972| 704| 732| 857| 1,045| 1,730| 6,713| 21,665| 26,222| 28,552| 11,825| |25000Z: DIABETES, ADULT / DIABETES TYPE II / NIDDM | 29,971| 339| 126| 228| 681| 2,929| 3,685| 4,254| 4,648| 4,742| 4,809| 3,368| 162| .| .| .| |25001 : ***UNRECONCILABLE CODE*** | 178| .| .| .| .| .| .| .| .| .| .| .| 104| 73| 1| .| |25001A: Type I, juvenile type, ketosis prone diabetes | 31,683| 239| 106| 134| 198| 685| 551| 613| 669| 978| 1,432| 5,466| 7,615| 6,027| 5,175| 1,795| |25001Z: JUVENILE ONSET DIABETES MELLITUS / DIABETES TYPE I /| 23,457| 456| 185| 229| 464| 1,759| 2,422| 3,109| 3,441| 3,916| 4,169| 3,134| 172| 1| .| .| |2500A : ***UNRECONCILABLE CODE*** | 116| 3| .| .| 4| 5| 2| 5| 6| 8| 51| 13| 16| 2| 1| .| |2500Z : DIABETES | 15,933| 7,290| 2,690| 2,979| 2,924| 47| 1| .| 2| .| .| .| .| .| .| .| |2501Z : DIABETES (CODE NOT IN HCFA LISTS). | 79| 79| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |25040 : ***UNRECONCILABLE CODE*** | 15| .| .| .| .| .| .| .| .| .| .| .| 7| 7| 1| .| |25040Z: DIABETES WITH RENAL MANIFESTATIONS TYPE II | 32,265| 215| 86| 143| 660| 3,267| 4,044| 4,085| 5,153| 5,705| 4,961| 3,928| 17| 1| .| .| |25041 : ***UNRECONCILABLE CODE*** | 25| .| .| .| .| .| .| .| .| .| .| .| 11| 14| .| .| |25041Z: DIABETES WITH RENAL MANIFESTATIONS TYPE I | 27,451| 261| 84| 115| 444| 2,312| 3,275| 3,739| 4,246| 4,848| 4,570| 3,526| 31| .| .| .| |2504Z : DIABETES WITH RENAL MANIFESTATIONS | 31,918| 19,016| 4,087| 4,646| 4,095| 69| 2| 1| .| .| 2| .| .| .| .| .| |25090Z: ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |2700 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |2700A : Cystinosis | 77| 12| 1| 5| 4| 3| 2| 3| 3| 2| 3| 3| 12| 8| 13| 3| |2700Z : CYSTINOSIS, MALIGNANT | 109| 37| 3| 9| 6| 3| 6| 8| 9| 13| 6| 9| .| .| .| .| |2718B : Primary oxalosis | 80| 6| 1| 1| 1| 2| .| 1| 1| 2| 5| 17| 13| 11| 15| 4| |2718Z : OXALATE NEPHROPATHY / OXALOSIS | 226| 61| 16| 19| 17| 17| 9| 19| 20| 23| 18| 7| .| .| .| .| |2727A : Fabrys disease | 76| 6| .| 3| 3| 1| 2| 1| 2| 4| .| 11| 10| 18| 11| 4| |2727Z : FABRYS DISEASE | 122| 27| 9| 4| 12| 8| 10| 9| 7| 15| 10| 11| .| .| .| .| |2728Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| .| |2733Z : MACROGLOBULINEMIA | 22| .| .| .| .| 1| .| 1| 6| 5| 5| 4| .| .| .| .| |27410 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |27410A: Gouty nephropathy | 199| 19| 6| 2| 2| 5| 3| 2| .| 3| 2| 15| 37| 37| 50| 16| |27410Z: GOUTY NEPHROPATHY, UNSPECIFIED | 47| .| .| .| .| .| 3| 4| 10| 13| 10| 7| .| .| .| .| |27411Z: URATE NEPHROPATHY / URIC ACID NEPHROLITHIASIS | 37| .| .| .| .| .| .| 4| 7| 11| 8| 7| .| .| .| .| |2741Z : GOUTY NEPHROPATHY / URATE NEPHROPATHY | 388| 247| 30| 25| 16| 20| 18| 18| 8| 2| 1| 3| .| .| .| .| |2754A : Nephrocalcinosis | 204| 2| .| .| .| .| .| .| 1| 1| 2| 2| 62| 58| 56| 20| |2754Z : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |2773 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 2| .| .| .| |2773A : Amyloidosis | 1,035| 47| 12| 15| 19| 20| 12| 9| 13| 8| 25| 85| 207| 238| 241| 84| |2773Z : AMYLOIDOSIS | 1,978| 538| 130| 131| 140| 125| 141| 151| 178| 176| 145| 119| 3| .| 1| .| |2820Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| 1| .| .| .| .| .| .| .| .| .| .| .| |28260 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |28260A: Sickle cell disease/anemia | 311| 2| 3| 2| 4| 2| 3| 1| 1| 5| 6| 25| 78| 77| 72| 30| |28260Z: SICKLE-CELL ANEMIA, UNSPECIFIED | 157| 1| .| 1| 3| 3| .| 11| 26| 41| 41| 30| .| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |28263Z: SICKLE-CELL/HB-C DISEASE (HB-S/HB-C DISEASE) | 29| .| .| .| .| .| .| 3| 4| 9| 6| 7| .| .| .| .| |28269A: Sickle cell trait and other sickle cell (HbS/Hb othe| 31| 1| .| 1| .| .| .| .| .| .| 2| 10| 2| 4| 8| 3| |28269Z: OTHER SICKLE-CELL (INCLUDES: HB-S/HB-D DISEASE, HB-S| 6| .| .| .| .| .| .| .| .| 1| 2| 3| .| .| .| .| |2826A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| |2826Z : SICKLE CELL DISEASE | 268| 74| 31| 25| 32| 16| 49| 33| 6| 1| .| 1| .| .| .| .| |2831 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |2831A : Hemolytic uremic syndrome | 699| 29| 4| 3| 12| 11| 8| 16| 11| 9| 28| 82| 149| 154| 135| 48| |2831Z : HEMOLYTIC UREMIC SYNDROME | 750| 150| 46| 35| 46| 57| 73| 58| 77| 78| 73| 55| 2| .| .| .| |2870 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 1| 2| .| .| |2870A : Henoch-Schonlein syndrome | 174| 15| 4| 4| 3| 3| 3| 5| 4| 10| 5| 16| 31| 37| 20| 14| |2870Z : HENOCH-SCHONLEIN SYNDROME | 210| 55| 11| 14| 11| 18| 8| 20| 21| 19| 21| 12| .| .| .| .| |2873Z : AMYLOIDOSIS (CODE NOT IN CURRENT HCFA LISTS--ASSUMED| 11| 11| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |29 AL : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |29Z : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| 1| 1| .| .| .| .| .| .| |30400Z: ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4010 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |4010D : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |4010Z : MALIGNANT HYPERTENSION | 1,643| 491| 101| 118| 98| 116| 122| 134| 124| 132| 108| 99| .| .| .| .| |4011 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |4011Z : BENIGN HYPERTENSION | 88| 5| 3| 4| 3| 5| 6| 10| 8| 26| 9| 9| .| .| .| .| |4019 : ***UNRECONCILABLE CODE*** | 39| .| .| .| .| .| .| .| .| .| .| .| 19| 20| .| .| |4019Z : ESSENTIAL HYPERTENSION, UNSPECIFIED | 49,623| 5,863| 2,454| 2,671| 3,228| 3,474| 4,142| 4,850| 5,632| 6,231| 6,191| 4,857| 30| .| .| .| |401Z : ESSENTIAL HYPERTENSION | 13,264| 13,264| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |40301Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| |4030Z : NEPHROSCLEROSIS, MALIGNANT / HYPERTENSIVE RENAL DISE| 1,378| 178| 120| 114| 133| 90| 81| 66| 102| 134| 183| 176| 1| .| .| .| |4031Z : NEPHROSCLEROSIS, BENIGN / HYPERTENSIVE RENAL DISEASE| 848| 87| 31| 35| 46| 65| 57| 55| 92| 129| 131| 119| 1| .| .| .| |4039 : ***UNRECONCILABLE CODE*** | 213| .| .| .| .| .| .| .| .| .| .| .| 110| 92| 10| 1| |40391Z: ***UNRECONCILABLE CODE*** | 6| 2| .| .| .| .| 1| 1| 2| .| .| .| .| .| .| .| |40399 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |4039A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |4039D : Renal disease due to hypertension (no primary renal | 81,413| 3,179| 903| 1,050| 1,176| 1,418| 1,029| 1,093| 992| 1,369| 2,143| 8,360| 16,675| 17,141| 17,693| 7,192| |4039Z : NEPHROSCLEROSIS / HYPERTENSIVE RENAL DISEASE / OTHER| 69,883| 7,975| 3,845| 4,144| 4,649| 5,355| 6,970| 7,359| 7,859| 8,508| 7,494| 5,505| 217| 2| 1| .| |403Z : HYPERTENSIVE RENAL DISEASE | 2,243| 2,242| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| |4040Z : HYPERTENSIVE HEART AND RENAL DISEASE, MALIGNANT | 147| 15| 19| 5| 9| 11| 11| 9| 12| 20| 21| 15| .| .| .| .| |4041Z : HYPERTENSIVE HEART AND RENAL DISEASE, BENIGN | 60| 6| 2| 2| 1| 7| 3| 4| 6| 12| 7| 10| .| .| .| .| |4049Z : CARDIORENAL SYNDROME / HYPERTENSIVE HEART AND RENAL | 1,540| 204| 51| 40| 56| 121| 170| 139| 169| 224| 192| 174| .| .| .| .| |404Z : HYPERTENSIVE HEART AND RENAL DISEASE | 308| 308| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4100 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |4280 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |4280Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |4289A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |4401 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 3| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |4401A : Renal artery stenosis | 4,166| 21| 25| 18| 18| 20| 21| 29| 36| 48| 64| 267| 913| 1,065| 1,159| 462| |4401Z : STENOSIS, RENAL ARTERY | 2,432| 98| 75| 81| 100| 102| 144| 221| 350| 413| 495| 352| 1| .| .| .| |4431 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |44310Z: ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4431Z : BUERGERS (BERGERS) DISEASE | 376| 30| 37| 21| 34| 53| 54| 50| 27| 26| 28| 16| .| .| .| .| |4460C : Polyarteritis | 200| 13| 1| 1| 3| 4| 2| 2| 1| 7| .| 12| 44| 39| 45| 26| |4460Z : POLYARTERITIS, RENAL | 306| 71| 27| 24| 22| 15| 22| 29| 22| 26| 16| 31| 1| .| .| .| |4462 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |44620Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| .| |44621Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| |44629Z: *** CODE IN ERROR: ASSUMED TO BE 4462. | 15| 15| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4462A : Vasculitis and its derivatives | 936| 59| 13| 14| 18| 19| 14| 14| 11| 12| 14| 83| 169| 222| 207| 67| |4462Z : ANTI-GLOMERULOBASEMENT MEMBRANE GLOMER. / GOODPASTUR| 2,154| 973| 75| 106| 132| 129| 163| 138| 124| 119| 116| 78| 1| .| .| .| |4464 : ***UNRECONCILABLE CODE*** | 4| .| .| .| .| .| .| .| .| .| .| .| 3| 1| .| .| |4464B : Wegeners granulomatosis | 939| 33| 6| 9| 11| 10| 9| 12| 14| 17| 24| 108| 181| 214| 209| 82| |4464Z : GRANULOMATOSIS / WEGENERS GRANULOMATOSIS / WEGENERS | 1,036| 156| 52| 44| 55| 70| 84| 92| 141| 133| 127| 80| 2| .| .| .| |4466Z : THROMBOTIC THROMBOCYTOPENIC PURPURA | 198| 16| 8| 9| 12| 16| 23| 20| 20| 34| 26| 14| .| .| .| .| |4828Z : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |49007Z: ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |50000A: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |53831 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |5724A : Hepatorenal syndrome | 404| 3| .| 3| 1| 2| 1| 2| .| 3| 12| 23| 82| 109| 127| 36| |5724Z : HEPATORENAL SYNDROME | 253| 19| 9| 9| 9| 15| 26| 25| 35| 35| 40| 31| .| .| .| .| |5800C : Post infectious GN, SBE | 293| 20| 2| 3| 9| 4| 5| 3| 2| 3| 5| 19| 62| 65| 62| 29| |5800Z : GLOMERULONEPHRITIS, ACUTE | 222| 40| 9| 11| 17| 18| 30| 25| 14| 13| 26| 19| .| .| .| .| |5804 : ***UNRECONCILABLE CODE*** | 29| .| .| .| .| .| .| .| .| .| .| .| 11| 17| 1| .| |58040Z: ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |5804B : Rapidly progressive GN | 1,509| 77| 24| 28| 14| 24| 27| 25| 22| 25| 36| 119| 291| 377| 295| 125| |5804Z : GLOMERULONEPHRITIS, ACUTE WITH LESION OF RAPIDLY PRO| 1,945| 368| 150| 150| 129| 151| 162| 183| 172| 148| 176| 128| 28| .| .| .| |58089 : ***UNRECONCILABLE CODE*** | 7| .| .| .| .| .| .| .| .| .| .| .| 2| 5| .| .| |58089A: Acute interstitial nephritis | 489| 7| 4| 3| 3| 5| 5| 3| .| 6| 6| 24| 115| 119| 121| 68| |58089Z: ACUTE INTERSTITIAL NEPHRITIS | 191| 27| 11| 9| 5| 14| 13| 18| 21| 22| 26| 23| 2| .| .| .| |5809Z : ACUTE GLOMERULONEPHRITIS WITH UNSPECIFIED PATHOLOGIC| 272| 66| 19| 16| 17| 20| 19| 21| 25| 24| 30| 15| .| .| .| .| |5810A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |5811 : ***UNRECONCILABLE CODE*** | 10| .| .| .| .| .| .| .| .| .| .| .| 5| 4| 1| .| |5811Z : FOCAL GLOMERULONEPHRITIS / FOCAL GLOMERULOSCLEROSIS | 2,173| 398| 115| 113| 130| 190| 224| 208| 224| 217| 193| 150| 10| 1| .| .| |5818 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| |5818Z : FOCAL GLOMERULOSCLEROSIS WITH NEPHROTIC SYNDROME | 121| 4| 1| 1| 1| .| 1| 7| 17| 26| 33| 28| 2| .| .| .| |5819 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 2| .| 1| .| |5819A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| |5819Z : NEPHROTIC SYNDROME / NEPHROSIS | 2,294| 418| 123| 124| 152| 159| 175| 247| 246| 262| 210| 171| 6| 1| .| .| |5820 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |58200Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |5820A : Other proliferative GN | 1,328| 53| 10| 9| 19| 18| 15| 22| 28| 37| 45| 222| 271| 249| 238| 92| |5820Z : ***UNRECONCILABLE CODE*** | 20| 2| .| .| .| 1| 1| 1| 4| 1| 6| 1| 3| .| .| .| |5821 : ***UNRECONCILABLE CODE*** | 28| .| .| .| .| .| .| .| .| .| .| .| 15| 11| 2| .| |58210Z: ***UNRECONCILABLE CODE*** | 3| 1| 1| .| .| .| .| 1| .| .| .| .| .| .| .| .| |5821A : Focal glomerulosclerosis, focal sclerosing GN | 7,554| 221| 56| 59| 66| 101| 98| 117| 103| 123| 172| 526| 1,653| 1,831| 1,710| 718| |5821Z : FOCAL GLOMERULOSCLEROSIS | 4,553| 625| 227| 241| 302| 330| 389| 403| 477| 574| 592| 383| 9| 1| .| .| |5824Z : ***UNRECONCILABLE CODE*** | 5| 4| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| |5826A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |58281Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |58289 : ***UNRECONCILABLE CODE*** | 5| .| .| .| .| .| .| .| .| .| .| .| 2| 2| 1| .| |58289Z: CHRONIC INTERSTITIAL NEPHRITIS / HEREDITARY INTERSTI| 8,795| 2,851| 649| 573| 601| 504| 633| 596| 684| 685| 564| 451| 3| 1| .| .| |5828Z : ***UNRECONCILABLE CODE*** | 21| 19| .| .| .| 1| 1| .| .| .| .| .| .| .| .| .| |5829 : ***UNRECONCILABLE CODE*** | 76| .| .| .| .| .| .| .| .| .| .| .| 43| 30| 3| .| |58291A: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |5829A : Glomerulonephritis (GN) | 23,307| 2,534| 443| 479| 509| 575| 502| 491| 417| 515| 795| 2,401| 4,330| 4,059| 3,806| 1,451| |5829Z : CHRONIC GLOMERULONEPHRITIS, INCLUDING WITH UNSPECIFI| 26,375| 6,426| 1,613| 1,667| 1,760| 1,894| 1,997| 2,209| 2,374| 2,431| 2,246| 1,717| 40| 1| .| .| |582Z : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |5830B : Radiation nephritis | 93| .| .| .| 1| 1| .| .| .| 1| .| .| 19| 35| 30| 6| |5830Z : PROLIFERATIVE GLOMERULONEPHRITIS / RADIATION NEPHRIT| 636| 171| 37| 37| 43| 48| 48| 67| 59| 49| 45| 31| 1| .| .| .| |5831 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 1| 2| .| .| |5831A : Membranous nephropathy | 1,738| 70| 27| 20| 21| 32| 25| 29| 19| 45| 36| 129| 346| 397| 395| 147| |5831Z : MEMBRANOUS GLOMERULONEPHRITIS | 2,374| 505| 123| 163| 188| 157| 206| 193| 229| 205| 243| 157| 5| .| .| .| |5832 : ***UNRECONCILABLE CODE*** | 8| .| .| .| .| .| .| .| .| .| .| .| 4| 4| .| .| |5832A : Membranoproliferative GN type 1, diffuse MPGN | 1,474| 90| 25| 26| 20| 31| 26| 34| 36| 29| 51| 113| 255| 335| 280| 123| |5832C : Dense deposit disease, MPGN type 2 | 99| 2| .| .| .| .| 2| .| 1| 1| 2| 1| 23| 26| 25| 16| |5832Z : MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS / MESANGIOC| 1,941| 515| 135| 134| 115| 133| 150| 161| 161| 168| 164| 101| 4| .| .| .| |5834 : ***UNRECONCILABLE CODE*** | 4| .| .| .| .| .| .| .| .| .| .| .| 1| 3| .| .| |5834C : Goodpastures Syndrome | 416| 6| 1| 1| .| 1| 2| 10| 6| 9| 19| 60| 89| 91| 92| 29| |5834Z : ANTI-GBN GLOMERULONEPHRITIS | 299| 13| 1| 7| 5| 1| 1| 15| 79| 64| 73| 40| .| .| .| .| |5836 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 2| .| .| .| |5836A : Tubular necrosis (no recovery) | 3,945| 222| 37| 30| 49| 45| 42| 32| 27| 28| 70| 316| 752| 893| 1,016| 386| |5836Z : ***UNRECONCILABLE CODE*** | 22| 3| 1| .| .| .| 1| .| .| 2| 12| 1| 2| .| .| .| |5837Z : NEPHRITIS OR NEPHROPATHY WITH RENAL MEDULLARY LESION| 244| 15| 5| 10| 9| 15| 11| 25| 50| 56| 25| 22| 1| .| .| .| |58381 : ***UNRECONCILABLE CODE*** | 4| .| .| .| .| .| .| .| .| .| .| .| 2| 2| .| .| |58381B: IgA nephropathy, Bergers disease | 1,872| 14| 7| 2| 7| 2| 5| 13| 7| 12| 5| 8| 412| 594| 555| 229| |58381C: IgM nephropathy | 204| 2| 1| .| 1| .| .| .| 1| 1| .| 4| 71| 50| 50| 23| |58381Z: NEPHRITIS AND NEPHROPATHY, NOT SPECIFIED AS ACUTE OR| 1,200| 92| 21| 27| 27| 38| 34| 90| 232| 245| 207| 184| 3| .| .| .| |58389 : ***UNRECONCILABLE CODE*** | 16| .| .| .| .| .| .| .| .| .| .| .| 10| 6| .| .| |58389A: ***UNRECONCILABLE CODE*** | 8| .| .| .| .| .| .| .| .| .| .| 6| 2| .| .| .| |58389B: Chronic interstitial nephritis | 5,360| 459| 133| 143| 137| 168| 91| 95| 76| 101| 150| 693| 1,121| 911| 759| 323| |58389Z: ANALGESIC NEPHROPATHY / OTHER INTERST NEPHRITIS / IN| 3,601| 545| 211| 300| 197| 269| 331| 327| 368| 387| 368| 285| 13| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |5838B : ***UNRECONCILABLE CODE*** | 9| 5| .| .| .| 1| .| .| 1| .| .| 1| 1| .| .| .| |5839 : ***UNRECONCILABLE CODE*** | 14| .| .| .| .| .| .| .| .| .| .| .| 10| 4| .| .| |58398Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| |5839B : Secondary GN, other | 300| 6| 1| 1| .| 2| 5| 2| .| 2| 5| 4| 76| 87| 75| 34| |5839C : Nephropathy due to heroin abuse and related drugs | 489| 31| 21| 12| 20| 26| 16| 18| 9| 12| 22| 73| 83| 74| 52| 20| |5839D : Drash syndrome, mesangial sclerosis | 28| .| .| 1| .| .| .| 1| .| .| .| .| 9| 2| 9| 6| |5839Z : GLOMERULON. / NEPHRITIS / NEPHROPATHY / BRIGHTS DISE| 30,840| 17,487| 1,340| 1,330| 1,407| 1,407| 1,635| 1,515| 1,380| 1,358| 1,179| 793| 8| 1| .| .| |5840Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| .| |5845 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 3| .| .| .| |5845A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |5845Z : NEPHROTOXINS (VARIOUS) / TOXIC NEPHROPATHY (SPECIFY)| 2,213| 151| 80| 78| 92| 123| 198| 240| 297| 312| 370| 264| 8| .| .| .| |58500Z: ***UNRECONCILABLE CODE*** | 4| .| .| .| .| .| 4| .| .| .| .| .| .| .| .| .| |585Z : CHRONIC RENAL FAILURE / CHRONIC UREMIA / HEROIN ABUS| 1| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| .| |58600Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |586Z : RENAL FAILURE, UNSPECIFIED / UREMIA, NOT OTHERWISE S| 3,272| 1,205| 365| 356| 440| 354| 335| 190| 12| 9| 3| 3| .| .| .| .| |587 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |5870Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| |587Z : GLOMERULOSCLEROSIS | 1,805| 302| 136| 134| 168| 153| 168| 174| 178| 167| 129| 96| .| .| .| .| |5890Z : UNILATERAL SMALL KIDNEY | 43| 5| .| 2| .| 2| .| 1| 7| 9| 11| 6| .| .| .| .| |5891 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |58910A: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |5891Z : BILATERAL SMALL KIDNEY | 226| .| .| 3| .| .| 2| 10| 43| 52| 79| 37| .| .| .| .| |5899Z : SMALL KIDNEY, UNSPECIFIED | 88| 6| .| .| .| 2| .| 5| 25| 26| 17| 7| .| .| .| .| |589Z : SMALL KIDNEY OF UNKNOWN CAUSE | 255| 82| 32| 26| 29| 27| 27| 28| 2| 1| 1| .| .| .| .| .| |5900 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |59000 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 1| 1| .| .| |59000Z: CHRONIC PYELONEPHRITIS WITHOUT LESION OF RENAL MEDUL| 696| 52| 8| 4| 6| 12| 11| 46| 148| 145| 158| 103| 3| .| .| .| |59001 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 2| .| .| .| |59001Z: PYELONEPHRITIS, CHRONIC WITH LESION OF RENAL MEDULLA| 466| 28| 4| 3| 2| 5| 6| 35| 115| 109| 100| 58| 1| .| .| .| |5900A : Chronic pyelonephritis, reflux nephropathy | 1,948| 87| 12| 19| 13| 23| 19| 18| 21| 25| 33| 128| 455| 489| 447| 159| |5900Z : CHRONIC PYELONEPHRITIS | 3,033| 1,249| 307| 279| 254| 263| 283| 243| 55| 47| 34| 18| 1| .| .| .| |59080Z: PYELONEPHRITIS, UNSPECIFIED / NECROSIS, RENAL (GANGR| 5,587| 4,569| 167| 199| 180| 170| 174| 108| 14| 3| 2| 1| .| .| .| .| |5908Z : ***UNRECONCILABLE CODE*** | 2| 1| .| .| .| .| .| .| .| 1| .| .| .| .| .| .| |5909A : Nephropathy caused by other agents | 1,161| 13| 3| 3| 3| 5| .| 4| 3| 3| 5| 21| 286| 322| 346| 144| |5909Z : INFECTIONS OF KIDNEY | 131| 30| 9| 10| 4| 11| 11| 7| 11| 12| 17| 9| .| .| .| .| |591 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |5910Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |5919Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| |591Z : HYDRONEPHROSIS | 447| 93| 26| 29| 30| 26| 36| 39| 48| 55| 42| 23| .| .| .| .| |5920 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 1| 1| .| .| |5920C : Nephrolithiasis | 654| 23| 6| 14| 7| 13| 8| 10| 4| 8| 11| 34| 149| 168| 136| 63| |5920Z : CALCULI (RENAL) / NEPHROLITHIASIS / STAGHORN CALCULU| 877| 191| 62| 54| 52| 65| 84| 67| 90| 92| 75| 45| .| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |5929B : Urolithiasis | 115| 1| 1| .| .| 1| 2| 1| 1| 1| .| 1| 22| 38| 35| 11| |5929Z : URINARY CALCULUS, UNSPECIFIED | 23| 3| 3| 1| 1| 3| 1| 4| 2| 2| 3| .| .| .| .| .| |5937Z : ***UNRECONCILABLE CODE*** | 3| 2| .| .| 1| .| .| .| .| .| .| .| .| .| .| .| |59381 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 1| 1| .| .| |59381B: Renal artery occlusion | 1,964| 16| 14| 11| 10| 12| 8| 12| 20| 29| 33| 211| 434| 484| 496| 174| |59381E: Cholesterol emboli, renal emboli | 2,609| .| 1| .| .| .| .| 4| 5| 5| 3| 7| 581| 781| 906| 316| |59381Z: THROMBOSIS RENAL ARTERY / KIDNEY ARTERY EMBOLISM / O| 2,207| 126| 77| 88| 105| 90| 113| 153| 328| 405| 412| 307| 3| .| .| .| |59389 : ***UNRECONCILABLE CODE*** | 10| .| .| .| .| .| .| .| .| .| .| .| 8| 2| .| .| |59389A: Other renal disorders | 2,977| 226| 55| 68| 98| 90| 51| 29| 16| 19| 18| 38| 556| 644| 797| 272| |59389Z: OBSTRUCTIVE KIDNEY / OBSTRUCTIVE NEPHROPATHY | 1,339| 57| 10| 14| 23| 89| 160| 186| 222| 216| 201| 158| 3| .| .| .| |5938A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| |5990 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 1| 2| .| .| |5990Z : URINARY TRACT INFECTION, SITE NOT SPECIFIED | 1,614| 30| 2| 6| 11| 15| 19| 101| 378| 430| 354| 263| 5| .| .| .| |5996 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| 1| 1| .| .| |5996A : Acquired obstuctive uropathy | 3,779| 234| 54| 61| 63| 66| 61| 43| 40| 59| 85| 357| 723| 816| 788| 329| |5996C : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |5996Z : URINARY OBSTRUCTION, UNSPECIFIED / OBSTRUCTIVE UROPA| 858| 55| 4| 4| 7| 12| 11| 63| 170| 195| 200| 136| 1| .| .| .| |599Z : OBSTRUCTIVE UROPATHY, ACQUIRED / URINARY OBSTRUCTION| 4,603| 2,115| 447| 443| 426| 398| 400| 310| 43| 7| 4| 10| .| .| .| .| |600Z : HYPERPLASIA OF PROSTATE | 12| 1| 2| 1| 2| 1| 1| 2| 1| 1| .| .| .| .| .| .| |64620A: Post partum renal failure | 72| 7| .| .| .| 1| 1| 1| .| 4| 6| 8| 11| 11| 15| 7| |64620Z: RENAL FAILURE (IN PREGNANCY, CHILDBIRTH, PUERPERIUM)| 31| 1| 1| .| .| 2| 2| 2| 7| 3| 5| 8| .| .| .| .| |6462Z : RENAL FAILURE (IN PREGNANCY, CHILDBIRTH, PUERPERIUM)| 47| 18| 4| 7| 3| 5| 8| 2| .| .| .| .| .| .| .| .| |6954Z : LUPUS ERYTHEMATOSUS | 476| 116| 23| 21| 25| 32| 46| 45| 47| 58| 45| 18| .| .| .| .| |7100 : ***UNRECONCILABLE CODE*** | 16| .| .| .| .| .| .| .| .| .| .| .| 5| 10| 1| .| |71000Z: ***UNRECONCILABLE CODE*** | 1| .| .| 1| .| .| .| .| .| .| .| .| .| .| .| .| |7100E : Lupus erythematosus, (SLE nephritis) | 4,407| 168| 44| 68| 83| 89| 71| 96| 93| 91| 151| 442| 863| 908| 883| 357| |7100Z : SYSTEMIC LUPUS ERYTHEMATOSUS / LUPUS NEPHRITIS | 5,737| 966| 361| 380| 412| 434| 510| 519| 567| 597| 591| 390| 10| .| .| .| |7101 : ***UNRECONCILABLE CODE*** | 5| .| .| .| .| .| .| .| .| .| .| .| 3| 2| .| .| |71010Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| |7101B : Scleroderma | 746| 40| 12| 8| 7| 11| 10| 8| 4| 9| 20| 71| 157| 173| 158| 58| |7101Z : SCLERODERMA | 1,476| 513| 101| 82| 86| 86| 100| 98| 102| 131| 96| 78| 3| .| .| .| |7140Z : RHEUMATOID ARTHRITIS | 58| 11| 5| 4| 2| 3| 5| 3| 9| 7| 7| 2| .| .| .| .| |72889Z: RAMBDOMYOLYSIS | 101| 1| .| .| .| .| 1| 5| 22| 26| 30| 16| .| .| .| .| |73513Z: ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| |7530 : ***UNRECONCILABLE CODE*** | 6| .| .| .| .| .| .| .| .| .| .| .| 4| 2| .| .| |7530A : ***UNRECONCILABLE CODE*** | 4| .| .| .| .| .| .| .| .| 1| .| 1| 1| 1| .| .| |7530B : Renal hypoplasia, dysplasia, oligonephronia | 939| 108| 21| 23| 28| 35| 34| 26| 28| 33| 39| 77| 138| 169| 144| 36| |7530Z : HYPOPLASIA KIDNEY DISEASE / SOLITARY KIDNEY | 595| 171| 42| 34| 33| 32| 60| 39| 62| 43| 49| 26| 4| .| .| .| |7531 : ***UNRECONCILABLE CODE*** | 22| .| .| .| .| .| .| .| .| .| .| .| 13| 9| .| .| |75313 : ***UNRECONCILABLE CODE*** | 23| .| .| .| .| .| .| .| .| .| .| .| 11| 12| .| .| |75313A: Polycystic kidneys, adult type (dominant) | 9,129| 682| 141| 180| 186| 179| 126| 165| 150| 197| 299| 831| 1,831| 1,750| 1,722| 690| |75313Z: ***UNRECONCILABLE CODE*** | 264| 51| 2| 4| 7| 17| 13| 21| 22| 19| 69| 23| 16| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |75314A: Polycystic, infantile (recessive) | 145| 6| .| 1| .| 2| 2| 1| 2| 2| 1| .| 27| 41| 39| 21| |75316A: Medullary cystic disease, including nephronophthisis| 171| 9| .| 7| 2| .| .| 1| 4| 1| 1| 6| 43| 48| 34| 15| |7531A : ***UNRECONCILABLE CODE*** | 21| 10| .| .| 1| .| 2| .| .| .| 4| 2| 2| .| .| .| |7531B : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |7531Z : CYSTIC KIDNEY DISEASE / MEDULLARY CYSTIC, MULTICYSTI| 19,071| 7,325| 1,012| 1,065| 1,081| 1,094| 1,175| 1,291| 1,362| 1,419| 1,272| 943| 28| 4| .| .| |7532 : ***UNRECONCILABLE CODE*** | 7| .| .| .| .| .| .| .| .| .| .| .| 5| 2| .| .| |7532A : Congenital obstructive uropathy | 1,210| 137| 10| 11| 22| 24| 21| 29| 22| 25| 47| 132| 241| 223| 209| 57| |7532Z : OBSTRUCTIVE DEFECTS OF RENAL PELVIS AND URETER | 306| 62| 16| 15| 23| 10| 17| 29| 35| 49| 30| 13| 7| .| .| .| |7533A : Congenital nephrotic syndrome | 159| 8| .| .| 1| 1| .| .| 1| .| 2| .| 41| 44| 43| 18| |7533Z : CALCULI RENAL, CONGENITAL / OBSTRUCTIVE UROPATHY, CO| 1,152| 720| 70| 46| 65| 67| 83| 59| 14| 13| 8| 7| .| .| .| .| |7535Z : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| 1| .| .| .| .| .| .| .| .| .| |7536A : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| .| |7539 : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| .| .| .| 2| .| .| |7539Z : DYSPLASIA (ANOMALY) OF KIDNEY | 782| 181| 67| 55| 63| 58| 64| 67| 81| 58| 55| 29| 4| .| .| .| |753Z : CONGENITAL ANOMALIES OF URINARY SYSTEM / RENAL AGENE| 336| 124| 34| 37| 38| 28| 38| 35| 2| .| .| .| .| .| .| .| |7564Z : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |7567 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| .| |7567A : Prune belly syndrome | 92| 5| 2| 1| .| 1| 1| 1| 1| .| .| 2| 24| 26| 24| 4| |7567Z : ***UNRECONCILABLE CODE*** | 5| .| .| .| .| .| .| .| .| .| 1| 3| 1| .| .| .| |7595A : Tuberous sclerosis | 118| 1| .| .| .| .| 2| 1| 1| 4| 3| 10| 26| 29| 24| 17| |7595Z : TUBEROUS SCLEROSIS | 91| 1| .| .| .| 1| .| 6| 16| 34| 20| 13| .| .| .| .| |7598 : ***UNRECONCILABLE CODE*** | 5| .| .| .| .| .| .| .| .| .| .| .| 2| 3| .| .| |7598A : Hereditary nephritis, Alports syndrome | 740| 80| 15| 16| 18| 16| 9| 20| 15| 19| 22| 58| 121| 142| 126| 63| |7598B : Hereditary/familial nephropathy | 194| 3| .| .| 2| 1| .| .| .| .| 1| 1| 59| 67| 45| 15| |7598Z : ALPORTS SYNDROME | 1,020| 320| 47| 57| 55| 75| 89| 68| 91| 79| 78| 60| 1| .| .| .| |77777Z: ***UNRECONCILABLE CODE*** | 3| .| .| .| .| 1| 1| 1| .| .| .| .| .| .| .| .| |7999 : ***UNRECONCILABLE CODE*** | 56| .| .| .| .| .| .| .| .| .| .| .| 31| 23| 2| .| |7999A : Etiology uncertain | 15,336| 1,226| 233| 311| 376| 403| 241| 237| 244| 333| 512| 1,427| 2,654| 2,979| 2,949| 1,211| |7999Z : CAUSE UNKNOWN | 24,687| 8,735| 1,141| 1,274| 1,507| 1,570| 1,583| 1,731| 2,000| 2,214| 1,783| 1,131| 17| 1| .| .| |8660A : Traumatic or surgical loss of kidney(s) | 293| 6| .| .| .| .| 1| .| .| 1| 2| .| 68| 107| 70| 38| |8660Z : ***UNRECONCILABLE CODE*** | 2| .| .| .| .| .| .| .| .| .| 2| .| .| .| .| .| |88888 : ***UNRECONCILABLE CODE*** | 3| .| .| .| .| .| .| .| .| .| .| .| 2| 1| .| .| |88888Z: DIAGNOSIS NOT ON CODING LIST | 29| 1| .| .| .| .| .| 2| 1| 3| 7| 11| 4| .| .| .| |8999Z : CAUSE UNKNOWN [CODE IN ERROR--ASSUMED TO BE 7999] | 3,773| 3,773| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |935Z : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |9654Z : AROMATIC ANALGESICS, PHENACETIN (ACETOPHENETIDIN) | 459| 450| .| .| 2| .| 1| .| 2| 2| 2| .| .| .| .| .| |9659A : Analgesic abuse | 663| 33| 3| 3| 6| 2| 2| 2| 2| 4| 3| 22| 148| 179| 182| 72| |9659Z : ANALGESIC ABUSE (SPECIFY) | 372| 129| 29| 27| 32| 25| 29| 21| 22| 27| 23| 8| .| .| .| .| |9778Z : RHABDOMYOLYSIS (X-RAY DYE REACTION) | 84| 1| .| .| .| .| .| 6| 21| 21| 19| 16| .| .| .| .| |9828 : ***UNRECONCILABLE CODE*** | 1| .| .| .| .| .| .| .| .| .| .| .| .| 1| .| .| |9828Z : ETHYLENE GLYCOL INGESTION | 34| 1| .| 2| 1| 1| 2| 5| 7| 7| 6| 2| .| .| .| .| |9849A : Lead nephropathy | 61| .| .| .| .| .| .| .| .| .| 1| 2| 14| 17| 19| 8| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- (CONTINUED) Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.36 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Detailed Disease Code and Year of First ESRD Service ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |99680A: Complication post bone marrow or other transplant | 306| 51| 4| 5| 7| 5| 8| 5| 1| 2| 7| 3| 41| 63| 79| 25| |99680Z: ***UNRECONCILABLE CODE*** | 4| .| .| 1| 1| 1| .| 1| .| .| .| .| .| .| .| .| |99681Z: REJECTION, TRANSPLANT, KIDNEY | 708| 470| 80| 63| 37| 24| 23| 6| 2| .| 3| .| .| .| .| .| |9968A : ***UNRECONCILABLE CODE*** | 1| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |9968Z : REJECTION, TRANSPLANT | 306| 277| 12| 7| 9| 1| .| .| .| .| .| .| .| .| .| .| |99985Z: ***UNRECONCILABLE CODE*** | 9| 9| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |99999Z: CAUSE UNKNOWN | 1,558| 1,106| 93| 80| 125| 57| 7| 24| 14| 18| 25| 8| 1| .| .| .| |OTHER : ***UNRECONCILABLE CODE*** | 88| 40| 1| 2| 1| 4| 2| 6| 8| 4| 10| 4| 4| 2| .| .| |RNS : ***UNRECONCILABLE CODE*** | 15| 6| 2| .| 3| 1| .| 2| 1| .| .| .| .| .| .| .| |UNK : ***UNRECONCILABLE CODE*** | 58| 14| .| 6| 2| 9| 9| 14| 2| 1| .| 1| .| .| .| .| |UUUUUZ: ***UNRECONCILABLE CODE*** | 413| 413| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |UZ : ***UNRECONCILABLE CODE*** | 204| 204| .| .| .| .| .| .| .| .| .| .| .| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.37 Primary Disease Causing ESRD: New ESRD Patients by Disease Group, Detailed Disease Code, and Year of First ESRD Service Using 8-Group Classification Used in Most ADR Tables Primary Disease Group 1: Diabetes ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |ALL |299,300| 30,284| 8,255| 9,526| 10,660| 12,040| 14,684| 16,533| 19,016| 21,234| 21,673| 26,135| 29,662| 32,251| 33,727| 13,620| |25000A: Type II, adult-onset type or unspecified type diabet|106,543| 2,389| 891| 1,052| 1,194| 972| 704| 732| 857| 1,045| 1,730| 6,713| 21,665| 26,222| 28,552| 11,825| |25000Z: DIABETES, ADULT / DIABETES TYPE II / NIDDM | 29,971| 339| 126| 228| 681| 2,929| 3,685| 4,254| 4,648| 4,742| 4,809| 3,368| 162| .| .| .| |25001A: Type I, juvenile type, ketosis prone diabetes | 31,683| 239| 106| 134| 198| 685| 551| 613| 669| 978| 1,432| 5,466| 7,615| 6,027| 5,175| 1,795| |25001Z: JUVENILE ONSET DIABETES MELLITUS / DIABETES TYPE I /| 23,457| 456| 185| 229| 464| 1,759| 2,422| 3,109| 3,441| 3,916| 4,169| 3,134| 172| 1| .| .| |2500Z : DIABETES | 15,933| 7,290| 2,690| 2,979| 2,924| 47| 1| .| 2| .| .| .| .| .| .| .| |2501Z : DIABETES (CODE NOT IN HCFA LISTS). | 79| 79| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |25040Z: DIABETES WITH RENAL MANIFESTATIONS TYPE II | 32,265| 215| 86| 143| 660| 3,267| 4,044| 4,085| 5,153| 5,705| 4,961| 3,928| 17| 1| .| .| |25041Z: DIABETES WITH RENAL MANIFESTATIONS TYPE I | 27,451| 261| 84| 115| 444| 2,312| 3,275| 3,739| 4,246| 4,848| 4,570| 3,526| 31| .| .| .| |2504Z : DIABETES WITH RENAL MANIFESTATIONS | 31,918| 19,016| 4,087| 4,646| 4,095| 69| 2| 1| .| .| 2| .| .| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Primary Disease Group 2: Hypertension ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |ALL |235,816| 34,078| 7,722| 8,381| 9,632| 10,886| 12,877| 14,138| 15,735| 17,685| 17,486| 20,468| 18,856| 19,473| 20,255| 8,144| |4010Z : MALIGNANT HYPERTENSION | 1,643| 491| 101| 118| 98| 116| 122| 134| 124| 132| 108| 99| .| .| .| .| |4011Z : BENIGN HYPERTENSION | 88| 5| 3| 4| 3| 5| 6| 10| 8| 26| 9| 9| .| .| .| .| |4019Z : ESSENTIAL HYPERTENSION, UNSPECIFIED | 49,623| 5,863| 2,454| 2,671| 3,228| 3,474| 4,142| 4,850| 5,632| 6,231| 6,191| 4,857| 30| .| .| .| |401Z : ESSENTIAL HYPERTENSION | 13,264| 13,264| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4030Z : NEPHROSCLEROSIS, MALIGNANT / HYPERTENSIVE RENAL DISE| 1,378| 178| 120| 114| 133| 90| 81| 66| 102| 134| 183| 176| 1| .| .| .| |4031Z : NEPHROSCLEROSIS, BENIGN / HYPERTENSIVE RENAL DISEASE| 848| 87| 31| 35| 46| 65| 57| 55| 92| 129| 131| 119| 1| .| .| .| |4039D : Renal disease due to hypertension (no primary renal | 81,413| 3,179| 903| 1,050| 1,176| 1,418| 1,029| 1,093| 992| 1,369| 2,143| 8,360| 16,675| 17,141| 17,693| 7,192| |4039Z : NEPHROSCLEROSIS / HYPERTENSIVE RENAL DISEASE / OTHER| 69,883| 7,975| 3,845| 4,144| 4,649| 5,355| 6,970| 7,359| 7,859| 8,508| 7,494| 5,505| 217| 2| 1| .| |403Z : HYPERTENSIVE RENAL DISEASE | 2,243| 2,242| 1| .| .| .| .| .| .| .| .| .| .| .| .| .| |4040Z : HYPERTENSIVE HEART AND RENAL DISEASE, MALIGNANT | 147| 15| 19| 5| 9| 11| 11| 9| 12| 20| 21| 15| .| .| .| .| |4041Z : HYPERTENSIVE HEART AND RENAL DISEASE, BENIGN | 60| 6| 2| 2| 1| 7| 3| 4| 6| 12| 7| 10| .| .| .| .| |4049Z : CARDIORENAL SYNDROME / HYPERTENSIVE HEART AND RENAL | 1,540| 204| 51| 40| 56| 121| 170| 139| 169| 224| 192| 174| .| .| .| .| |404Z : HYPERTENSIVE HEART AND RENAL DISEASE | 308| 308| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4401A : Renal artery stenosis | 4,166| 21| 25| 18| 18| 20| 21| 29| 36| 48| 64| 267| 913| 1,065| 1,159| 462| |4401Z : STENOSIS, RENAL ARTERY | 2,432| 98| 75| 81| 100| 102| 144| 221| 350| 413| 495| 352| 1| .| .| .| |59381B: Renal artery occlusion | 1,964| 16| 14| 11| 10| 12| 8| 12| 20| 29| 33| 211| 434| 484| 496| 174| |59381E: Cholesterol emboli, renal emboli | 2,609| .| 1| .| .| .| .| 4| 5| 5| 3| 7| 581| 781| 906| 316| |59381Z: THROMBOSIS RENAL ARTERY / KIDNEY ARTERY EMBOLISM / O| 2,207| 126| 77| 88| 105| 90| 113| 153| 328| 405| 412| 307| 3| .| .| .| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Detailed primary disease codes ending in Z are from the pre-1995 version of the Medical Evidence Form (HCFA-2728). Other codes are from the current (1995) version. ***UNRECONCILABLE CODE*** indicates a code that is not in the list of codes used for either version of the Form. Diseases are grouped in two ways: Table A.37 shows the eight categories used in most tables and graphics in the text and Reference Tables of the ADR. Tables A.38-A.39 use the two levels of disease groups used only in Reference Tables A.15-A.22. Table A.37 (Continued) Primary Disease Causing ESRD: New ESRD Patients by Disease Group, Detailed Disease Code, and Year of First ESRD Service Using 8-Group Classification Used in Most ADR Tables Primary Disease Group 3: Glomeruloneph. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |Detailed Primary Disease | | Year of First ESRD Service | | | |-----------------------------------------------------------------------------------------------------------------------| | | ALL |.<1985 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | |------------------------------------------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------| |ALL |116,404| 31,145| 4,601| 4,748| 5,098| 5,479| 5,962| 6,187| 6,254| 6,485| 6,526| 7,430| 7,920| 8,079| 7,508| 2,982| |4431Z : BUERGERS (BERGERS) DISEASE | 376| 30| 37| 21| 34| 53| 54| 50| 27| 26| 28| 16| .| .| .| .| |44629Z: *** CODE IN ERROR: ASSUMED TO BE 4462. | 15| 15| .| .| .| .| .| .| .| .| .| .| .| .| .| .| |4462Z : ANTI-GLOMERULOBASEMENT MEMBRANE GLOMER. / GOODPASTUR| 2,154| 973| 75| 106| 132| 129| 163| 138| 124| 119| 116| 78| 1| .| .| .| |5800C : Post infectious GN, SBE | 293| 20| 2| 3| 9| 4| 5| 3| 2| 3| 5| 19| 62| 65| 62| 29| |5800Z : GLOMERULONEPHRITIS, ACUTE | 222| 40| 9| 11| 17| 18| 30| 25| 14| 13| 26| 19| .| .| .| .| |5804B : Rapidly progressive GN | 1,509| 77| 24| 28| 14| 24| 27| 25| 22| 25| 36| 119| 291| 377| 295| 125| |5804Z : GLOMERULONEPHRITIS, ACUTE WITH LESION OF RAPIDLY PRO| 1,945| 368| 150| 150| 129| 151| 162| 183| 172| 148| 176| 128| 28| .| .| .| |5809Z : ACUTE GLOMERULONEPHRITIS WITH UNSPECIFIED PATHOLOGIC| 272| 66| 19| 16| 17| 20| 19| 21| 25| 24| 30| 15| .| .| .| .| |5811Z : FOCAL GLOMERULONEPHRITIS / FOCAL GLOMERULOSCLEROSIS | 2,173| 398| 115| 113| 130| 190| 224| 208| 224| 217| 193| 150| 10| 1| .| .| |5818Z : FOCAL GLOMERULOSCLEROSIS WITH NEPHROTIC SYNDROME | 121| 4| 1| 1| 1| .| 1| 7| 17| 26| 33| 28| 2| .| .| .| |5819Z : NEPHROTIC SYNDROME / NEPHROSIS | 2,294| 418| 123| 124| 152| 159| 175| 247| 246| 262| 210| 171| 6| 1| .| .| |5820A : Other proliferative GN | 1,328| 53| 10| 9| 19| 18| 15| 22| 28| 37| 45| 222| 271| 249| 238| 92| |5820Z : ***UNRECONCILABLE CODE*** | 20| 2| .| .| .| 1| 1| 1| 4| 1| 6| 1| 3| .| .| .| |5821A : Focal glomerulosclerosis, focal sclerosing GN | 7,554| 221| 56| 59| 66| 101| 98| 117| 103| 123| 172| 526| 1,653| 1,831| 1,710| 718| |5821Z : FOCAL GLOMERULOSCLEROSIS | 4,553| 625| 227| 241| 302| 330| 389| 403| 477| 574| 592| 383| 9| 1| .| .| |5829A : Glomerulonephritis (GN) | 23,307| 2,534| 443| 479| 509| 575| 502| 491| 417| 515| 795| 2,401| 4,330| 4,059| 3,806| 1,451| |5829Z : CHRONIC GLOMERULONEPHRITIS, INCLUDING WITH UNSPECIFI| 26,375| 6,426| 1,613| 1,667| 1,760| 1,894| 1,997| 2,209| 2,374| 2,431| 2,246| 1,717| 40| 1| .| .| |5830Z : PROLIFERATIVE GLOMERULONEPHRITIS / RADIATION NEPHRIT| 636| 171| 37| 37| 43| 48| 48| 67| 59| 49| 45| 31| 1| .| .| .| |5831A : Membranous nephropathy | 1,738| 70| 27| 20| 21| 32| 25| 29| 19| 45| 36| 129| 346| 397| 395| 147| |5831Z : MEMBRANOUS GLOMERULONEPHRITIS | 2,374| 505| 123| 163| 188| 157| 206| 193| 229| 205| 243| 157| 5| .| .| .| |5832A : Membranoproliferative GN type 1, diffuse MPGN | 1,474| 90| 25| 26| 20| 31| 26| 34| 36| 29| 51| 113| 255| 335| 280| 123| |5832C : Dense deposit disease, MPGN type 2 | 99| 2| .| .| .| .| 2| .| 1| 1| 2| 1| 23| 26| 25| 16| |5832Z : MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS / MESANGIOC| 1,941| 515| 135| 134| 115| 133| 150| 161| 161| 168| 164| 101| 4| .| .| .| |5834C : Goodpastures Syndrome | 416| 6|